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 STriatal Enrich Protein Phosphatase (STEP) is a brain specific protein tyrosine phosphatase, 
which is only expressed in the central nervous system (CNS). STEP has two major isoforms, 
including STEP46 and STEP61 and membrane-bound STEP61 is implicated in multiple neurologic 
disorders. For example, the level of STEP61 is elevated in animal disease models and postmortem 
samples of Alzheimer’s disease and Schizophrenia, whereas its activity is reduced in brain 
ischemia and Huntington’s diseases.  
 STEP61 regulates Hebbian forms of synaptic plasticity, which has been considered as a 
mechanism by which the information is encoded and stored at the synapse. STEP61 is involved in 
the internalization of the N-methyl-D-aspartate receptors (NMDARs) and the α-amino-hydroxy-
5-methyl-4-isoxazolepropinoic acid receptors (AMPARs) via dephosphorylating Tyr1472 of 
GluN2B subunit in NMDAR and 3 Tyr (Tyr869, Tyr873, and Tyr876) of GluA2 subunit in AMPAR.  
Despite extensive studies on the role of STEP61 in activity-dependent synaptic plasticity, including 
long-term synaptic potentiation and depression, it was unknown whether STEP contributes to 
homeostatic synaptic plasticity, a compensatory mechanism by which neurons adjust their synaptic 
strength within a normal range in response to chronic activity challenge. In addition, whether STEP 
regulates somatic intrinsic properties of hippocampal pyramidal neurons has to be addressed. This 
dissertation is focused on finding novel roles of STEP in homeostatic adjustment of synaptic 
strength and neuronal intrinsic properties in the hippocampus.  
 The first chapter of this work describes background information about keywords related to 
research topics written in this dissertation. In the second chapter, I describe the results on the 
involvement of STEP in homeostatic synaptic plasticity using in vitro primary hippocampal 
cultured neurons. In the third and fourth chapter, I describe the alteration of STEP expression and 
activity and the elevation of amyloid-β following an electroconvulsive seizure (ECS) and Kainic-
acid (KA) induced status epilepticus (SE) accompanied by network hyper-excitability. The fifth 
chapter provides a novel evidence into STEP regulates neuronal intrinsic properties in the 
hippocampal neurons. In the part of appendix, I describe subcellular fractionation technique using 
hippocampi from rats which underwent ECS, and molecular and electrophysiological verification 
of chemical long-term potentiation (cLTP). Taken together, the findings in this dissertation suggest 
that STEP plays crucial roles in mediating homeostatic responses at the excitatory synapses and 
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In this dissertation, I describe activity-dependent regulation of STEP and its novel roles in 
homeostatic synaptic plasticity, which provides limits to Hebbian synaptic plasticity. Despite the 
extensive studies on the roles of STEP in controlling excitatory synaptic transmission during 
Hebbian synaptic plasticity, its role in regulating intrinsic excitability is unknown. This 
dissertation therefore includes my studies on the novel roles of STEP in controlling seizure 
propensity and neuronal intrinsic properties through HCN channels. Previous studies implicate 
STEP in Alzheimer’s Disease (AD) in which pathologic accumulation of amyloid-β (Aβ) is one 
key hallmark of this disease. I will also present the novel roles of STEP in controlling Aβ levels 
upon seizures.  
This introduction will therefore provide background information regarding key proteins in 
this dissertation including STEP, Aβ, and HCN channels. It will also provide background 
information on Hebbian and homeostatic synaptic plasticity as well as epilepsy. At the end of this 
introduction, I will summarize the background. 
 
STriatal Enriched Protein phosphatase (STEP) 
STriatal Enriched Protein phosphatase (STEP) is a brain-specific tyrosine phosphatase, 
which is highly expressed within the striatum, the cortex, hippocampus, and amygdala (Bult, Zhao 
et al., 1996, Pulido, Zuniga et al., 1998). STEP has multiple splice variants, implicated in several 
neuropsychiatric disorders. Among 4 isoforms including STEP20, STEP38, STEP46, and STEP61, 
only STEP46 and STEP61 have an active phosphatase domain with a catalytic site and a kinase-
interacting motif (KIM) domain (Bult et al., 1996; Pulido et al., 1998), necessary for binding to all 
substrates. Throughout rodent development, both STEP46 and STEP61 are differentially expressed 
and their expression pattern and colocalization with certain proteins are varied (Bult, Zhao et al., 
1997, Bult et al., 1996). STEP61 has two polyproline (PP) domains that interact with Fyn and two 
transmembrane (TM) domains that target STEP61 to the postsynaptic density, extrasyanptic sties, 
and the endoplasmic reticulum, whereas STEP46 contains only one (Ser
49) within the KIM domain, 
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both of which plays a role in regulating their activity (Sharma, Zhao et al., 1995). In particular, 
STEP61 has two serine (Ser) phosphorylation sites (Ser
49 and Ser221) and their phosphorylation at 
serine residues site sterically inhibits STEP from associating with all of its substrates (Paul, Nairn 
et al., 2003). For instance, pharmacological stimulation of N-methyl-D-aspartate receptor 
(NMDARs) dephosphorylates tyrosine (Gombos, Spiller et al.) residues of STEP, resulting in the 
activation of STEP via a calcineurin/PP1 pathway (Valjent, Pascoli et al., 2005). In contrast, 
stimulation of dopamine D1 receptors (D1Rs) or blockade of dopamine D2 receptors (D2Rs) 
activates PKA, a cyclic adenosine monophosphate (Campion, Dumanchin et al.)-dependent 
protein kinase A (Kim, Lee et al., 2008, Valjent et al., 2005), which in turn dephosphorylates and 
thereby prevents STEP from interacting with their substrates. Synaptic NMDAR stimulation 
activates multiple kinases which relate to phosphorylation of STEP61 and recruit the ubiquitin 
proteasome system to dendritic spines, eventually resulting in the degradation of STEP61 (Kurup, 
Zhang et al., 2010b). In addition, extrasynaptic NMDAR stimulation triggers calpain-mediated 
proteolysis of STEP61 and thereby produces a truncated cleavage product, STEP33 which is not 
able to bind to and dephosphorylate its substrates (Braithwaite, Adkisson et al., 2006, Paul & 
Connor, 2010, Poddar, Deb et al., 2010).  
Substrates of STEP include the GluN2B subunit of the NMDAR and the GluA2 subunit of 
the α-amino-hydroxy-5-methyl-4-isoxazolepropinoic acid receptor (AMPAR), both of which are 
crucial ionotropic glutamate receptors implicated in synaptic plasticity (Paul & Connor, 2010, 
Pelkey, Askalan et al., 2002, Poddar et al., 2010) and STEP dephosphorylation of GluN2B and 
GluA2 subunits gives rise to internalization of NMDARs and AMPARs from the synaptic 
membrane (Zhang, Venkitaramani et al., 2008) (Figure 1). To be specific, STEP Knockout (STEP 
KO) mice display elevated level of GluN1/GluN2B receptors at synaptosomal fraction, facilitating 
excitatory post-synaptic currents mediated by AMPARs and NMDARs (Venkitaramani, Moura et 
al., 2011, Zhang, Kurup et al., 2010). Primary hippocampal cultures neurons from STEP KO mice 
show increased surface expression of AMPARs and do not undergo DHPG (S-3,5-
dihydroxyphenylglyince)-induced AMPAR internalization (Zhang et al., 2008). In addition, STEP 
dephosphorylates regulatory tyrosine residues of Fyn and Pyk2 kinases, the mitogen-activated 
protein kinases (MAPKs), extracellular-regulated kinase 1/2 (ERK1/2), and p38 which are 
responsible for synaptic strengthening (Francis, Koveal et al., 2014, Munoz, Tarrega et al., 2003). 
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Taken together, STEP is currently believed to contribute to the process of hebbian plasticity, 
including LTP and LTD via regulating the function and localization of NMDARs and AMPARs. 
   
Figure 1. Regulation of STEP phosphorylation. Active STEP dephosphorylates regulatory 
tyrosines within STEP substrates. STEP dephosphorylation of Fyn, Pyk2, ERK1/2, and p38 leads 
to their inactivation. STEP dephosphorylation of GluN2B and GluA2 subunits results in 
internalization of NMDARs and AMPARs from synaptosomal surface membranes. Adapted from 
Jang SS et al., 2015.  
 
STEP dampens synaptic strength through the coordinated dephosphorylation of diverse 
substrates which determine synaptic strength (Francis et al., 2014, Munoz et al., 2003, Paul et al., 
2003, Pelkey et al., 2002, Poddar et al., 2010), which has been reported to be implicated in the 
pathophysiology of neuropsychiatric disorders, including Alzheimer’s disease (AD), 
Schizophrenia, Fragile X Syndrome (FXS), Hungtion’s disease, and Temporal Lobe Epilepsy 
(TLE). The level of STEP61 is elevated in postmortem samples of Alzheimer’s disease and 
Schizophrenia (Carty, Xu et al., 2012, Kurup, Zhang et al., 2010a, Lau & Zukin, 2007, Xu, 
Chatterjee et al., 2014), while its activity is reduced in brain ischemia and Hungtington’s diseases 
(Gladding, Sepers et al., 2012, Saavedra, Giralt et al., 2011). In particular, pilocarpine-induced 
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status epilepticus associated with the development of temporal lobe epilepsy leads to elevation of 
STEP61 (Choi, Lin et al., 2007). Recently, TC-2153 known as an inhibitor of STEP has been 
utilized for understating the roles of STEP in neurocognitive diseases. Intraperitoneal injection of 
TC-2153 reverses biochemical abnormalities at the synapse and behavioral deficits in AD mouse 
model (Xu et al., 2014). 
 
Amyloid-β 
Alzheimer’s disease (AD) is the most common neurodegenerative disorder , which is 
accompanied by a progressive impairment of cognitive function, Depression, Apathy, Psychosis, 
and Epilepsy (Burns & Iliffe, 2009, Querfurth & LaFerla, 2010). AD is characterized by 
histological changes, including amyloid plaques composed of amyloid-β (Aβ) aggregates and 
intracellular neurofibrillary tangles (NFTs) composed to tau aggregates, the loss of neurons and 
synapses, and widespread Lewy body in the hippocampus, cortex, and other regions in the brain 
(Querfurth & LaFerla, 2010). Of particular, abnormal accumulation of Aβ peptides and 
intracellular neurofibrillary tangles (NFTs) are observed in the brain regions (Goedert et al, 1991), 
including the hippocampus and medial temporal lobe responsible for crucial for memory function. 
Amyloid-β is a peptide of 40-42 amino acids, the main component of amyloid-plaques 
observed in the brain of AD patients (Holsinger et al., 2002, Qiu et al, 2006). Aβ peptide derives 
from the amyloid-precursor protein (APP) by proteolytic cleavage of APP at plasma membrane 
(Flood et al., 2002, McConlogue et al., 2007).  In neuronal cells, APP is initially cleaved by integral 
membrane proteases α-secretase or β-secretase, followed by γ-secretases (De Strooper, Saftig et 
al., 1998, Vassar, Bennett et al., 1999). While β-secretase produces two kinds of Aβ peptides such 
as 40 resides (Aβ40) and 42 residues (Aβ42) in length defined “amyloidogenic pathway” (De 
Strooper et al, 1998; Vassar et al, 1999), α-secretase cleaves the peptide within Aβ region and fails 
to generate Aβ peptides defined “non-amyloidogenic pathway (Chow et al., 2010). 
Aβ is produced as a monomer and forms complexes as aggregates ranging from dimer and 
trimer to protofibrils and fibrils (Jankowsky et al, 2004). Accumulated Aβ42 inside neurons leads 
to neurotoxic effects including cell apoptosis (Passer et al., 2000) and accumulation of Aβ 
oligomeric state within cell body blocks proteasome system (Fu et al., 2011), directly promoting 
the expression of tau protein. Conversely, inhibition of proteasome increases the amount of Aβ, 
indicating that the degradation of Aβ operates in proteasome-dependent pathways (Fu et al., 2011). 
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Post-translational process of APP and nitration at tyrosine 10 of Aβ are associated with Aβ 
aggregation (Guivernau et al., 2016), inhibiting LTP in acute hippocampal slice. In addition, 
phosphorylation and glycosylation of Aβ42 regulate the formation of Aβ aggregates, affecting the 
impairment of learning and memory function in the brain (Walter et al., 2000). 
The pathological relevance of Aβ in AD has been reported through the experiments using 
synthetic, purified, and naturally secreted Aβ into primary neuronal culture, hippocampal culture, 
hippocampal slices, and in vivo brain (Kuo et al., 1996, Mucke et al., 2000, Naslund et al., 2000, 
Snyder et al., 2005, Moolman et al., 2004, Spires et at., 2005, Walsh et al., 2002, Cleary et al., 
2005). Soluble Aβ oligomers at nanomolar to low micromolar concentration could cause synaptic 
dysfunctions (Spires et al., 2005, Walsh et al., 2002, Snyder et al., 2005), including inhibition of 
LTP (Snyder et al., 2005, Walsh et al., 2002) and loss of dendritic spines at excitatory synapse 
(Moolman et al., 2004, Spires et al., 2005). Taken together, it would be important not only to 
understand how the amount and states of Aβ are regulated, but to investigate the downstream 
pathways of Aβ related with synaptic dysfunction as well.  
 
Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels (HCNs) 
  Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are transmembrane 
proteins, which are non-selective cation channels comprised of four either identical or non-
identical subunits (Ludwig, Zong et al., 1998). Each subunit consists of six membrane-spanning 
(S1-S6) domains and an ion-conducting pore loop between S5 and S6, containing the glycine-
tyrosine-glycine (GYG) motif as the selectivity filter for K+ (Doyle et al., 1998). The C-terminus 
of HCN channels contains a cyclic nucleotide-binding domain (CNBD) composed of ~120 amino 
acids and 80-amino acid-long C-linker region, which is an important modulatory domain for 
surface expression of HCN channels (Zagotta, Olivier et al., 2003). The currents produced by HCN 
channels are called “Ih” which are characterized by four major hallmark properties: [i] channel 
activation by membrane hyperpolarization (Macri et al., 2004), [ii] facilitation of channel 
activation by direct interaction with cAMP (Bobker et al., 1989), [iii] permeability for Na+ and K+ 
(DiFrancesco et al., 1986), [iv] a specific pharmacological profile including Cs+ sensitivity 
(Ludwig et al., 1998).  
HCN channels are regulated by interacting proteins and low molecular factors existing in 
the cytosol and the extracellular space (Frace, Maruoka et al., 1992, Gamper & Shapiro, 2007, 
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Munsch & Pape, 1999, Stevens, Seifert et al., 2001, Wu & Cohen, 1997, Zong, Eckert et al., 2005). 
The functional properties and surface expression of HCN channels are modulated as follows; (1) 
acidic lipids such as phosphatidylinositol 4,5-bisphosphate (PIP2) facilitate channel activation by 
relieving an inhibition of channel opening, acting as an allosteric activator as well as involving the 
fine tuning of subthreshold properties of excitable cells (Frace, Maruoka et al., 1992, Gamper & 
Shapiro, 2007). (2) Intracellular protons slow down the speed of channel opening and induce the 
shift of the voltage dependence of channel activation to more hyperpolarized potentials (Munsch 
& Pape, 1999, Stevens, Seifert et al., 2001). Acidic or alkaline pH leads to the shift in the midpoint 
potential of HCN2 activation to more hyperpolarized or depolarized potentials, respectively. (3) 
Chloride ion, a small anion has an influence on the conductance of Ih currents, which is markedly 
pronounced for HCN2 and HCN4 subunits. A single amino acid residue in the pore region plays a 
role as molecular determinant of extracellular Cl- sensitivity, suppressing the instantaneous 
component of Ih currents (Frace et al., 1992, Wahl-Schott, Baumann et al., 2005). (4) Tyrosine 
phosphorylation regulates the surface expression and kinetics of HCN channels via tyrosine 
kinases of the Src family and the receptor-like protein tyrosine phosphatase-alpha (RPTP-alpha). 
Src binds to the C-linker-CNBD and phosphorylates the channel at this domain, accelerating the 
activation of the channel (Wu & Cohen, 1997, Zong, Eckert et al., 2005). In contrast, RPTP-alpha-
mediated dephosphorylation of HCN2 reduces the surface expression of HCN2 channel and the 
amplitude of HCN2 currents upon a time-dependent manner (Huang et al., 2008). (5) the 
serine/threonine kinase, p38-mitogen-activated protein (MAP) kinase shifts the voltage-dependent 
activation towards more positive potentials, affecting temporal summation and neuronal 
excitability (Poolos, Bullis et al., 2006). (6) Marcomoleular protein complexes interacting with 
HCNs involve the fine regulation of electrophysiological properties in HCNs (Santoro, Wainger 
et al., 2004). For example, a brain-specific protein termed TRIP8 (TPR-containing Rab8b 
interacting protein) colocalizes with HCN1 in dendrites of cortical and hippocampal pyramidal 
neurons, negatively regulating the expression of HCNs in the plasma membrane (Santoro, Wainger 
et al., 2004).  
 Ih currents have unique biophysical features and control excitability and electrical 
responsiveness of the membrane (Day et al., 2005, Doan et al., 1999, Ludwig et al., 2003, Nolan 
et al., 2007). At voltages near resting membrane potential (RMP), HCNs are constitutively open 
and allow a depolarizing noninactivating inward currents (Doan et al., 1999, Day et al., 2005), 
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which in turn sets the membrane potential to more depolarized voltages (Doan et al., 1999, Ludwig 
et al., 2003). Ih currents via HCNs lower the membrane resistance (Rm), stabilizing RMP by 
attenuating the amplitude of excitatory postsynaptic potentials (EPSPs) and slowing down its 
kinetics (Day et al., 2005, Doan et al., 1999). At pre-synaptic terminal, activation of Ih currents 
contributes to LTP generation in hippocampal mossy fiber synapses by modulating the release 
machinery with the cytoskeleton (Beaumont, Zhong et al., 2002, Beaumont & Zucker, 2000).  
Dys-regulation of HCN expression is likely to contribute to the pathogenesis of human 
diseases, including epilepsies, neuropathic pain, and cardiac arrhythmias (McCormick et al., 2001, 
Campbell et al., 2006, Armoundas et al., 2001). In a rat model of childhood febrile seizure, Ih 
currents are enhanced in hippocampal CA1 neurons, which is coupled to an elevated probability 
of rebound depolarizations and APs (Brewster et al., 2002). In particular, HCN2-deficient mice 
display bilaterally synchronous SWDs in the EEG, accompanied by the increased burst activity 
and network oscillations (Ludwig, Budde et al., 2003). In Kainic acid-induced temporal lobe 
epilepsy (TLE), Ih is down-regulated in Layer III pyramidal neurons of the entorhinal cortex (EC), 
elevating intrinsic excitability and thereby giving rise to profound synchronous network activity 
(Shah, Anderson et al., 2004).  
 
Hebbian Synaptic Plasticity  
 Since the first observation on long-term synaptic potentiation in the hippocampi of rabbit 
in 1973, long-term elevation of post-synaptic responsiveness has been considered as the underlying 
mechanism of learning and memory, termed “Hebbian plasticity” (Bliss & Lomo, 1973, Hebb, 
1949). This form of plastic changes at post-synapse are widely observed in a variety of regions, 
including hippocampus, cortex, and cerebellum, which are mediated via an association of 
correlated firing of both neurons (Bi et al., 2001, Collingridge et al., 2010, Andersen et al., 1977, 
Lee et al., 2009, Lisman, 2017). A high frequency stimulation (HFS) at perforant pathway induces 
stronger and long-lasting excitatory postsynaptic potentials (EPSPs) of pyramidal neurons at the 
dentate gyrus in hippocampus (Bliss & Lomo, 1973). This LTP phenomenon is mainly triggered 
by the activation of N-Methyl-D-aspartic acid receptor (NMDAR) and α-amino-3-hydroxy-5-
methyl-isoxazolepropionic acid receptor (AMPAR), which are two major ionotropic glutamate 
receptors at excitatory synapse.  
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LTP is classified into two phases; (1) early LTP (E-LTP) and late LTP (L-LTP), in 
accordance with the duration following LTP induction (Luscher et al., 2012, Bliss et al., 1993). 
The induction of LTP, during an early stage, is dependent on NMDAR activation (Luscher et al., 
2012, Davies et al., 1981, Bliss et al., 1993, Bliss et al., 201). A long and high frequency 
stimulation (HFS) - induced Ca2+ influx activates Ca2+-mediated protein kinases such as 
Ca2+/calmodulin-dependent protein kinase II (CaMKII) and protein kinase C (PKC) highly 
enriched at the postsynaptic density zone (PSD), leading to the phosphorylation of AMPAR 
(Malinow et al., 1989; Kleschevnikov, 2001). Consequently, phosphorylation of AMPAR permits 
them to be inserted into the postsynaptic membrane and thereby increases the surface expression 
of AMPAR at postsynaptic site (Malinow et al., 1989; Kleschevnikov et al, 2001). The 
maintenance period of LTP, called late-LTP (L-LTP), requires gene transcription and protein 
synthesis in post-synaptic neuron (Malenka et al., 1994; Pettit et al., 1994; Bozdagi et al., 2000; 
Lu et al, 2001; Jurado et al, 2013). During L-LTP, a lot of transcription factors such as cAMP 
response element-binding protein (CREB) are dynamically altered, contributing to the 
maintenance of LTP (Pettit et al., 1994; Bozdagi et al., 2000; Lu et al, 2001). Following LTP 
induction, global transcription of genes that encode regulatory proteins and protein kinases are 
initiated, of particular, modulating the phosphorylation status and synaptic accumulation of 
AMPAR at dendritic spine (Malinow et al., 1989; Malenka et al., 1994; Bozdagi et al., 2000; Lu 
et al., 2001).  
Contrary to LTP, activity-dependent long-term depression (LTD) in the efficacy of 
synapses is observed in a variety of brain regions such as hippocampus, striatum, and visual cortex 
(Lisberger et al., 1998, Huang et al, 2012, Malenka et al, 1994, Gladding et al., 2009). Of particular, 
cerebellar LTD involves motor learning and memory (Lisberger et al., 1998). Following a 
simultaneous stimulation of a climbing fiber and a parallel fiber, LTD at synapse between parallel 
fiber and Purkinje cells (PCs) is observed, which is mediated by the phosphorylation and 
endocytosis of AMPAR anchoring at the postsynaptic membrane of PCs (Lisberger et al, 1998, 
Huang et al, 2012). In hippocampus, LTD at a Shaffer collateral-CA1 synapse is determined by 
the frequency and timing of Ca2+ influx following a low frequency stimulation (about 1 Hz) 
(Malenka et al, 1994). A small and slow rise Ca2+ selectively activates phosphatases and thereby 
induces the internalization of AMPAR via clathrin-mediated pathway (Malenka et al, 1994; 
Gladding et al., 2009).  
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Homeostatic synaptic plasticity  
Homeostatic synaptic plasticity refers to the ability of neurons to adjust their synaptic 
strength within a normal state in response to chronic activation/inactivation of neural network 
(Turrigiano et al., 2008, Pozo et al., 2010). Such an adaptive phenomenon at synapses is called 
“synaptic scaling”, which occurs over the timescale of days (Turrigiano et al., 1998, Achiron et al., 
1998, Thiagarajan et al., 2005). Synaptic scaling plays a role in tuning the synaptic strength at a 
relatively constant rate, in turn, preventing excessive elevation or depression of network activity 
(Ibata et al., 2008, Turrigiano et al., 2004). During synaptic scaling, neurons sense their action 
potential firing in Ca2+-dependent manner and thereby change post-synaptic strength to maintain 
network activity within a normal range (Ibata et al., 2008, Thiagarajan et al., 2005). There are two 
possible mechanisms that have been suggested to date; (1) the adjustment of synaptic strength at 
post-synapse (Figure 2) and (2) the regulation of NT release from pre-synapse (Branco et al., 2008, 
De Gois et al., 2005, Murthy et al., 2001). Similar to the mechanisms that underlie Hebbian 
plasticity such as LTP and LTD, synaptic scaling is mediated by dynamic changes of molecules 
that involve the regulation in the surface expression of AMPARs and their removal from active 
sites at post-synapse (Sun et al., 2008, Wierenga et al., 2005, Ju et al, 2004). Under the conditions 
in which network activity is elevated or dampened, the changes of intracellular Ca2+ lead to the 
activation of calcium-dependent kinases and/or phosphatases such as CaMKII and Calcineurin, 
which in turn trigger AMPAR trafficking at post-synaptic site (Thiagarajan et al., 2002; Arendt et 
al., 2015).  
In hippocampal cultures, chronic inactivity in neurons results in up-regulation of mEPSC 
amplitude, the quantal size, and the release of vesicle that contains glutamate which is mediated 
via CaMKII and CaMKIV signaling pathway (Thiagarajan et al., 2002; Bleier et al., 2017). This 
strongly indicates that CaMKs is essential for synaptic up-scaling against prolonged blockade of 
neuronal activity. In organotypic hippocampal culture, elevated activity by PTX, a GABAa blocker, 
activates Ca2+ dependent polo-like kinase 2 (Plk2) through the phosphorylation of cyclin-
dependent kinase 5 (Cdk5), contributing to down-regulation of synaptic strength (Seeburg et al., 
2008; Seeburg et al., 2008). During synaptic down-scaling, protein phosphatases such as 
calcineurin and protein phosphatase-1(PP1) are elevated and thereby lead to the compositional 





Figure 2. Postsynaptic expression mechanisms in Homeostatic Synaptic Plasticity. In normal 
synapses, chronic activity blockade leads to synaptic scaling expressed by a compensatory increase 
in synaptic AMPAR density and currents, whereas chronic activity elevation leads to synaptic 
downscaling expressed by a compensatory decrease in synaptic AMPAR density and current.  
 
The interplay between Hebbian and homeostatic synaptic plasticity  
Hebbian plasticity is associated with rapid changes of synaptic strength in response to 
associative inputs, operating via a positive feedback mechanism (Abbott et al., 2000, Miller et al., 
1996). Once LTP is induced, potentiated synapses undergo further potentiation, allowing synapses 
to be susceptible to the following stimulation. Such a successive potentiation causes the synapses 
to be unstable state and run-away excitation at synapse (Turrigiano et al., 2008). In a similar way, 
following the induction of LTD, synaptic depression would be accumulated over the time and then 
eventually would become pathological (Turrigiano et al., 2008). To prevent unnecessary run-away 
excitation or depression, homeostatic synaptic plasticity operates via a negative feedback 
mechanism by returning saturated synaptic strength to a normal state (Turrigiano et al., 2008). 
Compared to fast and local specific responses at the post-synapses detected during Hebbian 
plasticity, synaptic scaling broadly occurs over the time range of days (Ibata et al., 2008, Sutton et 
al., 2006). Such a local interplay of Hebbian plasticity and homeostatic alterations between a LTP-
expressing synapse and the neighboring synapses is crucial for stabilizing the overall synaptic 
 
11 
strength by redistributing the weight of selective inputs at synapses (Hou et al., 2008, Sutton et al., 
2006). For example, a synapse undergoing LTP is accompanied by weaker synapses and thinner 
spines that correlate with the reduction of glutamate receptors (Hobbiss et al., 2018). In addition, 
motor learning promotes the incidence of multiple-synapse boutons and thereby elicits local 
dendritic excitation at two distinct spines in dendrites of Purkinje cells (Federmeier et al., 2002). 
Taken together, both Hebbian and homeostatic synaptic plasticity at individual synapse are thought 
to be necessary for storing the information at synapse and preventing synapses from run-away 
responses following specific inputs that contain a variety of environmental stimuli. 
 
Epilepsy  
Epilepsy is a chronic disease characterized by recurrent epileptic seizures indicative of 
neuronal hyper-excitability, accompanied by progressive hippocampal sclerosis and cognitive 
decline (Chang et al., 2003). The common type of epilepsy is temporal lobe epilepsy (TLE), which 
arises from the mesial temporal lobes of the brain including the hippocampus and amygdala (Fisher 
et al., 2014).  
Among several types of seizures, status epilepticus (SE) is defined as a continuous seizure 
that lasts longer than 5 minutes or 2 or more seizures within a five-minute without returning to a 
normal level of consciousness between episodes (Delgado-Escueta et al., 1983, DeLorenzo et al., 
1992). The main cause of SE is an infection with a fever, stroke, and physical insults, which results 
in a significant loss of inhibitory neurons containing GABA in the hilar regions of the hippocampus 
(Rao et al., 2006), consequently leading to recurrent seizures. Experimental models have been 
developed that can mimic the continuous seizure state or SE (Reddy et al., 2013, Mello et al., 1996, 
Gorter et at., 2001). The common pharmacological models of SE are kainic acid and pilocarpine, 
which have been used to investigate the transition of a single episode of SE into chronic epilepsy. 
 In addition, Electroconvulsive seizure (ECS) is an experimental animal model that induces 
neuronal hyper-excitability and causing transient seizures with very low mortality (Jang et al., 
2017). In ECS models, electrical stimulation can be delivered to rodents via stereotaxically 
implanted electrodes or ear electrodes to evoke generalized tonic-clonic seizures (Jang et al., 2017). 
An ECS induction method in rats elicits global stimulation of neuronal activity in their hippocampi. 
Compared to chemoconvulsants such as pilocarpine and kainic acid that induce status 
epilepticus (SE) and chronic manifestation of spontaneous recurrent seizures, acute and chronic 
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ECS are not related to epileptogenesis due to the fact that they do not induce the generation of 
chronic epilepsy whereas they promote adult neurogenesis in the hippocampi and reorganize the 
neural network (Segi-Nishida et al., 2008; Inta et al, 2013). Therefore, ECS has been useful to 
study how elevation of brain activity affects the expression and functions of synaptic proteins in 
vivo, which contribute to persistent alterations in synaptic structures and strength. 
 
Summarized introduction 
Since STEP was first identified as a brain-specific and non-receptor-type tyrosine 
phosphatase in 1991 (Lombroso et al., 1991), accumulating evidence has demonstrated that STEP 
serves as a negative regulator for controlling synaptic strength via dephosphorylating tyrosine 
residues of its substrates, including GluN2B subunit of NMDAR and GluA2 subunit of AMPAR 
(Paul & Connor, 2010; Pelkey, Askalan et al., 2002; Poddar et al., 2010). In the hippocampus, an 
increase of STEP in postsynaptic neurons prevents the induction of LTP at Schaffer Collateral 
CA1 synapses (Abbott & Nelson, 2000), indicating that STEP involves Hebbian synaptic plasticity. 
In addition, it has been discovered that STEP expression and activity are altered in several kinds 
of neurological diseases, including epilepsy, Alzheimer’s disease, and Schizophrenia (Carty et al., 
2012, Kurup et al., 2010a, Lau & Zukin, 2007, Xu et al., 2014).  
Under the pathological condition, disruption of STEP activity leads to immediate-early 
gene expression and a significant rescue from cell death following pilocarpine-induced status 
epilepticus (SE) (Choi et al., 2007). Pharmacological inhibition of STEP recovers cognitive 
deficits in AD (Xu et al., 2014), implying that STEP61 serves as a key regulator of Aβ-induced 
synaptic weakening. Despite an importance of STEP in modulating activity-dependent synaptic 
plasticity and neuronal cell survival, it has remained unknown whether STEP regulates neuronal 
intrinsic properties under the normal physiological condition and homeostatic synaptic adjustment 
against prolonged activity challenge.  
In this dissertation, I address the alterations of STEP in response to chronic alterations of 
hippocampal network activity and novel roles of STEP in homeostatic synaptic plasticity using in 
vitro and in vivo experimental systems. In addition, I provide the evidence that STEP regulates 
seizure propensity, activity-dependent Aβ level, the intrinsic excitability of hippocampal 
pyramidal neurons, and the expression and function of HCN channels.  
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 Sustained changes in network activity cause homeostatic synaptic plasticity in part by 
altering the postsynaptic accumulation of N-methyl-D-aspartate receptors (NMDAR) and α-
amino-3-hydroxyle-5-methyl-4-isoxazolepropionic acid receptors (AMPAR), which are primary 
mediators of excitatory synaptic transmission. A key trafficking modulator of NMDAR and 
AMPAR is STriatal-Enriched protein tyrosine Phosphatase (STEP61) that opposes synaptic 
strengthening through dephosphorylation of NMDAR subunit GluN2B and AMPAR subunit 
GluA2. However, the role of STEP61 in homeostatic synaptic plasticity is unknown. Findings: We 
demonstrate here that prolonged activity blockade leads to synaptic scaling, and a concurrent 
decrease in STEP61 level and activity in rat dissociated hippocampal cultured neurons. Consistent 
with STEP61 reduction, prolonged activity blockade enhances the tyrosine phosphorylation of 
GluN2B and GluA2 whereas increasing STEP61 activity blocks this regulation and synaptic scaling. 
Conversely, prolonged activity enhancement increases STEP61 level and activity, and reduces the 
tyrosine phosphorylation and level of GluN2B as well as GluA2 expression in a STEP61–dependent 
manner. Conclusions: Given that STEP61-mediated dephosphorylation of GluN2B and GluA2 
leads to their internalization, our results collectively suggest that activity-dependent regulation of 
STEP61 and its substrates GluN2B and GluA2 may contribute to homeostatic stabilization of 
excitatory synapses.  
 
BACKGROUND 
In response to sustained changes in neuronal activity, homeostatic synaptic plasticity 
maintains synaptic strength and flexibility within physiological limit. This plasticity is expressed 
in part by dynamic changes in the postsynaptic levels of NMDARs and AMPARs that mediate 
excitatory synaptic transmission (Turrigiano, 2012). A key trafficking modulator of both NMDAR 
and AMPAR is STEP61, a protein tyrosine (Gombos et al.) phosphatase in the central nervous 
system that has two main alternatively spliced forms, the cytosolic STEP46 and the membrane-
associated STEP61 (Goebel-Goody & Lombroso, 2012). Tightly associated with the postsynaptic 
density, STEP61 regulates the Tyr phosphorylation and surface density of NMDARs and AMPARs 
(Kurup et al., 2010b, Snyder, Nong et al., 2005, Zhang et al., 2010, Zhang et al., 2008). This 
regulation contributes to Hebbian long-term potentiation (Pelkey et al., 2002, Zhang et al., 2010) 
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and several neuropsychiatric disorders most notably Alzheimer's disease [4] and Fragile X-
syndrome (Goebel-Goody & Lombroso, 2012).  
We have previously identified mRNA transcripts whose expressions are regulated by 
prolonged activity perturbation (Lee, Royston et al., 2015) due to a critical role of transcription in 
homeostatic synaptic plasticity (Goold & Nicoll, 2010, Ibata, Sun et al., 2008). Of these activity-
regulated transcripts, we identified PTPN5 that encodes STEP (Lee et al., 2015). The present study 
investigated whether STEP61 contributes to homeostatic synaptic plasticity. 
 
MATERIALS AND METHODS 
Hippocampal neuronal culture 
The Institutional Animal Care and Use Committee at the University of Illinois Urbana-
Champaign approved all experimental procedures involving animals. Primary dissociated 
hippocampal cultures were prepared from Sprague-Dawley rat embryos at embryonic day 18 and 
plated at high density (330 cells/mm2) as described (Lee et al., 2015). At 10-13 days in vitro, 
neurons were treated for 24-48 h with vehicle control (0.1% dH2O), TTX (1 μM), and BC (20 μM) 
(all Tocris).  
Electrophysiology  
Whole-cell patch-clamp recordings of mEPSCs (>150 events per neuron) were performed 
at 23-25°C from pyramidal neurons held at -60 mV in external solution containing 1 μM TTX and 
20 μM BC as described (Diering, Gustina et al., 2014, Shin, Zhang et al., 2012) using a Multiclamp 
700B amplifier, Digidata1440A, and the pClamp 10.2 (Molecular Devices). Signals were acquired 
3 min after making the whole-cell configuration, filtered at 1 kHz, and sampled at 10 kHz on gap 
free mode (5 min). The mEPSCs were detected with a 10 pA thresholds and analyzed by Mini 
Analysis (Synaptosoft).  
QPCR 
The QPCR was performed with the StepOnePlus real-time PCR system (Applied Biosystems) 
using total RNA (1-2 μg) as described (Lee et al., 2015). The forward and reverse primer sequences 
for PTPN5 were 5’-GGAGTCAGCCCATGAATACC-3’ and 5’-
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CAGACGTACCCTGCTGTGAG-3’ respectively. The primer sequences for GAPDH has been 
previously described (Lee et al., 2015). Following normalization to control GAPDH cDNA levels, 
the fold change of PTPN5 cDNA levels for each treatment compared to control was determined.  
Immunoblot Analysis 
Neuronal lysate samples were prepared in RIPA buffer supplemented with protease 
inhibitors and Tyr phosphatase inhibitors (1 mM NaVO3, 10 mM Na4O7P2, and 50 mM NaF) as 
described (Lee et al., 2015) and were subjected to immunoblot analysis with primary antibodies 
against STEP61 (Santa Cruz), STEP61-pS
221((Paul et al., 2003)), GluN2B and GluA2 (Millipore), 
GluN2B-pY1472 (PhosphoSolutions), GluA2-p3Y and GAPDH (Cell Signaling). Densitometric 
quantification following normalization to GAPDH was performed with ImageJ software (National 
Institutes of Health).  
Immunocytochemistry 
Permeabilized immunostaining were performed with anti-myc antibodies (Thermo-
Scientific) as described (Diering et al., 2014, Shin et al., 2012). Fluorescence images of the neurons 
were acquired using the same exposure time and analyzed with ImageJ to compare their 
background-subtracted fluorescence intensities. 
Statistical Analyses 
Using Origin 9.1 (Origin Lab), the Student’s t test and one-way ANOVA with Tukey’s and 
Fisher’s multiple comparison tests were performed to identify the statistically significant 
difference with a priori value (p) < 0.05 between 2 groups and for >3 groups, respectively.  
 
RESULTS AND DISCUSSION 
Prolonged alterations of hippocampal network activity regulate STEP61 level and activity. 
Prolonged blockade of network activity for 48 hours (h) with the sodium channel blocker 
tetrodotoxin (TTX) induced synaptic scaling in dissociated hippocampal cultured neurons as 
demonstrated previously (Shepherd, Rumbaugh et al., 2006, Shin et al., 2012) (Figure 3A-D), and 
reduced STEP61 mRNA and protein expression compared to CTL treatment (Figure 3E, F). 
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Conversely, prolonged activity enhancement for 48 h using the GABAA receptor antagonist 
bicuculline (BC) increased STEP61 protein level (Figure 3G), but did not alter its mRNA level and 
the miniature excitatory postsynaptic current (mEPSC) (Figure 3A-E). 
 To test whether prolonged TTX or BC treatment affects STEP61 activity, we examined the 
phosphorylation of STEP61 at Ser
221 within its kinase-interactive motif domain, which prevents 
STEP61 interaction with all known substrates (Figure 4A) (Paul et al., 2003). TTX treatment for 
36-48 h enhanced Ser221–phosphorylation of STEP61, indicating decreased STEP61 activity (Figure 
2B, D). In contrast, 36-48 h BC treatment reduced Ser221–phosphorylation, indicating increased 
STEP61 activity (Figure 4C, D).  
Prolonged alterations of hippocampal network activity regulate Tyr-phosphorylation of 
GluN2B and GluA2 in a STEP61-dependent manner.  
STEP61 dephosphorylates the NMDAR subunit GluN2B at Tyr
1472 (Kurup et al., 2010b, 
Snyder et al., 2005) and reduces Tyr-phosphorylation of the AMPAR subunit GluA2 following 
group 1 metabotropic glutamate receptor (mGluR) stimulation (Zhang et al., 2008). Although the 
specific Tyr residues on GluA2 regulated by STEP61 are unknown, the GluA2 phosphorylation 
state at Tyr869, Tyr873, and Tyr876 (3Tyr) regulates AMPAR trafficking (Hayashi & Huganir, 2004). 
To determine if the TTX- or BC-induced changes in STEP61 alter Tyr-phosphorylation of GluN2B 
and GluA2, we performed immunoblot analyses using specific antibodies to phosphorylated 
Tyr1472 of GluN2B (Snyder et al., 2005) and phosphorylated 3Tyr of GluA2 (Hayashi & Huganir, 
2004) (Figure 3).  Consistent with the TTX-induced decrease in STEP61 level and activity (Figure 
4B, D), prolonged TTX treatment increased the levels of Tyr1472-phosphorylated GluN2B 
(GluN2B-pY1472) and 3Tyr-phopshorylated GluA2 (GluA2-p3Y) compared to CTL treatment 
without affecting their total protein expression (Figure 5A-C). In contrast, BC treatment for 24-48 
h decreased the levels of GluN2B-pY1472 and GluA2-p3Y (Figure 5D-F), concurrently with an 
increase in STEP61 level and activity (Figure 4C, D). Interestingly, total levels of GluN2B and 
GluA2 were reduced by 48 h BC application (Figure 5D, E).   
We next examined if STEP61 mediates the TTX- or BC-induced changes in Tyr-
phosphorylation of GluN2B and GluA2. Transactivator of transcription (TAT) sequence was fused 
to STEP46 and a myc tag (Figure 6A), allowing the TAT fusion proteins to be membrane permeable 
(Additional file 1: Figure S1A, B) (Paul, Olausson et al., 2007). Preincubation for 30 min with 
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active TAT-STEP wild-type (WT) but not control inactive TAT-myc reduced the levels of 
GluN2B-pY1472 and GluA2-p3Y in CTL-treated neurons (Figure 6B, C, Additional file 1: Figure 
S1C) and occluded the TTX-induced increase in GluN2B-pY1472 and GluA2-p3Y levels compared 
to CTL application (Figure 6B, C), suggesting that the increase in Tyr-phosphorylation of GluN2B 
and GluA2 is mediated by the TTX-induced reduction in STEP61.  
In TAT-STEP C/S, a C300S point mutation inactivates STEP46, allowing it to bind 
constitutively to substrates but not to dephosphorylate them (Paul et al., 2003, Paul et al., 2007, 
Xu, Kurup et al., 2009). Consistently, introduction of TAT-STEP C/S in CTL-treated neurons 
significantly increased the levels of GluN2B-pY1472 and GluA2-p3Y compared to TAT-myc 
application (Figure 6D, E, Additional file 1: Figure S1D). Preincubation with TAT-STEP C/S but 
not TAT-myc blocked the BC-induced reduction in the levels of GluN2B-pY1472, total GluN2B, 
and total GluA2 but not GluA2-p3Y (Figure 6D, E). Since specific Tyr residues regulated by 
STEP61 remain unknown, our analyses for GluA2-p3Y may not have revealed the effect of TAT-
STEP C/S if STEP61 causes dephosphorylation of only one Tyr. Nonetheless, these results suggest 
that STEP61 mediates the BC-induced changes in Tyr
1472-phosphorylation of GluN2B and 
abundance of GluN2B and GluA2.  
Enhancement of STEP activity blocks synaptic scaling.  
Dephosphorylation of Tyr1472 within a conserved endocytic motif of GluN2B (Roche, 
Standley et al., 2001) via STEP61 reduces surface NMDAR level (Snyder et al., 2005, Zhang et al., 
2010) by clathrin-mediated internalization (Lavezzari, McCallum et al., 2003). Furthermore, 
AMPAR internalization can be induced by mGluR stimulation through STEP61 (Zhang et al., 2008) 
and by dephosphorylation of GluA2 at 3Tyr (Hayashi & Huganir, 2004). We hypothesized that 
prolonged activity blockade induces synaptic scaling (Figure 3A-D) by inhibiting endocytosis of 
synaptic NMDARs and AMPARs upon STEP61 reduction (Figure 3F, 2B). To test this, we 
enhanced STEP activity by administering TAT-STEP WT for 30 min prior to recording. In the 
presence of TAT-myc, 48 h TTX treatment increased the mEPSC amplitude but not frequency 
compared to CTL application (Figure 7A-D). However, this TTX-induced synaptic scaling was 
abolished by TAT-STEP WT preincubation (Figure 7A-D), indicating that STEP61 reduction 
contributes to synaptic scaling. 
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Interestingly, prolonged activity enhancement increased STEP61 (Figure 3G, 4C) and 
decreased Tyr-phosphorylation of GluN2B and GluA2 (Figure 5D-F, 6D, E) without inducing 
synaptic down-scaling (Figure 5A-D), suggesting that this STEP61 upregulation may cause 
internalization of extrasynaptic GluN2B and GluA2. Indeed, activity-dependent AMPAR 
endocytosis requires GluA2 (Lee, Simonetta et al., 2004) and occurs extrasynaptically (Ashby, De 
La Rue et al., 2004). Similarly, GluN2B-containing NMDARs enriched in extrasynaptic sites 
(Tovar & Westbrook, 1999) undergo robust endocytosis (Lavezzari et al., 2003, Roche et al., 2001). 
The BC-induced STEP61-dependent decrease in GluA2 and GluN2B abundance (Figure 5D, E, 6D, 
E) may provide an additional homeostatic defense to limit membrane depolarization and 
overstimulation of extrasynaptic GluN2B-containing NMDARs, which is shown to cause 
excitotoxicity (Hardingham & Bading, 2010).  
It remains unknown how prolonged activity perturbation regulates STEP61. Previous 
studies have reported that Ser221 of STEP61 is dephosphorylated by calcium-dependent calcineurin 
upon NMDAR activation (Paul et al., 2003) and phosphorylated by protein kinase A (PKA) upon 
stimulation of dopamine D1 receptor (Paul, Snyder et al., 2000). Interestingly, synaptic scaling is 
shown to involve reduced calcium influx to the postsynaptic neuron (Ibata et al., 2008), reduced 
calcineurin activity (Kim & Ziff, 2014), and enhanced PKA activity at excitatory synapses 
(Diering et al., 2014). Hence, prolonged activity blockade could increase Ser221-phosphorylation 
of STEP61 (Figure 4B, D) by reduced calcineurin activity and/or enhanced PKA activity, in 
addition to decreasing STEP61 level by transcriptional down-regulation (Figure 3E, F). Considering 
that a loss of PKA from synapses was found during synaptic downscaling (Diering et al., 2014), 
reduced PKA activity may contribute to the BC-induced decrease in Ser221-phosphorylation of 
STEP61 (Figure 4C, D).  
 
CONCLUSION 
In summary, we demonstrate a bidirectional modulation of STEP61 level and activity by 
prolonged alterations of hippocampal network activity, resulting in correlative changes in Tyr-
phosphorylation of STEP61 substrates, GluN2B and GluA2. We also show that the reduction in 
STEP61 contributes to synaptic scaling. Future studies should test if this regulation alters NMDAR 
and AMPAR surface density during homeostatic plasticity (Figure 7E). Investigating how 
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prolonged activity perturbation regulates STEP61 should provide mechanistic insights into the 
dysregulation of STEP61 expression, which are present in multiple neuropathologies (Goebel-
Goody & Lombroso, 2012).  
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Figure 3. Prolonged alterations of hippocampal network activity induce homeostatic 
synaptic plasticity and regulate STEP61 level. (A-D) Whole-cell patch clamp recording of 
miniature excitatory postsynaptic currents (mEPSCs) from rat dissociated hippocampal neurons 
cultured in high density that were treated for 48 h with vehicle control (CTL, 0.1% H2O), TTX (1 
μM), or BC (20 μM) at 12-14 days in vitro. (A) Representative traces of mEPSCs. (B) Normalized 
cumulative fraction of the mEPSC amplitudes. (C-D) Summary plots of average mEPSC 
amplitudes (C) and frequencies (D) for CTL (n = 19), TTX (n = 20), or BC (n = 16). TTX treatment 
for 48 h induced synaptic scaling whereas 48 h BC treatment had no effect. (E) Microarray (n = 4) 
and QPCR (n = 5) analyses revealed that 48 h application of TTX but not BC reduced the 
expression of PTPN5, which encodes STEP. (F-G) Immunoblot analysis of STEP61 following 48 
h administration of CTL, TTX (F), BC (G) (n = 9 per treatment). Data shown represent the mean 





Figure 4. Prolonged alterations of hippocampal network activity regulate STEP61 activity. 
(A) A schematic depicting the regulation of STEP61 activity by its phosphorylation at Ser
221 within 
its kinase-interactive motif, a binding site for all STEP substrates. (B-D) Immunoblot analysis of 
STEP61 and Ser
221–phosphorylated STEP61 (STEP61-pS
221) in hippocampal cultured neurons 
following CTL, TTX, or BC treatment for 24-48 h (n = 3 per treatment). (B, D) Prolonged TTX 
treatment reduced STEP61 protein level and activity. (C, D) Prolonged BC treatment enhanced 
STEP61 protein level and activity. (D) The relative phosphorylation state of STEP61 as calculated 
by the ratio of STEP61-pS
221 level over total STEP61 level. Data shown represent the mean ± SEM 






Figure 5. Prolonged alterations of hippocampal network activity regulate Tyr-
phosphorylation and levels of GluN2B and GluA2. Immunoblot analysis of hippocampal 
cultured neurons that were treated for 48 h with CTL, 24-48 h TTX, or 24-48 h BC treatment (D-
F) (n = 6 per treatment). Prolonged TTX treatment increased the level of Tyr1472–phosphorylated 
GluN2B (GluN2B-pY1472) (A) and the level of GluA2 that were phosphorylation at Tyr 869, Tyr 
873, and Tyr 876 (3Tyr) (GluA2-p3Y) (B). (D-F) Prolonged BC treatment decreased the levels of 
GluN2B-pY1472 (D) and GluA2-p3Y (E). Total GluN2B and GluA2 levels were reduced at 48 h 
BC application. (C, F) The relative phosphorylation state of GluN2B and GluA2 as calculated by 
the ratio of phosphorylated proteins over total proteins followed by normalization to GAPDH. 







Figure 6. TAT-STEP WT or 
C/S blocks the activity-
induced bidirectional 
changes in GluN2B and 
GluA2. (A) A simplified 
schematic (not to scale) of 
cell-permeable TAT-STEP 
molecular tools. (B-E) 
Immunoblot analysis of 
hippocampal cultured neurons 
that were treated for CTL, 
TTX (B-C), or BC (D-E) for 
24 h and 48 h (n = 8 per 
treatment). Prior to neuronal 
lysate preparation, neurons 
were preincubated for 30 min 
with TAT-myc, TAT-STEP 
WT, or TAT-STEP C/S 
proteins. (B-C) TAT-STEP 
WT blocked the TTX-induced 
increase in Tyr1472–
phosphorylation of GluN2B 
(GluN2B-pY1472) (B) and 
3Tyr-phosphorylation of 
GluA2 (GluA2-p3Y) (C). (D-
E) TAT-STEP C/S blocked the BC-induced reduction in Tyr1472–phosphorylation and level of 
GluN2B (D) as well as GluA2 level but not 3Tyr–phosphorylation of GluA2 (E). Data shown 
represent the mean ± SEM following normalization to CTL values in the presence of TAT-myc 
























Figure 7. TAT-STEP WT blocks homeostatic scaling induced by prolonged inhibition of 
hippocampal network activity. (A-D) Whole-cell patch clamp recording of mEPSCs from 
cultured hippocampal neurons that were treated for 48 h with vehicle control (CTL, 0.1% H2O) 
and TTX (1 μM). Prior to mEPSCs recording, neurons were preincubated for 30 min with TAT-
myc and TAT-STEP WT protein. (A) Representative traces of mEPSCs. (B) Normalized 
cumulative fraction of the mEPSC amplitudes. (C) TAT-STEP WT abolished the TTX-induced 
increase in the mEPSC amplitudes. (D) TAT-STEP WT did not affect the mEPSC frequencies. 
Data shown (C, D) represent the mean ± SEM (*p<0.05). (E) Model by which activity-dependent 
changes in STEP61 level and activity regulate Tyr-dephosphorylation of GluA2 and GluN2B, 
leading to changes in surface AMPAR and NMDAR expression during homeostatic synaptic 
plasticity. Gray arrows indicate internalization. Orange arrows indicate lateral movement of 
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Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive 
cognitive decline. Pathologic accumulation of soluble amyloid β (Aβ) oligomers impairs synaptic 
plasticity and causes epileptic seizures, both of which contribute to cognitive dysfunction in AD. 
However, whether seizures could regulate Aβ-induced synaptic weakening remains unclear. Here 
we show that a single episode of electroconvulsive seizures (ECS) increased protein expression of 
membrane-associated STriatal-Enriched protein tyrosine Phosphatase (STEP61) and decreased 
tyrosine-phosphorylation of its substrates N-methyl D-aspartate receptor (NMDAR) subunit 
GluN2B and extracellular signal regulated kinase 1/2 (ERK1/2) in the rat hippocampus at 2 days 
following a single ECS. Interestingly, a significant decrease in ERK1/2 expression and increase in 
APP and Aβ levels was observed at 3-4 days following a single ECS when STEP61 level returned 
to the baseline. Given that pathologic levels of Aβ increase STEP61 activity and STEP61-mediated 
dephosphorylation of GluN2B and ERK1/2 leads to NMDAR internalization and ERK1/2 
inactivation, we propose that up-regulation of STEP61 and down-regulation of GluN2B and 
ERK1/2 phosphorylation mediate compensatory weakening of synaptic strength in response to 
acute enhancement of hippocampal network activity, whereas delayed decrease in ERK1/2 
expression and increase in APP and Aβ expression may contribute to the maintenance of this 
synaptic weakening.  
 
INTRODUCTION 
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive and 
irreversible cognitive decline (McKhann, Drachman et al., 1984). Although AD pathology shows 
amyloid plaques that consist of insoluble amyloid-β (Aβ) (Kidd, 1964), the abnormal accumulation 
of soluble Aβ oligomeric peptides correlates closely with cognitive dysfunction in early AD and 
disrupts synaptic plasticity (Hsieh, Boehm et al., 2006), which is widely believed to underlie 
learning and memory (Hsieh et al., 2006, Lynch, 2004). Specifically, soluble Aβ oligomers at 
pathologic levels inhibit long-term potentiation (LTP) and enhance long-term depression (LTD) 
of excitatory synaptic strength in the hippocampus, a brain region susceptible for 
neurodegeneration in AD (Hsieh et al., 2006). Interestingly, the pathological accumulation of 
amyloid precursor protein (Simon, de Maturana et al.) and oligomeric Aβ also causes aberrant 
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neuronal hyperexcitability in cortical and hippocampal neuronal networks of AD mouse models 
(Busche, Chen et al., 2012, Jankowsky, Slunt et al., 2005, Lalonde, Fukuchi et al., 2012, Palop & 
Mucke, 2010, Vogt, Thomas et al., 2011), consistent with the fact that humans and animal models 
with early-onset autosomal dominant familial AD have epileptic seizures (Amatniek, Hauser et al., 
2006, Corbett, Leiser et al., 2013, Jayadev, Leverenz et al., 2010, Lalonde, Dumont et al., 2005, 
Larner & Doran, 2006, Minkeviciene, Rheims et al., 2009, Palop, Chin et al., 2007, Sanchez, Zhu 
et al., 2012, Snyder et al., 2005, Verret, Mann et al., 2012, Westmark, Westmark et al., 2008, 
Ziyatdinova, Gurevicius et al., 2011). Experimental inhibition of epileptic seizures prevents 
memory loss in AD transgenic model mice (Sanchez et al., 2012), suggesting that Aβ-induced 
aberrant increases in neuronal network activity also contribute to cognitive dysfunction in AD. 
However, whether seizures could regulate Aβ-induced synaptic weakening remains unclear. 
STriatal-Enriched protein tyrosine Phosphatase 61 (STEP61) has recently emerged as a key 
regulator of Aβ-induced synaptic weakening (Kurup et al., 2010a, Kurup et al., 2010b, Snyder et 
al., 2005, Zhang, Kurup et al., 2011, Zhang et al., 2010, Zhang et al., 2008) and as a post-synaptic 
density protein highly regulated by hyperexcitability in hippocampal neurons (Jang, Royston et al., 
2015). Application of Aβ oligomers to cortical cultures reduces surface expression of glutamate-
gated ionotropic receptors including N-methyl D-aspartate receptors (NMDARs) and α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) by up-regulating STEP61 
activity (Kurup et al., 2010b, Snyder et al., 2005, Zhang et al., 2011, Zhang et al., 2010, Zhang et 
al., 2008). While STEP61 levels are elevated in the cortices of several AD mouse models (Chin, 
Palop et al., 2005, Kurup et al., 2010b), genetic ablation of STEP61 blocks Aβ-induced reduction 
in surface AMPAR and NMDAR expression (Kurup et al., 2010b, Zhang et al., 2010) and prevents 
memory loss and LTP impairment in AD mouse models (Zhang et al., 2011, Zhang et al., 2010), 
suggesting a critical role of STEP61 in mediating Aβ-induced synaptic weakening and cognitive 
dysfunction in AD. We have also reported that prolonged enhancement of hippocampal network 
activity in primary culture leads to elevated STEP61 expression and STEP61–dependent reduction 
in tyrosine (Gombos et al.)-phosphorylation of its substrates, NMDAR subunit GluN2B and 
AMPAR subunit GluA2 (Jang et al., 2015). 
Given that STEP61 level is elevated in human AD which displays epileptic seizures as a 
comorbid condition (Amatniek et al., 2006, Jayadev et al., 2010, Larner & Doran, 2006, Snyder et 
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al., 2005), we hypothesize that hippocampal neuronal hyperexcitability induced by seizures will 
increase STEP61 level, leading to compensatory down-regulation of synaptic strength by 
dephosphorylating GluN2B, GluA2, and ERK1/2, key proteins critical for synaptic plasticity. To 
test this hypothesis, we induced a single electroconvulsive seizure (ECS) or chronic ECS (a single 
ECS each day for 7 consecutive days) in adult rats to elevate hippocampal network activity in vivo 
(Cardoso, Carvalho et al., 2009, Madsen, Newton et al., 2003, Segi-Nishida, Warner-Schmidt et 
al., 2008, Shibley & Smith, 2002) and examined protein expression of STEP61 and Aβ, as well as 
tyrosine-phosphorylation of STEP61 substrates GluN2B, GluA2, and ERK1/2. ECS is an animal 
model for electroconvulsive therapy (ECT), which provides an efficient and relatively fast acting 
treatment for depression, anxiety, and other psychiatric conditions in humans (Duman & Vaidya, 
1998). During ECS, sufficient current administration reliably elicits non-recurring stage 4-5 tonic 
clonic seizures (Cardoso et al., 2009, Madsen et al., 2003, Segi-Nishida et al., 2008, Shibley & 
Smith, 2002). We chose ECS to globally elevate brain activity in vivo because a single ECS does 
not induce cell death or notable structural remodeling (Duman & Vaidya, 1998) which are evident 
in pilocarpine- or kainate-induced chronic epilepsy models (Grone & Baraban, 2015, 
Kandratavicius, Balista et al., 2014). Furthermore, ECS does not involve invasive surgical 
methodologies as often used in kindling following intracranial electrode placement (Grone & 
Baraban, 2015, Kandratavicius et al., 2014). 
We discovered that a single ECS increases the expression of membrane-associated STEP61 
and decreases Tyr1472-phosphorylation of GluN2B and Tyr204/187–phosphorylation of ERK1/2 in 
the hippocampus at 48 hours (h) following a single ECS. Interestingly, up-regulation of APP and 
Aβ levels was observed at 72-96 h following a single ECS when STEP61 level returned to the 
baseline. Chronic ECS results in a transient increase in APP and Aβ expression at 48 h and Aβ 
expression at 96 h following chronic ECS, but did not alter STEP61 expression and Tyr-
phosphorylation of its substrates. Furthermore, a persistent decrease in GluN2B expression was 
observed over a course of 96 h following chronic ECS. These results suggest that elevated 
expression of APP, Aβ, and STEP61 and dephosphorylation of GluN2B and ERK1/2 may 
contribute to compensatory weakening of synaptic strength in response to seizure-induced 




MATERIAL AND METHODS 
Materials  
Antibodies used include: anti-STEP61 (catalogue SC-23892, Santa Cruz), anti-GluN2B 
(#14544, Cell Signaling), anti-ERK1/2 (SC-154, Santa Cruz), anti-GluA2 (#5306, Cell Signaling), 
anti-APP (#SC-28365, Santa Cruz), and anti-β-actin (#4967, Cell Signaling). Phosphorylation site 
specific antibodies used include: anti-GluN2B-pTyr1472 which recognizes phosphorylated Tyr-
1472 of GluN2B (P1516-1472, PhosphoSolutions), anti-ERK1/2-pThr202/Tyr204 which recognizes 
phosphorylated Thr202/Tyr204 of ERK1 and Thr185/Tyr187 of ERK2 (#9106, Cell Signaling), anti-
GluA2-p3Y which recognizes phosphorylated Tyr869, Tyr873, and Tyr876 (3Y) of GluA2 (#3921S, 
Cell Signaling), and anti-GluA2-pY876 which recognizes phosphorylated Tyr876 of GluA2 (#4027S, 
Cell Signaling).   
Animals 
The Institutional Animal Care and Use Committee at the University of Illinois at Urbana-
Champaign approved all experimental procedures involving animals in this study.  
Electroconvulsive seizure (ECS) 
Male Sprague-Dawley rats (bred in house; strain origin: Charles River Laboratories) were 
weaned at postnatal day (P) 28, housed in groups of 2-4 male littermates, and weighed 3 times per 
week. All animals were maintained in standard conditions with a 12 hour (h) light:dark cycle and 
ad libitum access to food and water. Male rats were used to eliminate potential confounding sex 
differences. Rats received either a single ECS or chronic ECS (a single ECS each day for 7 
consecutive days) as previously described (Chen, Eisch et al., 2001a, Chen, Shin et al., 2001b, 
Madsen et al., 2003) with the following modification. All ECS was induced between 7:30 and 
10:00 a.m. in adult rats weighing 200-250 grams. One at a time, rats were connected via ear clip 
electrodes to a pulse generator (Ugo Basile, Comerio, Italy), and a 0.5 sec, 100 pulse/sec, 55 mA 
shock was delivered to elicit a stage 4-5 seizure. All ECS lasted <10 sec, after which, rats were 
returned to their home cage. Sham “No seizure” animals (NS) were handled identically, including 
ear-clip electrodes attachment, but no current was delivered. One experiment for a single ECS or 




Whole brain lysate preparation  
At specific time point following a single ECS or chronic ECS, animals were sacrificed by 
CO2 inhalation and rapidly decapitated. The hippocampi were dissected from their brains and 
homogenized in ice-cold homogenization buffer (solution A) containing (in mM): 320 sucrose, 1 
NaHCO3, 1 MgCl2, 0.5 CaCl2, 1 NaVO3, 10 Na4O7P2, 50 NaF, and Halt protease inhibitors 
(Thermo Fisher Scientific) (1.25 mL total volume per pair of hippocampi). The crude membrane 
fraction (P2) was isolated from the hippocampi homogenates as previously described (Carlin, Grab 
et al., 1980) with the following modification. After centrifuging for 10 min at 1,400g, the 
postnuclear supernatant were separated (S1) from insoluble tissue and nuclear pellet (P1). The 
pellet was reconstituted in an additional of ice-cold solution A (1.25 mL total volume per pair of 
hippocampi) and centrifuged for additional 10 min at 710g. The resultant supernatant was 
combined with the S1 fraction, and the entire volume was then spun at 13,800g for 10 min. The 
supernatant (S2) was removed, and the remaining pellet (P2 membrane fraction) was resuspended 
in ice-cold solution B containing (in mM): 320 sucrose, 1 NaHCO, 1 NaVO3, 10 Na4O7P2, 50 NaF, 
and protease inhibitor cocktails (1 mL total volume per pair of hippocampi). BCA assay (Pierce) 
analysis was performed to determine protein concentrations across samples, which were 
subsequently normalized to 1 mg/ml in solution B. The S1, S2, and P2 lysates were stored at -80°C 
until use.  
Western blot analysis 
After adding SDS sample buffer, the lysates (S1, P2, or S2) were heated at 37°C or 75°C 
for 30 min. Lysate samples were run on SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
gels and transferred to polyvinyl difluoride (PVDF) membrane (Millipore). Each gel contained 
lysates from one experiment for a single ECS or chronic ECS, including from one NS rat and one 
ECS-treated rat per each time point following the last ECS. Immunoblot analysis was performed 
as previously described (Lee et al., 2015, Lee & Chung, 2014) with the following modifications. 
Each blot was blocked in 5% milk and 0.1% Tween-20 in Tris buffered saline (TBS) for 1 h, and 
then incubated in primary antibodies in washing buffer (1% milk and 0.1% Tween-20 in TBS) 
overnight at 4°C. Primary antibodies used include: anti-STEP61 (1:200), anti-GluN2B (1:1000), 
anti-GluA2 (1:1000), anti-APP (1:200), anti-β-actin (1:1000), anti-GluN2B-pTyr1472 (1:1000), 
anti-GluA2-p3Y (1:1000), anti-GluA2-pY876 (1:500), and anti-ERK1/2- pThr202/Tyr204 (1:1000).  
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After incubating in HRP-conjugated secondary antibody in washing buffer for 1 h, blots were 
visualized with enhanced chemifluorescence substrate (ECL, Thermo Fisher Scientific), and 
developed with a Konica SRX-101A film processor. Densitometric quantification was performed 
with ImageJ Software (National Institutes of Health) as previously described (Lee et al., 2015, Lee 
& Chung, 2014). The band intensity of a protein of interest was divided by the β-actin band 
intensity per each time point. The ratio of NS control group was taken as 100%, and the ratio of 
ECS-treated group at each time point was normalized to the ratio of NS control to obtain the % of 
relative protein expression.  
Statistical analysis  
All data shown represent the mean value ± SEM. The number of rats is expressed as sample 
size n. Statistical analyses were performed with either Microsoft Excel or Origin (version 8.5; 
Origin lab). For most data sets, a priori value (*p) < 0.05 was considered statistically significant 
following one way-ANOVA and post-hoc ANOVA tests (Fisher’s test). For Figure 1A, Student 
T-test was used due to low sample size (n = 2 – 3 rats per postnatal day). For the statistical analysis 
of the levels of Tyr204/187-phosphorylated ERK1/2 in Figure 4A and Aβ in Figure 5A, student T-
test was used because one way-ANOVA and post-hoc ANOVA tests (Fisher’s test) were not 
adequate to perform in the data sets that contained a large variability when 5 sets of independent 
experiments for a single ECS were compared. For Student T-test, a priori value (#p)<0.05 was 











RESULTS and DISCUSSION 
A single ECS but not chronic ECS transiently increased STEP61 expression in the 
hippocampus. 
To test whether elevation of hippocampal network activity in vivo regulates STEP61 level, 
ECS was induced in rats and their hippocampal membrane fractions were collected for western 
blot analysis. First, we examined the developmental expression of STEP61 in male rats (Figure 8A). 
Hippocampal STEP61 expression began to increase at P12 compared to P3-P10 (332.8± 16.3% of 
P10, p<0.005, T-test compared to P10) (Figure 8A).  Although highly variable, STEP61 expression 
steadily increased from P12 to P28, and reached a plateau at P42 with statistical significance 
(543.5± 18.0% of P10, p<0.05, T-test compared to P10 and P12) (Figure 8A). Since hippocampal 
STEP61 expression stabilized by P42 (Fig. 1A), ECS were induced only in male rats that were at 
>P42 and weighed 220-240g. For the induction of ECS, male rats received a single electric shock 
(0.5 sec, 100 pulse/sec, 55 mA) for once (a single ECS) or 7 consecutive days (chronic ECS) as 
previously described (Chen et al., 2001b, Madsen et al., 2003) (Figure 8B-C).  “No seizure” 
animals (NS) were handled identically but no current was delivered. STEP61 protein level in the 
crude membrane P2 fractions of hippocampus progressively increased up to 169.9 ± 28.3% by 48 
h following induction of a single ECS compared to NS groups (p<0.01, Figure 8D, Supplemental 
Fig. 1). Interestingly, elevated STEP61 level decreased back to the level of NS group by 72 h post 
a single ECS (Figure 8D). Although an increasing trend has been observed for STEP61 expression 
over the course of 96 h following chronic ECS, this trend did not reach statistical significance due 
to a large standard deviation (Figure 8E). Taken together, these data indicate that a single ECS but 
not chronic ECS caused a transient but significant increase in membrane-associated STEP61 
expression in the hippocampus in vivo.  
A single ECS but not chronic ECS transiently decreased Tyr1472 -phosphorylation of GluN2B 
in the hippocampus.  
Enriched in the postsynaptic density, STEP61 dephosphorylates NMDAR subunit GluN2B 
at Tyr1472, leading to internalization of GluN2B-containing NMDAR (Braithwaite et al., 2006, 
Kurup et al., 2010b, Snyder et al., 2005, Venkitaramani et al., 2011, Zhang et al., 2010, Zhang et 
al., 2008). We hypothesized that a single ECS-induced increase in STEP61 expression would 
decrease Tyr1472 –phosphorylation of GluN2B in the hippocampus. Consistent with our hypothesis, 
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western blot analysis of hippocampal P2 lysates revealed a significant reduction in the level of 
Tyr1472-phosphorylated GluN2B (GluN2B-pY1472) compared to NS group from 48 - 72 h following 
a single ECS, with the most reduction seen at 48 h (Fig. 2A, 27.0 ± 12.7% of NS, p<0.005) when 
STEP61 expression was transiently enhanced (Figure 8D). The level of Tyr
1472-phosphorylated 
GluN2B was returned to the level of NS group by 96 h post a single ECS (Figure 9A) when 
elevated STEP61 level decreased back to the level of NS group (Figure 8D). Total GluN2B 
expression did not change following a single ECS (Figure 9A). Although chronic ECS did not alter 
the level of Tyr1472-phosphorylated GluN2B compared to NS control (Figure 9B), there was a 
modest but significant reduction in total GluN2B expression from 0 h to 24 h and 72 h to 96 h 
following chronic ECS compared to NS control (Figure 9B, 96 h: 63.8 ± 6.7%, p<0.005). These 
data indicate that a single ECS transiently reduced Tyr1472-phosphorylation of GluN2B whereas 
chronic ECS persistently reduced total GluN2B expression in the hippocampus. 
A single ECS but not chronic ECS increased the level of Tyr876–phosphorylated GluA2 in 
the hippocampus. 
 STEP61 reduces Tyr phosphorylation of AMPAR subunit GluA2 and mediates AMPAR 
internalization upon acute stimulation of group 1 metabotropic glutamate receptors (mGluR) and 
application of Aβ (Zhang et al., 2011, Zhang et al., 2008). Although it is unclear which specific 
Tyr residue (s) in GluA2 is directly dephosphorylated by STEP61, AMPAR internalization is 
reported to involve dephosphorylation of Tyr869, Tyr873, and Tyr876 (3Tyr) within the intracellular 
GluA2 C-terminal region (GluA-p3Y) (Hayashi & Huganir, 2004). We therefore hypothesized that 
a single ECS-induced increase in STEP61 expression would decrease the level of 3Tyr-
phosphorylated GluA2 as well as Tyr876-phosphorylated GluA2 in the hippocampus. There was an 
increasing trend for the level of 3Tyr-phosphorylated GluA2 over the course of 96 h following a 
single ECS compared to NS control, although this increase did not reach statistical significance 
due to a large standard deviation (Figure 10A). To our surprise, the level of Tyr876-phosphorylated 
GluA2 was unaltered at 48 h following a single ECS (Figure 10B, 77.8 ± 21.4% of NS, p>0.05) 
when STEP61 expression was significantly increased compared to NS control (Figure 10D). Instead, 
the level of Tyr876-phosphorylated GluA2 was significantly increased by 2-fold at 96 h following 
a single ECS (Figure 3B, 178.6 ± 27.5% of NS, p<0.05) when STEP61 expression was similar to 
that of NS control (Figure 9D). A single ECS had no effect on total GluA2 expression (Figure 
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10C). Chronic ECS did not alter the levels of 3Tyr-phosphorylated GluA2, Tyr876-phosphorylated 
GluA2 and total GluA2 (Figure 10D-F). These data indicate that a single ECS regulates Tyr876-
phosphorylation of GluA2 in the hippocampus. 
A single ECS and chronic ECS differently altered Tyr204/187-phosphorylation of ERK1/2 in 
the hippocampus. 
STEP61-mediated dephosphorylation of ERK1/2 at Tyr
204/187 inactivates ERK1/2, opposing 
synaptic strengthening during LTP (Paul et al., 2003, Venkitaramani, Paul et al., 2009). Thus, we 
next tested whether a single ECS-induced increase in STEP61 expression would decrease Tyr
204/187-
phosphorylatiion of ERK1/2 in the hippocampus. There was an initial increasing trend for the level 
of Tyr204/187-phosphorylated ERK1/2 (ERK-pY204/187) until 24 h following a single ECS (Figure 
11A, p>0.05). At 48 h following a single ECS when STEP61 expression was significantly increased 
(Figure 8D), the level of Tyr204/187-phosphorylated ERK1/2 was markedly reduced to 31.9 ± 10.2% 
of NS (p<0.005, Figure 11A). As STEP61 level reduced to those of NS groups from 48 h to 96 h 
post a single ECS (Figure 8D), the level of Tyr204/187-phosphorylated ERK1/2 also gradually 
increased to the level of NS groups (Figure 11A). Total ERK1/2 expression was significantly 
reduced at 72 h to 96 h following a single ECS (Figure 11A, 72 h:  84.2 ± 6.4% of NS, p<0.05, 96 
h:  81.1 ± 4.0% of NS, p<0.05). Interestingly, chronic ECS caused about a 6-fold increase in the 
level of Tyr204/187-phosphorylated ERK1/2 at 0 h time point compared to NS group (Figure 11B, 0 
h: 580.5 ± 273.6% of NS, p<0.05). However, this initial increase was decreased to the level of NS 
group by 24 h post chronic ECS (Figure 11B, p<0.05 between 0 h and 24 h). There was no change 
in total ERK1/2 expression in the hippocampus following chronic ECS (Figure 11B). Collectively, 
these results show that a single ECS and chronic ECS dynamically modulate Tyr204/187-
phosphorylation of ERK1/2.  
A single ECS and chronic ECS increased the expression of APP and Aβ oligomers in the 
hippocampus. 
 Aβ peptide is derived from the cleavage of the amyloid precursor protein (Simon et al.) by 
β-secretase and γ-secretase at the Golgi and to a lesser extent endoplasmic reticulum (Puzzo & 
Arancio, 2013). Aβ oligomers have been shown to reduce surface expression of NMDARs and 
AMPARs by up-regulating STEP61 activity (Kurup et al., 2010b, Snyder et al., 2005, Zhang et al., 
2011, Zhang et al., 2010, Zhang et al., 2008). Furthermore, an Aβ-mediated disruption of the 
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proteasome leads to increased STEP61 levels in human AD brains and AD mouse models (Kurup 
et al., 2010b, Snyder et al., 2005, Zhang et al., 2011, Zhang et al., 2010). Since Aβ is produced and 
secreted from neurons in response to synaptic activity (Bero, Yan et al., 2011, Cirrito, Yamada et 
al., 2005, Kamenetz, Tomita et al., 2003), we next examined whether ECS could increase the 
production of Aβ peptides by performing western blotting in crude soluble S2 fractions of the 
hippocampus. Upon induction of a single ECS, the level of Aβ oligomers increased by 3-fold 
compared to the NS group at 72 h (Figure 12A, Aβ-72 h: 345.3 ± 75.8%, p<0.05) when STEP61 
level is similar to that of NS group (Figure 8D). APP expression was also increased by 3-fold at 
72-96 h following a single ECS (Figure 12A, APP-72 h: 406.5 ± 83.0%, p<0.005; APP-96 h: 363.6 
± 81.9%, p<0.01). Chronic ECS also caused a 2- to 3-fold increase in the expression of Aβ 
oligomers at 48 h and 96 h (Figure 12B, Aβ-48 h: 235.4 ± 44.7%, p<0.05 Aβ-96 h: 283.5 ± 43.1%, 
p<0.01), and 2-fold increase in the expression of APP at 48 h following chronic ECS (Figure 12B, 
228.0 ± 34.3% p<0.005). These data indicate that both a single ECS and chronic ECS led to a 
delayed increase in the levels of APP and Aβ oligomers in the hippocampus. 
The physiologic consequences of STEP61 regulation in the hippocampus by ECS. 
We show that STEP61 level was markedly increased in rat hippocampus at 48 h after a 
single induction of ECS (Figure 7D), which induces global elevation of hippocampal neuronal 
activity (Duman & Vaidya, 1998). Consistent with this increase in STEP61 expression, the level of 
Tyr1472-phosphorylated GluN2B was reduced at 48-72 h following a single ECS without altering 
total GluN2B expression (Figure 9A). Considering that STEP61-mediated dephosphorylation of 
GluN2B leads to internalization of GluN2B-containing NMDARs (Snyder et al., 2005), up-
regulation of STEP61 (Figure 7D) may serve as a compensatory mechanism to reduce surface 
density of NMDARs in the hippocampus in response to seizures (Figure 11). Consistent with the 
previous report on ECS-induced decreases in PSD-95 and GluN2A/B expression (Yao, Guo et al., 
2010), chronic ECS caused a persistent decrease in total GluN2B expression over the course of 96 
h following chronic ECS (Figure 9B). NMDAR activation requires coincident binding of 
glutamate and membrane depolarization produced by opening of AMPARs (Paoletti & Neyton, 
2007). Hence, although chronic ECS did not alter GluA2 level (Figure 10F), a persistent decline 




STEP61 mediates AMPAR internalization upon mGluR activation and Aβ application by 
dephosphorylating GluA2 (Zhang et al., 2011, Zhang et al., 2008), suggesting a possibility that a 
single ECS-induced increase in STEP61 expression could lead to synaptic weakening by decreasing 
Tyr-phosphorylation of GluA2. Unexpectedly, the level of Tyr876-phosphorylated GluA2 was 
enhanced at 96 h following a single ECS (Figure 10B). No significant changes were seen in the 
level of 3Tyr-phosphorylated GluA2 and total GluA2 following a single ECS (Figure 10A and 
10C). Since the level of Tyr876-phosphorylated GluA2 was unaltered at 48 h following a single 
ECS when STEP61 was increased (Figure 8D, 11B), Tyr
876 of GluA2 might not have been directly 
regulated by STEP61. It is also possible that STEP61 dephosphorylates a specific residue within the 
3Tyr motif, but that kinase-mediated phosphorylation of another residue within the same motif 
could mask the STEP61 effect. Identification of specific phosphorylation sites regulated by STEP61 
may aid future studies to dissect the role of STEP61 in ECS-induced regulation of GluA2 Tyr-
phosphorylation. 
The level of Tyr204/187-phosphorylated ERK1/2 was markedly decreased at 48 h following 
a single ECS, (Figure 11A) when STEP61 expression was at its peak (Figure 8D). Since STEP61-
mediated dephosphorylation of ERK1/2 at Tyr204/187 inactivates ERK1/2 (Paul et al., 2003, 
Venkitaramani et al., 2009), our results suggest a significant reduction in ERK1/2 activity by ECS-
induced up-regulation of STEP61. The total ERK1/2 expression was also reduced at 72-96 h 
following a single ECS (Figure 11A). Considering that activation of ERK1/2 drives synaptic 
delivery of AMPAR (Patterson, Szatmari et al., 2010) and activity-dependent regulation of gene 
transcription during LTP (Wiegert & Bading, 2011), ERK1/2 inactivation at 48 h and ERK1/2 
reduction at 72-96 h following a single ECS would also facilitate synaptic weakening (Figure 13). 
Interestingly, chronic ECS caused a 6-fold increase in the level of Tyr204/187-phosphorylated 
ERK1/2 at 0 h following chronic ECS compared to NS control, which was returned to the level of 
NS control by 24 h post chronic ECS (Figure 11B). These temporal changes in ERK1/2 activity is 
consistent with previous reports in cultured neurons that ERK1/2 undergoes rapid activation in 
response to glutamate stimulation, followed by a STEP61-dependent delayed inactivation to 
baseline (Paul & Connor, 2010, Paul et al., 2003, Valjent et al., 2005). Taken together, our results 
suggest that up-regulation of STEP61 and down-regulation of its substrates critical for synaptic 
plasticity may provide efficient means to mediate synaptic weakening (Figure 13). 
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The physiologic consequences of APP and Aβ regulation in the hippocampus by ECS.  
 Previous studies have shown that application of Aβ oligomers activates STEP61, which 
subsequently leads to internalization of NMDAR and AMPAR (Kurup et al., 2010b, Snyder et al., 
2005). We speculate that the delayed 3-fold increase in APP and Aβ expression at 72-96 h 
following a single ECS (Figure 12A) would enhance STEP61 activity, leading to a persistent 
reduction in NMDAR and AMPAR surface expression at these time points when STEP61 levels 
returned back to NS control levels (Figure 13). Such persistent decrease in synaptic strength is 
expected to lead to the elimination of synapses (Bastrikova, Gardner et al., 2008, Lamprecht & 
LeDoux, 2004, Zhou, Homma et al., 2004). Indeed, decreases in synapse density are evident in the 
hippocampi of patients with early AD and correlate strongly with memory impairment (Masliah, 
Mallory et al., 2001, Scheff, Price et al., 2007, Scheff, Price et al., 2006). Furthermore, a single 
ECS has been shown to cause memory deficits in rats when it was administered right after the 
hippocampus-dependent learning experience (Misanin, Miller et al., 1968, Yao et al., 2010), 
consistent with clinical observations of retrograde amnesia as one severe side effect for 
electroconvulsive therapy in humans (Lisanby, 2007). Hence, it will be interesting to test if seizure-
induced increase in APP and Aβ expression and down-regulation of NMDAR and ERK1/2 through 
STEP61 could be the basis of cognitive deficits in early AD and ECT.  
 Interestingly, a transient 2-fold increase in APP and Aβ expression was observed at 48 h 
post chronic ECS compared to NS control, which was followed by a 3-fold increase in Aβ 
expression at 96 h time point (Figure 12B). The initial increase in APP expression could be the 
basis for the delayed increase in Aβ levels. Animals administered with chronic ECS display 
increased dentate granule cell neurogenesis (Scott, Wojtowicz et al., 2000) and molecular layer 
mossy fiber sprouting (Gombos et al., 1999, Vaidya, Terwilliger et al., 2000). Since APP regulates 
neurite outgrowth as well as cell adhesion and promotes neuronal survival (Araki, Kitaguchi et al., 
1991, Milward, Papadopoulos et al., 1992, Schubert, 1989, Whitson, Selkoe et al., 1989), chronic 
ECS-induced increase in APP expression may regulate hippocampal neurogenesis and mossy fiber 
sprouting. Interestingly, similar 3-4 fold increase in APP levels has have been found in the 
postmortem temporal lobe from patients with early AD (Roberts, Nash et al., 1993) and from 
patients with intractable temporal lobe epilepsy with abnormal neurite outgrowth (Sheng, Boop et 
al., 1994). The AD transgenic mouse models with elevated APP expression display spontaneous 
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seizures, sharp wave discharges, and mossy fiber sprouting as well as ectopic expression of 
inhibitory neuropeptides in their hippocampus (Corbett et al., 2013, Lalonde et al., 2005, 
Minkeviciene et al., 2009, Palop & Mucke, 2010, Sanchez et al., 2012, Verret et al., 2012, 
Westmark et al., 2008, Ziyatdinova et al., 2011). Importantly, hippocampal neurons in transgenic 
APP-overexpressing AD mice display hyperexcitability well before plaque formation (Busche et 
al., 2012). Since Aβ application increases the activity of excitatory neurons in acute brain slices 
(Minkeviciene et al., 2009) and neuronal activity stimulates synthesis and synaptic release of Aβ 
(Bero et al., 2011, Cirrito et al., 2005, Kamenetz et al., 2003), we speculate that chronic-ECS 
induced initial increase in APP expression may result in neuronal hyperexcitability, which in turn 
causes heightened Aβ expression, ultimately leading to pathologic positive feedback loop of Aβ 
production (Noebels, 2011).  
The mechanisms underlying ECS-induced expression of STEP61 and APP 
 Previous studies have shown that STEP61 expression is regulated by multiple mechanisms. 
STEP61 is locally translated in dendrites upon mGluR5 activation through a mechanism dependent 
on ERK1/2 phosphorylation (Zhang et al., 2008). Interestingly, fragile X mental retardation protein 
(FMRP) binds to and inhibits translation of STEP mRNA (Darnell, Van Driesche et al., 2011) 
whereas genetic ablation of FMRP leads to increased STEP expression (Goebel-Goody, Baum et 
al., 2012a, Goebel-Goody, Wilson-Wallis et al., 2012b). Hence, it is possible that the initial 
increasing trend in ERK1/2 phosphorylation induced by a single ECS (Figure 11A) could increase 
STEP61 expression by 48 h (Figure 8D) by triggering local dendritic synthesis of STEP61 upon 
FMRP inhibition. In addition, STEP61 undergoes proteasome-dependent degradation upon poly-
ubiquitination (Xu et al., 2009), suggesting another possibility that a single ECS could elevate 
STEP61 expression by inhibiting proteasomal STEP61 degradation. Lastly, both a single ECS and 
chronic ECS stimulate robust induction of immediate early genes and subsequent downstream 
genes important for neural plasticity (Altar, Laeng et al., 2004, de Jong, Arts et al., 2014, Ma, Jang 
et al., 2009, Madsen et al., 2003, Newton, Collier et al., 2003, Segi-Nishida et al., 2008, Tsankova, 
Kumar et al., 2004, Vaidya et al., 2000, Zetterstrom, Pei et al., 1998). Considering that 48 h 
blockade of neuronal activity or NMDAR in cultured hippocampal neurons leads to a significant 
reduction in STEP61 mRNA and protein expression (Jang et al., 2015), a single ECS may stimulate 
transcription of STEP61 in the hippocampus through NMDAR activation. Further investigation is 
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needed to investigate if enhancement of hippocampal network activity upon a single ECS increases 
STEP61 protein level by enhancing transcription and translation of STEP61, and/or inhibiting its 
proteasomal degradation.   
 It is unclear how a single and chronic ECS caused a delayed increase in APP and Aβ 
expression in the hippocampus (Figure 12). Previous studies have shown that APP synthesis and 
processing are stimulated by interleukin-1 (IL-1) (Buxbaum, Oishi et al., 1992, Donnelly, 
Friedhoff et al., 1990, Goldgaber, Harris et al., 1989), which is synthesized and released from 
activated microglia (Hetier, Ayala et al., 1988, Righi, Mori et al., 1989). Consistently, neuronal 
expression of APP is associated with heightened IL-1 immunoreactivity in human temporal lobe 
epilepsy (Sheng et al., 1994). Interestingly, activated microglia are found in the hippocampus 24 
h after a single or repeated ECS, and the number of activated microglial cells remained increased 
for weeks after ECS (Jinno & Kosaka, 2008). Though highly speculative, it is possible that ECS-
induced persistent activation of microglia could stimulate IL-1 synthesis and release, leading to 
delayed APP production in neurons following a single ECS or chronic ECS.  
Chronic ECS did not induce significant alterations in the levels of STEP61, GluA2, and 
ERK1/2 compared to NS groups (Figure 8-11). While chronic ECS is therapeutically used to 
reduce stress (Duman & Vaidya, 1998), it is also possible that the “no seizure” (NS) animals might 
have been hyper-stressed by the repeated exposures to handling and the ECS apparatus, even 
though current was not delivered. Considering the interdependence of stress and STEP61 
expression (Yang, Huang et al., 2012), heightened stress in the NS animals in combination with 
dampened stress levels in chronic ECS-received rats may account for the lack of effects on STEP61 
regulation following chronic ECS administration.  
 
CONCLUSION  
Here, we show that a single ECS transiently increases protein expression of membrane-
associated STEP61 and decreases Tyr-phosphorylation of NMDAR subunit GluN2B and ERK1/2 
in the hippocampus. A delayed decrease in the levels of ERK1/2 as well as a delayed enhancement 
of APP and Aβ expression are also seen in the hippocampus following a single ECS. Chronic ECS 
treatment also leads to a persistent decrease in GluN2B level and a transient increase in APP and 
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Aβ production. To our knowledge this is the first study reporting the temporal expression of APP, 
Aβ, STEP61, and its substrates at various time points following a single ECS and chronic ECS. We 
propose that this regulation causes a transient weakening of synaptic strength to combat global 
enhancement of hippocampal neuronal activity induced by ECS. This regulation may also 
contribute to hippocampus-dependent memory loss induced by ECS, supporting anti-epileptic 
drugs as potential therapy for cognitive dysfunction in early AD. Given that Aβ-induced increase 
in STEP61 expression is involved in NMDAR and AMPAR internalization during synaptic 
weakening in AD (Kurup et al., 2010b, Snyder et al., 2005, Zhang et al., 2011, Zhang et al., 2010, 
Zhang et al., 2008), the work reported here emphasizes the need to dissect the detailed molecular 
mechanisms underlying activity-dependent regulation of STEP61. These mechanistic insights may 
help to explain the heightened STEP61 expression present in AD (Kurup et al., 2010b, Snyder et 
al., 2005, Zhang et al., 2010) and Fragile X syndrome (Goebel-Goody et al., 2012b) which have 
epileptic seizures as comorbid conditions.  
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Figure 8. A single ECS but not chronic ECS transiently increases membrane-associated 
STEP61 expression in the hippocampus. (A) Hippocampal expression of STEP61 during postnatal 
development. Immunoblot analysis and quantification of STEP61 and β-actin from the crude 
membrane (P2) fractions of rat hippocampi were obtained at postnatal day (P) 3, 7, 10, 12, 14 (n 
= 3 rats per time point) and 21, 28, and 42 (n = 2 rats per time point). Background-subtracted 
western blot band intensities of STEP61 and β-actin were normalized to those of P10 group, which 
was taken as 100%. STEP61 expression significantly increased from P10 to P12 by 3 fold 
(###p<0.005, T-test) and to P42 by 5 fold (#p<0.05, T-test). (B) Schematic workflow of an 
experiment from ECS induction in rats to biochemical fractionation of their hippocampi. (C) 
Schematic experimental design of a single ECS and chronic ECS (a single ECS per day for 7 
consecutive days). (D-E) Immunoblot analysis of STEP61 in the hippocampal crude membrane (P2) 
fraction following a single ECS (D, n = 5 rats per time point) and chronic ECS (E, n = 6 rats per 
time point). Time points shown represent the duration after the induction of a single ECS (D) or 
chronic ECS (E) prior to brain removal. The ratio of the STEP61 band intensity over the β-actin 
band intensity was calculated per each time point and normalized to the ratio of  “No seizure” (NS) 
sham group, which was taken as 100%. Data shown represent the mean band intensity ± SEM. (C) 
A single ECS transiently increases STEP61 expression in the hippocampus (**p < 0.01). (D) 




Figure 9. A single ECS but not chronic ECS transiently decreases the level of Tyr1472–
phosphorylated GluN2B in the hippocampus. Immunoblot analysis for the phosphorylation of 
GluN2B at Tyr1472 (Y1472) and total GluN2B expression in the hippocampal crude membrane (P2) 
fraction following a single ECS (n = 5 rats per time point) (A) and chronic ECS (n = 6 rats per 
time point) (B). The ratio of the Tyr1472-phosphorylated GluN2B band intensity over the β-actin 
band intensity (top graphs) and the ratio of total GluN2B band intensity over the β-actin band 
intensity (bottom graphs) were calculated per each time point, and normalized to that of “No 
seizure” (NS) sham group. Data shown represent the mean band intensity ± SEM. (A) A single 
ECS transiently decreases the level of Tyr1472–phosphorylated GluN2B in the hippocampus at 48 
h (***p < 0.005) and 72 h (*p < 0.05) following a single ECS. (B) Chronic ECS significantly 
decreases total GluN2B expression over the time course of 96 h in the hippocampus (*p < 0.05, 




 Figure 10 
Figure 10. A single ECS but not chronic ECS increases the level of Tyr876–phosphorylated 
GluA2 in the hippocampus. Immunoblot analysis for phosphorylation of GluA2 at Tyr876 (Y876) 
or 3Tyr (3Y: Tyr869, Tyr873, and Tyr876) and total GluA2 expression in the hippocampal crude 
membrane (P2) fraction following a single ECS (n = 5 rats per time point) and chronic ECS (n=5 
rats for 72 h time point, and n = 6 rats per all other time points) (D-F). The ratio of the 
phosphorylated GluA2 band intensity over the β-actin band intensity (A-B, D-E) and the ratio of 
total GluA2 band intensity over the β-actin band intensity (C,F) were calculated per each time 
point, and normalized to that of  “No seizure” (NS) sham group. Data shown represent the mean 
band intensity ± SEM. A single ECS increases the level of Tyr876-phosphorylated GluA2 at 96 h 
time point (B, *p < 0.05), but does not alter the level of 3Tyr-phosphorylated GluA2 and total 



























Figure 11. A single ECS and chronic ECS differently alter Tyr204/187 -phosphorylation of 
ERK1/2 in the hippocampus. Immunoblot analysis for the phosphorylation of ERK1/2 at 
Tyr204/187 (Y204/187) and total ERK1/2 expression in the hippocampal crude membrane (P2) fraction 
following a single ECS (n = 5 rats per time point) (A) and chronic ECS (n = 6 rats per time point) 
(B). The ratio of the Tyr204/187-phosphorylated ERK1/2 band intensity over the β-actin band 
intensity (top graphs) and the ratio of total ERK1/2 band intensity over the β-actin band intensity 
(bottom graphs) were calculated per each time point, and normalized to that of “No seizure” (NS) 
sham group. Data shown represent the mean band intensity ± SEM.  (A) A single ECS transiently 
decreases the level of Tyr204/187–phosphorylated ERK1/2 in the hippocampus at 48 h (###p < 0.005, 
T-test) and total ERK1/2 expression at 72-96 h (*p < 0.05) following a single ECS. (B) Chronic 
ECS significantly increases the level of Tyr204/187–phosphorylated ERK1/2 at 0 h following chronic 






Figure 12. A single ECS and chronic ECS increase APP and oligomeric Aβ expression in the 
hippocampus. Immunoblot analysis of APP and oligomeric Aβ in the hippocampal crude soluble 
(S2) fraction following a single ECS (n = 5 rats per time point) (A) and chronic ECS (n = 6 rats 
per time point) (B). The ratio of the Aβ band intensity over the β-actin band intensity (top graphs) 
and the ratio of the APP band intensity over the β-actin band intensity (bottom graphs) were 
calculated per each time point and normalized to that of “No seizure” (NS) sham group. Data 
shown represent the mean band intensity ± SEM. (A) A single ECS increases Aβ expression at 72 
h (#p < 0.05, T-test) and APP expression at 72- 96 h following a single ECS (**p < 0.01, ***p < 
0.005). (B) Chronic ECS increases Aβ expression at 48 h and 96 h, as well as APP expression at 




Figure 13. Model by which seizure-induced changes in Aβ, STEP61, and Tyr-phosphorylation 
of STEP61 lead to synaptic weakening in the hippocampus. A single ECS increases STEP61 
expression and decreases Tyr-phosphorylation of NMDAR subunit GluN2B and ERK1/2 in the 
hippocampus at 48 h time point, leading to synaptic weakening via NMDAR internalization and 
ERK1/2 inactivation. A delayed decrease in ERK1/2 expression as well as a delayed enhancement 
of APP and Aβ expression at 72-96 h following a single ECS maintains this synaptic weakening.  
Chronic ECS-induced increase in APP expression and Aβ production as well as persistent decrease 
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Striatal enriched protein phosphatase (STEP) is a brain specific tyrosine phosphatase, 
which is crucial for activity-dependent synaptic alterations such as Hebbian and homeostatic forms 
of synaptic plasticity at excitatory synapses in the brain. STEP dephosphorylates tyrosine residues 
of GluN2B (Tyr1472) and GluA2 (Tyr869, 873, and 876) subunits in NMDAR and AMPAR, 
respectively, leading to their endocytosis from post-synaptic sites. Here, we show that KA-induced 
SE increases Aβ expression and STEP61 activity at 24h following an initial SE. In addition, STEP 
KO mice display prolonged latency to stage 4 seizures (continuous rearing and falling) and lower 
cumulative seizure scores, indicating that STEP regulates seizure propensity. Lastly, we found that 
a lack of STEP does not induce an increase of Aβ expression following KA-induced SE, implying 
that STEP is an upstream regulator for the production of Aβ in response to hippocampal network 




Epilepsy is a chronic neurological disorder characterized by recurrent epileptic seizures 
indicative of neuronal hyper-excitability and excessive and synchronized firing of APs (Chang & 
Lowenstein, 2003, Fisher, van Emde Boas et al., 2005). About 40% of epilepsy is linked with 
genetic mutations in ion channels and detected as early as infancy (Lerche, Jurkat-Rott et al., 2001). 
The rest of cause for epilepsy that occurs during adolescence and adult period has remained unclear. 
Intraperitoneal injection of Kainic acid (KA), an agonist of ionotropic KA receptor has been used 
to induce status epilepticus at the initial period and produce neuropathological damages shown in 
TLE patients (Ben-Ari et al., 2012), which is different from mild ECS that does not cause injury 
in the hippocampus.  
Alzheimer’s disease (AD) is an irreversible brain disorder with progressive cognitive 
decline, hippocampal sclerosis, and amyloid-β plaques consisting of insoluble aggregation of Aβ 
peptide (Kidd, 1964). Considering that neuronal activation increases Aβ production (Sanchez et 
al., 2012), it is likely that abnormal hyper-excitability in neural network might trigger the 
accumulation of Aβ, contributing to the pathogenesis of AD. Previously, it was reported that 
application of Aβ oligomers activates STEP61 , which in turn causes internalization of NMDAR 
and AMPAR (Snyder, Nong et al., 2005). In addition, our lab has reported that hippocampal Aβ 
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and STEP61 expression are increased following electroconvulsive seizure (ECS) in rats (Jang et al., 
2016). These findings raise hypotheses that (1) KA-induced SE accompanied by neuronal hyper-
excitability might lead to abnormal accumulation of Aβ and STEP61 expression and (2) elevation 
of Aβ and STEP61 expression following seizure-activity might synergistically contribute to 
homeostatic down-regulation of neuronal activity against hyper-network activity. To test this, we 
established Kainic acid-induced SE model and then evaluated the expression of Aβ, APP, and 
STEP61 in the hippocampus at the early time point following an initial SE.  
 
 
MATERIALS AND METHODS 
 
Kainate-induced status epilepticus (SE) model  
Experimental mice were group housed under 12h:12 lihgt:dark cycle with access to food 
and water ad libitum. All experiments were carried out during the light phase of the cycle. All 
experimental procedures involving animals conform to the United States National Institute of Health (NIH) 
guidelines and were approved by the Institutional Animal Care and Use Committee at the University of 
Illinois at Urbana-Champaign. The male mice were injected with kainic acid (30 mg/kg, IP) diluted 
in sterile 0.9% saline at 2.5 mg/ml whereas control mice will be injected with equal volume of 
saline as described. Seizures were confirmed by modified Racine scale (Racine et al., 1972; 
Boehringer et al, 2017).  
 
Whole Brain Lysate Preparation  
At 24 h following i.p injection of kainic acid (KA; 30 mg/ kg), the mice were sacrificed by 
CO2 inhalation and rapidly decapitated. The hippocampi were dissected from their brains and 
homogenized in ice-cold homogenization buffer (solution A) containing (in mM) 320 sucrose, 1 
NaHCO3, 1 MgCl2, 0.5 CaCl2, 1 NaVO3, 10 Na4O7P2, 50 NaF, and Halt protease inhibitors 
(Thermo Fisher Scientific) (1.25 mL total volume per pair of hippocampi). The crude membrane 
fraction (P2) was isolated from the hippocampi homogenates as previously described with the 
following modification (Jang & Royston et al., 2016). The supernatant (S2) was removed, and the 
remaining pellet (P2 membrane fraction) was resuspended in ice-cold solution B containing (in 
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mM) 320 sucrose, 1 NaHCO, 1 NaVO3, 10 Na4O7P2, 50 NaF, and protease inhibitor cocktails 
(1 mL total volume per pair of hippocampi).  
Western blot analysis 
After adding SDS sample buffer, the lysates (S1, P2, and S2) were heated at 37°C or 75°C 
for 30 min. Lysate samples were run on SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
gels and transferred to polyvinyl difluoride (PVDF) membrane (Millipore). Each gel contained 
lysates from one experiment for Kainate-induced SE animals. Each blot was incubated in blocking 
buffer (5% milk and 0.1% Tween-20 in Tris buffered saline (TBS) for 1 h followed by incubation 
with primary antibodies in washing buffer (1% milk and 0.1% Tween-20 in TBS) overnight at 4°C. 
Primary antibodies used include anti-STEP61 (#SC-23892, Santa Cruz), anti-GluN2B (#14544, 
Cell Signaling), anti-ERK1/2 (#SC-154, Santa Cruz), anti-GluA2 (#5306, Cell Signaling), anti-
APP (#SC-28365, Santa Cruz), and anti-β-actin (#4967, Cell Signaling). Phosphorylation site 
specific antibodies used include: anti-GluN2B-pTyr1472 which recognizes phosphorylated Tyr-
1472 of GluN2B (P1516-1472, PhosphoSolutions), anti-ERK1/2-pThr202/Tyr204 which recognizes 
phosphorylated Thr202/Tyr204 of ERK1. After incubating in HRP-conjugated secondary antibody 
in washing buffer for 1 h, the blots were exposed to enhanced chemiluminescence substrate (ECL, 
Thermo Fisher Scientific) for 1 minute. The luminescent signals were detected by exposing the 
blots to X-ray films, which were then developed with a Konica SRX- 101A film processor. 
Densitometric quantification was performed with ImageJ Software (National Institutes of Health) 
as previously described (Jang et al., 2015; Jang et al., 2016).  
 
Statistical analysis 
The proposed biochemical experiments will be independently repeated at least four times. 
The proposed recording experiments will be repeated until the sample number reaches n ≥ 10. 
The data will be analyzed by the Student’s t-test (for groups of 2) or ANOVA with Tukey’s post-








KA-induced SE leads to an increase in the expression of Aβ in S2 fraction of hippocampus 
Previously, it was reported that elevation of neuronal activity increases Aβ production 
(Sanchez et al., 2012) and abnormal hyper-excitability in neural network involves the pathogenesis 
of AD. Our lab reported that prolonged neuronal activity in primary cultured neurons (Jang et al., 
2015) and electroconvulsive seizure (ECS) in rats (Jang et al., 2016) elevate hippocampal STEP61 
and Aβ expression. To test if KA-induced SE accompanied by hippocampal hyper-excitabiltiy 
affects the production of Aβ and APP, we measured the amount of Aβ and APP in S2 and P2 
fractions of the hippocampus following i.p injection of KA (30 mg/kg). Our data show that the 
amount of Aβ is increased in cytosolic fraction (S2) with no change of APP in synaptosome 
fraction (P2) at 24 h following SE(Figure 14), implying that elevation of Aβ is likely to be mediated 
via enhanced enzymatic activity of β- and γ-secretases, but not APP.  
 
KA-induced SE does not alter the expression of STEP61, but reduce the level of 
phosphorylation (Y1472) in GluN2B, a substrate of STEP61 in P2 fraction of hippocampus 
 To test if STEP61 is altered following KA-induced SE, we evaluated the amount of STEP61 
and its substrates in P2 fraction of hippocampus. Our data reveal that i.p injection of KA does not 
alter STEP61 expression in P2 fraction. However, the level of phospho-GluN2B (Y
1472) is reduced 
without any changes in total GluN2B, p-ERK, and total ERK at 24h following SE (Figure 15), 
suggesting that KA-induced SE increases STEP61 activity, but not its expression.  
 
STEP KO mice display reduced seizure susceptibility to KA-induced SE 
 To test if STEP affects KA-induced SE, we evaluated the latency (min) to stage 4 seizure 
(continuous rearing and falling), accumulated seizure score, and death rate between WT and STEP 
KO mice for 120 min following i.p injection of KA (30 mg/kg) (Figure 16) based on modified 
Racine’s scales (Racine 1972). Our data show prolonged latency to Stage 4 seizure and reduced 
cumulative seizure score in STEP KO mice compared to those in WT mice (Figure 16). 
Furthermore, following i.p injection of KA, the death rate in STEP KO was lower than that in WT 




STEP KO mice display high basal level of Aβ and APP in the hippocampus 
 It has been reported that AD patients and AD animal models show the high level of STEP61 
in the hippocampus (Kurup et al., 2010; Kurup et al., 2010). Indeed, accumulation of Aβ is 
associated with an increase of STEP61 expression and activity, which is dependent upon the 
ubiquitin-proteasome system (UPS) and calcineurine (PP2B)/PP1 pathway, respectively (Kurup et 
al., 2010; Kurup et al., 2010). Pharmacological and genetic inhibition of STEP recover cognitive 
and cellular deficits in a mouse model of AD. To confirm if STEP modulates the levels of Aβ and 
APP in the hippocampus under the basal condition, we measured the amount of Aβ and APP in S2 
and P2 fractions of hippocampus from STEP KO mice. Our data reveal that STEP KO mice display 
high levels of Aβ in S2 and APP protein in P2 fractions, respectively (Figure 17), indicating that 
STEP reguates basal expression of Aβ and APP in the hippocampus.  
 
The lack of STEP abolishes increased Aβ caused by KA-induced SE 
 Based on previous observations that KA-induced SE leads to increase of Aβ and STEP61 
activity (Figure 14-15), we further hypothesized that STEP might contribute to elevation of Aβ in 
the hippocampus following SE and compared the amount of Aβ and APP in STEP KO mice. Our 
data show that KA-induced SE does not induce an increase of Aβ and APP in hippocampal S2 and 
P2 of STEP KO mice (Figure 18), indicating that STEP contributes to seizure-induced elevation 
of Aβ.   
 
DISCUSSION 
Previously, it was reported that global hyper-excitability at the brain network elevates 
hippocampal Aβ and STEP61 expression in the rodent in which electrical currents are applied (Jang 
et al., 2016). In this study, we used KA, a potent excitant that induces neuronal hyper-excitability 
accompanied by seizures under in vivo condition. Compared to electrical stimulation, chemical 
stimulation by KA is more localized and complicated (Ben-Ari & Cossart, 2000; Lothman et al., 
1981), leading to hippocampal hyper-excitability and damage that occur primarily in the CA3 area. 
Consistent with the previous report on ECS-induced increase in Aβ and STEP expression (Jang 
SS et al., 2016), KA-induced SE gives rise to elevation of Aβ expression and STEP activity at 24h 
following i.p injection of KA (Figure 15 and 17), implying that there might be a positive relation 
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between Aβ and STEP upon excessive neuronal activation. Considering an inhibitory role of Aβ 
and STEP in synaptic strength (Kurup et al., 2010b, Li, Hong et al., 2009), their elevation following 
SE (Figure 15 and 17) is likely to play a protective role against neuronal excitotoxicity via 
facilitating endocytosis of NMDAR and AMPAR. In addition, previous studies have shown that 
the level of STEP61 is increased in AD mouse models (Chin et al., 2005; Zhang et al., 2013) and 
STEP KO mice restore cognitive deficits in a mouse model of AD (Zhang et al., 2010), suggesting 
that STEP involves the pathogenesis of AD. However, it was unclear how STEP contributes to the 
progression of AD.  
Previously, it was reported that APP has tyrosine residues (Barbagallo et al., 2011;Reinhard 
et al., 2005) and an increased Tyr phosphorylation of APP changes APP trafficking in AD neurons 
(Poulsen et al., 2017. To be specific, Tyr682 dephosphorylation on the C-terminal domain of APP 
is crucial for deactivating APP signaling pathway that contributes to its endocytosis (Barbagallo 
et al., 2010; Muller et al., 2012). These observations raise the hypothesis that STEP is likely to 
control the surface expression of APP via dephosphorylating its tyrosine residues. In addition, the 
activity of STEP substrates such as ERK and p38 could also mediate APP processing and surface 
expression by modulating catalytic activity of β- and γ-secretase. In this study, we did not see any 
changes of Aβ and APP in STEP KO following KA-induced SE (Figure 18), strongly suggesting 
that STEP is involved in activity-dependent elevation of Aβ production.  
Considering that Aβ peptide is produced by proteolytic cleavage of APP anchoring at 
transmembrane (Kamenetz et al., 2003), STEP regulation of APP processing could be one of the 
upstream event that regulates the amount of Aβ. In addition, The ApoE4 isoform induces a low 
rate at clearance of Aβ, consequently leading to accumulation of Aβ (Castellano et al., 2011). 
Though highly speculative, STEP could control the function of ApoE4, mediating the clearance of 
Aβ in the brain. Further investigation is needed to study the mechanisms by which STEP modulates 
the amount of Aβ and APP at the early phase following an initial insult.  In this study, we also 
found that STEP KO mice display reduced seizure propensity (Figure 16) and an increase in the 
basal level of Aβ and APP (Figure 17). Given that elevation Aβ reduces synaptic strength, it is 
plausible that reduced seizure activity in STEP KO mice might be due to the high level of Aβ 




CONCLUSION AND FUTURE DIRECTION 
Here, we show the increase in the amount of Aβ and the activity of STEP61 in the 
hippocampus at 24 h following KA-induced SE (Figure 14-17), suggesting that both Aβ and 
STEP61 are elevated in response to seizure-like activity. Given that neuronal activity promotes 
synthesis and synaptic release of Aβ (Bero et al., 2011, Kamenetz et al., 2003) and Aβ elevates 
neuronal excitability (Varga et al., 2014), it is likely that KA-induced SE could trigger a pathologic 
positive feedback loop of Aβ production. Since Aβ increases STEP activity via activating α7-
nicotinic acetylcholine receptors in a PP1-dependent manner (Valjent et al., 2005), we speculate 
that elevated Aβ following KA-induced SE increases STEP activity. In addition, STEP KO display 
high levels of basal Aβ and APP (Figure 17), suggesting that STEP down-regulates the production 
of Aβ and APP under a normal condition. However, it is still unknown whether STEP and Aβ 
interact upon seizure activity and how they affect synaptic strength. Considering that STEP 
weakens synaptic strength by modulating internalization of NMDAR and AMPAR in AD (Kurup 
et al., 2010b, Snyder et al., 2005, Zhang et al., 2011, Zhang et al., 2010, Zhang et al., 2008), a lack 
of STEP may increase synaptic strength, resulting in elevation of Aβ in the hippocampus. Lastly, 
we show that STEP KO mice do not display an increase in the levels of Aβ and APP at 48 h 
following KA-induced SE (Figure 17 and 18), indicating that STEP is required for the production 
of Aβ and APP after SE. In the future, we need to address the mechanisms by which (1) STEP 
modulates basal and activity-dependent elevation of Aβ and (2) high levels of Aβ in the 






















Figure 14. Kainic acid (KA)-induced SE increases the levels of Amyloid-β in S2 fraction and 
APP in P2 fraction from hippocampus. Representative blots and graphs show that i.p injection 
of Kainic acid (30 mg/kg) increases the level of Aβ and APP in S2 and P2 fraction of hippocampus 
at 24 h following status epilepticus (SE) (n = 11). The ratio of western blot band of Aβ and APP 
over the GAPDH was calculated per each concentration of KA and normalied to the ratio of CTL 

















Figure 15. KA-induced SE does not change the expression of STEP61, but alters the level of 
GluN2B-pY1472. Representative blots and graphs show that i.p injection of Kainic acid (30 mg/kg) 
does not change the level of STEP61 (n = 11) and educes the level of GluN2B-Y
1472 (n = 7) in P2 
fractions of hippocampus lysates at 24 h following status epilepticus (SE). Statistical significance 




























Figure 16. STEP KO mice display prolonged latency to convulsion, reduced seizure 
propensity, and death rate following i.p injection of Kainic acid (30mg/kg). (A) Representative 
photos that show seizure behaviors and Plot that show seizure scores (y-axis) and time (x-axis) 
following i.p injection of Kainic acid (KA, 30 mg/kg) in WT (n = 32)  and STEP KO mice (n = 
19). (B) Graphs that show longer latency to Stage 4 seizures, lower cumulative seizure score, and 
lower death rate in STEP KO mice, compared to WT mice . Data shown represent the mean ± 











Figure 17. Basal levels of Aβ and APP is elevated in STEP KO mice. Representative blots and 
graphs show that STEP61 KO display high level of Aβ (n = 6) in S2 fraction and APP (n = 7) in P2 
fraction at 24 h . The ratio of western blot band of the Aβ and APP over the GAPDH was calculated 
and normalied to the ratio of WT (i.p injection of saline) groups. Statistical significance was 



















Figure 18. An increase in the levels of Aβ and APP following SE is abolished in STEP KO 
mice. Representative blots and graphs show that STEP KO does not change the level of Aβ (n = 
4) in S2 fraction and APP (n = 4), GluN2B-pY1472 (n = 3), and GluN2B (n = 3) in P2 fraction at 
24 h following status epilepticus (SE) induced by i.p injection of Kainic acid (30 mg/kg). The 
ratio of western blot band of the Aβ and APP over the GAPDH was calculated and normalied to 
the ratio of CTL (i.p injection of saline) groups. Statistical significance was determined using t-
























CHAPTER 5: STEP MODULATES INTRINSIC PROPERTIES AND THE 
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 STriatal Enriched Protein Phosphatase (STEP) encoded by the PTPN5 gene is a brain 
specific tyrosine phosphatase expressed in the hippocampus and cortex, contributing to the 
pathogenesis of several neurological diseases such as Alzheimer's disease (AD) and Parkinson’s 
disease (PD). Membrane-bound isoform STEP61 opposes Hebbian and homeostatic strengthening 
of excitatory synapse by dephosphorylating GluN2B subunit of N-methyl-D-aspartate receptor and 
GluA2 subunit of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor, 
subsequently leading to their internalization. Despite well-established roles of STEP61 in regulating 
excitatory synaptic strength, whether STEP61 modulates intrinsic neuronal properties remains 
unknown. In this study, we discovered that hippocampal CA2 pyramidal neurons from the mice 
that lack STEP display depolarized resting membrane potential (RMP) and enhanced action 
potential firing rate compared to the wild-type CA2 neurons. Elevated voltage sag, rebound 
potentials, and hyperpolarization-activated Ih currents were also observed in STEP knock-out CA2 
neurons and hippocampal cultured pyramidal neurons treated with a substrate-trapping membrane-
permeable STEP46 protein, TAT-STEP, suggesting that STEP61 may regulate hyperpolarization-
activated cyclic nucleotide-gated ion channels (HCN) Indeed, co-expression of wild-type STEP61 
and inactive mutant STEP61 decreased the current density and the protein expression of HCN2 
channels in Chinese hamster ovary (CHO hm1) cells. Furthermore, the presence of STEP61 reduced 
HCN2 protein levels via proteasome-dependent degradation and independent of HCN2 tyrosine 
phosphorylation sites, Y476 and Y481. Together our findings uncover newly defined role of 
STEP61 in controlling intrinsic membrane properties, Ih currents and HCN2 channel expression in 















 STEP is a brain specific tyrosine phosphatase, which is enriched in the striatum, the cortex, 
and the hippocampus (Boulanger, Lombroso et al. 1995, Braithwaite, Adkisson et al. 2006, Choi, 
Lin et al. 2007, Saavedra, Giralt et al. 2011, Carty, Xu et al. 2012, Xu, Kurup et al. 2012, Xu, 
Kurup et al. 2015). The STEP family is alternatively spliced from a single STEP gene (PTPN5), 
including two major isoforms; cytosolic STEP46 and membrane-bound STEP61. STEP61 
dephosphorylates GluN2B (Tyr1472) of NMDAR and GluA2 (Tyr869, Tyr873, and Tyr876) of 
AMPAR, promoting the internalization of NMDAR and AMPAR from post-synaptic sites as well 
as the kinases ERK1/2, Pyk2, and Fyn, leading to their inactivation (Fitzpatrick and Lombroso 
2011, Li, Xie et al. 2014, Xu, Kurup et al. 2015). In the hippocampus, STEP61 has been known to 
play a role in mediating Hebbian (Pelkey, Askalan et al. 2002) and homeostatic plasticity (Jang, 
Royston et al. 2015) at the excitatory synapses. Inhibition of endogenous STEP strengthens basal 
synaptic transmission and occludes tetanus-induced long-term potentiation (LTP) at Schaffer 
Collateral CA1 synapses (Pelkey, Askalan et al. 2002). In contrast, postsynaptic administration of 
STEP does not affect basal transmission and prevents LTP induction via a NMDAR-dependent 
mechanism (Pelkey, Askalan et al. 2002). Recently, our lab has reported that prolonged inhibition 
of hippocampal activity decreases the mRNA and protein expression of STEP61, resulting in an 
increase in the amplitude of miniature excitatory postsynaptic currents (mEPSCs) (Jang, Royston 
et al. 2015). Despite an important role of STEP in dampening synaptic strength at the excitatory 
synapses in the hippocampus, it remained unknown whether STEP regulates an intrinsic properties 
of hippocampal pyramidal neurons via regulating the function of voltage-dependent ion channels.  
 Neuronal intrinsic properties of hippocampal pyramidal neurons are determined by 
multiple types of ionic currents such as persistent sodium currents (INaP), hyperpolarization-
activated current (Ih), and M currents (IM), elicited upon membrane 
depolarization/hyperpolarization (Bean 2007). STEP is expressed in cell body of somatostatinergic 
hilar interneuron in the hippocampus (Choi, Lin et al. 2007) and dopaminoceptive neurons of the 
basal ganglia (Lombroso, Naegele et al. 1993), raising a possibility that STEP might involve the 
regulation of voltage-dependent ion channels localized at soma. Genetic ablation of STEP 
increases responsiveness of granule cells to hyperpolarizing inputs in hippocampal granule cell 
layer (GCL) (Briggs, Walker et al. 2011), implying that STEP is likely to modulate voltage-
dependent ion channels such as HCN channel activated upon membrane hyperpolarization.  
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 Among multiple ion channels, HCN channel is constitutively open at RMP and starts to be 
activated upon membrane hyperpolarization, producing Ih currents. Elevation of HCN channels 
leads to depolarized RMP and regulates neuronal excitability in CA1 pyramidal neurons via 
influencing the activity of other channels such as Kv7 channels (Yamada-Hanff and Bean 2015). 
Computational model in CA1 pyramidal neurons suggests that only an increased functional HCN 
current is likely to underlie direct excitatory effects on neuronal firings (Dyhrfjeld-Johnsen, 
Morgan et al. 2008). A growing number of literatures has demonstrated that HCN channel is tightly 
controlled by interacting molecules and enzymes in the cytosol and the extracellular spaces (Biel, 
Wahl-Schott et al. 2009). Cyclic nucleotides directly bind to the highly conserved cyclic-
nucleotide binding domain (CNBD) on the C-terminus of HCN channel, regulating the functional 
properties of HCN channels (Wainger, DeGennaro et al. 2001, Xu, Vysotskaya et al. 2010). In 
addition, Src kinase phosphorylates Tyr476 in HCN2 channel, altering HCN2 activation kinetics 
(Huang, Huang et al. 2008) while receptor-like tyrosine phosphatase-α (RPTPα) inhibits the 
protein expression and HCN2 channel and Ih current through HCN2 channel (Zong, Eckert et al. 
2005). In this study, we mainly focused on investigating novel roles of STEP in the intrinsic 
excitability and HCN channel-mediated components, including voltage sag, rebound potential, and 
Ih currents in hippocampal pyramidal neurons. Through extensive experiments using acute slice, 
primary cultured neurons, and CHO hm1 cells, we conclude that STEP negatively modulates the 




















MATERIALS AND METHODS 
 
Animals  
 Experimental mice were group housed under 12h:12h light:dark cycle with access to food 
and water ad libitum. All experiments were carried out during the light phase of the cycle. All 
experimental procedures involving animals conform to the United States National Institute of 
Health (NIH) guidelines and were approved by the Institutional Animal Care and Use Committee 
at the University of Illinois at Urbana-Champaign. Generation of the STEP knockout (KO) mice 
that lacks PTPN5 expression and all STEP isoforms were previously described (Venkitaramani, 
Paul et al. 2009). STEP KO mice were maintained as heterozygotes as described (Venkitaramani, 
Paul et al. 2009). Heterozygotes were bred to produce homozygote STEP KO mice and wild-type 
(WT) littermates. Male mice were used for whole-cell patch clamp recordings. Both male and 
female rat embryos are used for primary dissociated culture of hippocampal neurons. 
Acute transverse hippocampal slice  
 Acute transverse hippocampal slices for electrophysiology were prepared as previously 
described (Chevaleyre and Siegelbaum 2010). Briefly, STEP WT and KO male mice at postnatal 
(P) day 21-28 were anesthetized by isoflurane inhalation. Hippocampi were dissected out and their 
transverse slices (400 μM thickness) were prepared on a vibratome (Leica VT1000, Germany) in 
ice-cold oxygenated cutting solution containing (in mM): 10 NaCl, 195 sucrose, 2.5 KCl, 15 
glucose, 26 NaHCO3, 1.25 NaH2PO4, 1 CaCl2 and 2 MgCl2. The slices were transferred to a 
submerged holding chamber (32°C) filled with oxygenated artificial cerebral spinal fluid (ACSF) 
containing (in mM): 125 NaCl, 2.5 KCl, 10 glucose, 26 NaHCO3, 1.25 NaH2PO4, 2 Na Pyruvate, 
2 CaCl2 and 1 MgCl2. The slices were maintained oxygenated in ACSF at 32°C for 30 min and 
then at room temperature for at least 1h. Cutting and recording solutions were both saturated with 
95% O2 and 5% CO2, pH 7.4.  
Primary hippocampal neuronal culture  
 Primary hippocampal neuronal culture was prepared as previously described (Jang, 
Royston et al. 2015, Kim, Zhang et al. 2018). Briefly, the timed-pregnant Sprague-Dawley rats 
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(Charles River, US) were euthanized by carbon dioxide inhalation followed by decapitation. The 
rats at embryonic day (E) 18–19 were quickly removed by caesarian section and decapitated. The 
hippocampi of these embryos were dissected in ice-cold dissection solution containing (in mM): 
10 HEPES, 82 Na2SO4, 30 K2SO4, 10 Glucose, 5 MgCl2 (pH 7.4). Primary dissociated 
hippocampal cultures were prepared from the E18-19 rat hippocampi as described (Jang et al., 
2015) with the following modifications: Dissociated cells were plated on 12 mm glass coverslips 
(Warner Instruments, 105 cells per coverslip) coated with poly L-lysine (0.1 mg/mL). Neurons 
were maintained in neurobasal medium supplemented with B27 extract, 200 mM L-glutamine, and 
100 U/mL penicillin and streptomycin in a cell culture incubator (37ºC, 5% CO2) for 10 – 14 days 
in vitro (DIV). 
DNA constructs and mutagenesis 
 The plasmid pEGFP-C1 with mHCN2 cDNA (GenBank: NM_008226) has been 
previously described (Santoro, Liu et al. 1998) and was a gift from Dr. Steven A. Siegelbaum 
(Columbia University). The plasmids pcDNA3 with cDNA encoding STEP61 WT (GenBank: 
NM_006906) or STEP61 C/S have been previously described (Xu, Kurup et al. 2012, Xu, Kurup 
et al. 2015) nd were a gift from Dr. Paul Lombroso, Yale University. Mutations (Y476F and Y481F) 
were generated in mHCN2 using the Quick Change II XL Site-Directed Mutagenesis Kit (Agilent) 
and verified by sequencing the entire cDNA construct. The following primers were used for 
mutagenesis: Y476F (5’-C CAG AAG ATC CAC GAT TTC TAT GAA CAC CGG TAC C-3’) 
and Y481F (5’-C GAT TAC TAT GAA CAC CGG TTC CAA GGG AAG ATG TTT G-3’)  
CHOhm1 cells culture and transfection 
 Chinese hamster ovary (CHO hm1) cells were cultured and transfected as previously 
described (Kim, Zhang et al. 2018). CHOhm1 cells were maintained at 37ºC with 10% CO in 
DMEM medium (Invitrogen, Thermofisher Scientific Life Technologies) supplemented with 10% 
fetal bovine serum, 100 units/ml penicillin, 100 ug/ml streptomycin. For western blot, cells were 
seeded on 6-well plates (Corning, 700,000 cells per well that has diameter of 3.5 cm). For 
electrophysiological recordings, cells were plated on 12 mm glass coverslips (Warner Instruments, 
105 cells per coverslip) or 30 mm cell culture dishes (BD Biosciences, 7×105 cells per dish) coated 
with poly L-lysine (0.1 mg/mL) were maintained in DMEM medium. At 24 h after plating, cells 
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were transiently transfected with equal amounts of plasmids (0.5 ug each plasmid) including 
pEGFP-C1-mHCN2 and pcDNA3-STEP61 WT or STEP61 C/S using the FuGENE6 transfection 
reagent (Roche Diagnostics). In a separate experiment, cells were transfected with pcDNA-STEP61 
and pEGFP-C1-mHCN2 WT, Y476F, or Y481F. 
Electrophysiology 
 Whole cell patch clamp recording of hippocampal pyramidal CA2 neurons in acute 
transverse hippocampal slices was performed as previously described (Chevaleyre and Siegelbaum 
2010). Briefly, the slices were transferred to the recording chamber containing oxygenated ACSF 
which were perfused at 1–1.5 ml per min. The CA2 pyramidal neurons in these slices were 
identified as previously described (Chevaleyre and Siegelbaum 2010) under an upright microscope 
with infrared differential interference contrast (IR-DIC) optics. For recording pyramidal neurons 
in dissociated rat hippocampal neurons, we pre-incubated with TAT-myc or active TAT-STEP 
C/S (2 µM), a C300S point mutation, for 30 min before recording. The TAT nucleotide sequence 
(TAC-GGT-CGT-AAA-AAA-CGT-CGT-CAG-CGT-CGT-CGT-) is inserted at the N-terminal of 
the myc and the STEP46 cDNA, subcloned into pTrcHis-TOPO expression vector, and 
transformed into E. Coli, BL21 (Invitrogen, Carlsbad, CA).  
Recording pipettes were pulled from glass capillaries with an outer diameter of 1.5 mm on 
a micropipette puller (P-97; Sutter Instruments), and had a resistance of 4–6 MΩ when filled with 
internal solution containing (in mM): 130 potassium gluconate, 7 KCl, 2 NaCl, 1 MgCl2, 0.1 
EGTA, 2 ATP-Mg, 0.3 Na-GTP, 10 HEPES (pH 7.30 with KOH, 295 mOsmol/L with sucrose). 
All recordings in neurons were performed to obtain voltage and current clamp mode at room 
temperature (23 - 25ºC) in the presence of the fast synaptic transmission blockers 6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX; 20 uM) and bicuculline (20 uM) in external solution, 
containing (in mM): 126 NaCl, 3 KCl, 2 CaCl2, 2 MgSO4, 1 NaH2PO4, 25 NaHCO3 and 14 
Dextrose, bubbled with 95% O2 and 5% CO2 (pH 7.4, 285 - 295 mOsm). All whole-cell recordings 
were made 5 min after achieving the whole-cell configuration using a Multiclamp 700B amplifier 
(Molecular Devices). All data were acquired and analyzed with a digidata 1440A interface 
(Molecular Devices) and the pClamp suite of software (version 10.2; Molecular Devices). The 
hippocampal CA2 neurons in acute slices were clamped at – 70 mV and pyramidal neurons in 
primary dissociated hippocampal culture were clamped at – 60 mV with current injection.  
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Membrane capacitance was calculated by Cm = τ/R, at which the time constant (τ) and series 
resistance were calculated by fitting a single exponential to the voltage responses of the test pulse 
(-5 mV). RMP was measured under current clamp 3 min after achieving the whole-cell 
configuration to let the internal solution diffused enough into the cytosol. Neurons were eliminated 
from further analysis if the access resistance changed by more than 20% over the recording period. 
Neurons that display RMP of above – 60 mV for hippocampal CA2 neurons and – 40 mV for 
pyramidal neurons in primary dissociated hippocampal culture were discarded from the analysis. 
Input resistance was measured by injecting brief currents ranging from – 50 pA to + 50 pA in 10 
pA increments and was determined by calculating the slope through the V-I plot which was 
constructed by plotting the amplitude of the steady-state voltage (V) against the corresponding 
current (I) injection from a family of 400 – 500 ms current steps.  
To evaluate intrinsic excitability, current-clamp recordings were performed as previously 
described (Brager, Akhavan et al. 2012, Shim, Jang et al. 2016, Shim, Jang et al. 2018) with the 
following modifications. Neurons were eliminated from further analysis if the access resistance 
changed by more than 20% over the recording period. A series of current steps of 1 s duration 
ranging from + 20 to +200 pA in 20 pA increments with a step interval of 5 s was applied to the 
cell from the membrane potential of – 70 mV for hippocampal CA2 neurons in acute slices and of 
– 60 mV for primary cultured hippocampal neurons. The AP amplitude, half-width, and first spike 
latency were analyzed from the first evoked AP of the firing train when +200 pA of the 
depolarizing current was injected. AP amplitude was determined as difference between peak 
amplitude and the voltage threshold of the AP. The first spike latency was defined as the delay 
from beginning point of depolarizing current injection to the voltage threshold where the upstroke 
phase of the first spike was initiated. The amount of voltage sag and rebound potential was 
determined as difference between the maximum and steady-state voltage during the 
hyperpolarizing current injection from -100 to – 500 pA and from -20 to -200 pA for 1 s with a 
step interval of 5 s in CA2 pyramidal neurons in acute slices and primary hippocampal cultured 
neurons, respectively. This sag amplitude was converted to sag percent, representing percentage 
change between two states [(VMax – VSteady state)/VMax] X 100 (Shim, Jang et al. 2016).  
Whole cell patch clamp recording of transfected CHOhm1 cells was performed as 
previously described (Kim, Zhang et al. 2018). For CHO hm1 cells recordings, voltage-dependent 
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currents of HCN2 channels were measured at room temperature 1-2 days after transfection using 
whole-cell voltage clamp techniques. The intracellular solution contained (in mM): 130 KCl, 10 
NaCl, 0.5 MgCl2, 1 EGTA, 5 HEPES, pH 7.4 adjusted with KOH. Extracellular solution contained 
110 NaCl, 0.5 MgCl2, 1.8 CaCl2, 5 HEPES, 30 KCl, pH 7.4 adjusted with NaOH. Series resistance 
was typically between 3 and 5 MΩ. All data from CHOhm1 cells were acquired 5 min after 
achieving the whole-cell configuration. Whole-cell currents were low-pass Bessel filtered at 1 kHz 
and digitized at 10 kHz.  
Capacitive currents were cancelled and a series of test pulses ranging from -120 to 0 mV 
in 10 mV decrements from a holding potential of -20 mV was applied to the cells for 1s followed 
by 30 mV for 100 ms (Nava, Dalle et al. 2014). Ih currents were quantified as the difference 
between the steady-state current at the end of the test pulses and the minimum current measured 
within 100 ms of the start of the test potential and were normalized by cell capacitance. Tail 
currents were measured immediately after each step and then plotted as a function of the preceding 
membrane potential (Bonin, Zurek et al. 2013). The kinetics (V1/2, the membrane potential for half-
maximal activation and k, the slope factor) of Ih currents, measured at holding potentials between 
-120 mV and – 40 mV, were determined with the Boltzmann function: I/Imax = {1/1+exp[(Vm-
V1/2)/k]}. The time constants of current activation were obtained by fitting with an exponential 
function in Clampfit software. Some currents presenting complex kinetic behavior were not used 
for analysis. 
Brain fractionations and Lysate Preparation 
Biochemical fractionation of the hippocampi was performed as previously described (Jang, 
Royston et al. 2016). Briefly, the hippocampi were dissected and homogenized in ice-cold 
homogenization buffer (solution A) containing (in mM) 320 sucrose, 1 NaHCO3, 1 MgCl2, 0.5 
CaCl2, 1 NaVO3, 10 Na4O7P2, 50 NaF, and Halt protease inhibitors (Thermo Fisher Scientific). 
The crude membrane fraction (P2) was isolated from the hippocampi homogenates with the 
following modification. After centrifuging for 10 min at 1,400 g, the postnuclear supernatants were 
separated (S1) from insoluble tissue and nuclear pellet (P1). The pellets were reconstituted in ice-
cold solution A and centrifuged for additional 10 min at 710 g. The resultant supernatant was 
combined with the S1 fraction, and the entire volume was then spun at 13,800 g for 10 min. The 
supernatant (S2) was removed, and the remaining pellet (P2 membrane fraction) was resuspended 
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in ice-cold solution B containing (in mM) 320 sucrose, 1 NaHCO, 1 NaVO3, 10 Na4O7P2, 50 NaF, 
and protease inhibitor cocktails (1 mL total volume per pair of hippocampi). BCA assay (Pierce) 
analysis was performed to determine protein concentrations across samples, which were 
subsequently normalized to 1 mg/mL in solution B. The S1, S2, and P2 lysates were stored at 
−80°C until use. The cell lysate samples were prepared as described (Jang, Royston et al. 2015, 
Kim, Zhang et al. 2018). In brief, CHOhm1 cells were washed twice with PBS at 24 and 48 h after 
transfection. The plates were placed on ice and incubated with ice-cold RIPA buffer containing (in 
mM): 150 mM NaCl, 1 mM Na2EDTA, 0.1% sodium deoxycholate, 0.5% sodium pyrophosphate, 
1% Triton X-100, 50 mM Tris, protease inhibitors, and Tyr phosphatase inhibitors including 1 mM 
NaVO3, 10 mM Na4O7P2, and 50 mM NaF. The lysed cells were centrifuged for 30 min at 100,000 
x g (4ºC). The upernatant was transferred to the new tubes for the following experiments.  
Western blot analysis  
 Western blotting of the hippocampal lysate and Chohm1 cell lysate was performed as 
previously described (Jang, Royston et al. 2016, Kim, Zhang et al. 2018). The P2 fraction of 
hippocampus and the cell lysate samples were mixed with SDS sample buffer, heated at 75°C for 
30 min, run on SDS-polyacrylamide gel electrophoresis (SDS-PAGE) gels, and transferred to 
polyvinyl difluoride (PVDF) membrane (Millipore). Each blot was incubated in blocking buffer 
(5% milk and 0.1% Tween-20 in Tris buffered saline (TBS) for 1 h followed by incubation with 
primary antibodies in washing buffer (1% milk and 0.1% Tween-20 in TBS) overnight at 4°C. 
Primary antibodies used include primary antibodies against STEP61 (#4396, Cell signaling, 
1:1000), HCN2 (N71/37, Neuromab, 1:500), anti-GluN2B (#14544, Cell Signaling, 1:1000), anti-
ERK1/2 (#9102, Cell Signaling, 1:1000), anti-GluN2B-pTyr1472 (P1516-1472, PhosphoSolutions, 
1:500), anti-ERK1/2-pThr202/Tyr204 (#9106, Cell Signaling, 1:1000), and GAPDH (#2118, Cell 
Signaling, 1:1000). After incubating in HRP-conjugated secondary antibody in washing buffer for 
1 h, the blots were exposed to enhanced chemiluminescence substrate (ECL, Thermo Fisher 
Scientific) for 1 minute. The luminescent signals were detected by exposing the blots to X-ray 
films, which were then developed with a Konica SRX- 101A film processor. Densitometric 
quantification was performed with ImageJ Software (National Institutes of Health) as previously 




 Permeabilized immunostaining was performed with primary antibodies against STEP 
(#4396, Cell signaling, 1:50), HCN2 (N71/37, Neuromab, 1:50), and DAPI (#4083, Cell signaling, 
1:2000) as described (Kim, Zhang et al. 2018). Fluorescence images of CHO hm1 cells stained 
with antibodies were acquired as described using Zeiss Axiovert 200M inverted microscope 
equipped with AxioCam HRm Camera and Axiovert software, and saved without further 
modifications as 16-bit TIFF files. The images were acquired using the same exposure time and 
processed with ImageJ software.  
Statistical Analysis 
Data are presented as means ± SEM and statistical analyses were performed with either 
Microsoft Excel, Origin 9.1 (Origin Lab), and GraphPad Prism (Decker, Jurgensen et al.). The 
Student's t test and one-way ANOVA with Tukey's and Fisher's multiple comparison tests were 
performed to identify the statistically significant difference with a priori value (p) < 0.05 between 




Genetic deletion of STEP alters passive and activity properties of hippocampal CA2 neurons  
 To elucidate whether STEP regulates passive and active properties of hippocampal 
pyramidal neurons, we first compared the levels of STEP61, GluN2B-pY
1472, and ERK1/2-pY204/187 
in WT and STEP KO mice. Our western blots reveal that the levels of GluN2B-pY1472 and 
ERK1/2-pY204/187 are elevated in the crude synaptosome P2 fraction of STEP KO mice using 
established protocol (Figure 19A). For electrophysiological recordings, we focused on 
hippocampal CA2 region where STEP is enriched (Boulanger, Lombroso et al. 1995, Bult, Zhao 
et al. 1996), localized at the end of mossy fiber terminal, characterized by the thickness somatic 
layer (Chevaleyre and Siegelbaum 2010). Whole-cell patch clamp recording in CA2 neurons from 
acute transverse hippocampal slices of juvenile male mice (P21-28) reveals that somatic RMP in 
STEP KO neurons is significantly depolarized (WT = - 66.98 ± 0.75 mV, n = 19; STEP KO = - 
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65.04 ± 0.56 mV, n = 21; Figure 26A) without the changes in capacitance (WT = 222.89 ± 19.85 
MΩ, n = 20, **p < 0.01; STEP KO = 183.37 ± 15.81 MΩ, n = 21; Figure 26B). In addition, we 
measured input resistance by injecting negative and positive currents ranging from -50 to 50 mV 
for 500 ms in current-clamp mode and quantified average value at the time point from 400 to 500 
ms. We found that while instantaneous current-dependent voltage changes in neurons lacking 
STEP seem to be higher than those in WT neurons (Figure 19D), input resistance measured at the 
steady-state ranging from 400 – 500 ms does not differ between WT and STEP KO neurons (Figure 
19E).  
Next, to see whether STEP affects the intrinsic excitability of hippocampal C2 pyramidal 
neurons, we evoked action potentials by injecting positive currents ranging from 0 to +200 pA for 
1 s in current-clamp mode (Figure 19C). Our data show that the number of depolarization-evoked 
spikes is significantly increased in STEP KO neurons, compared to those in WT neurons (WT = 
12.31 ± 1.83 Hz, n = 18; STEP KO = 22.05 ± 2.04 Hz, n = 20, *** p< 0.001; Figure 19C and 19D). 
In AP analysis, we observed hyperpolarized AP threshold (WT = - 42.74 ± 0.87 mV, n = 18; STEP 
KO = - 45.52 ± 0.50 mV, n = 20; Figure 19E) with no changes in AP amplitude (WT = 80.99 ± 
2.54 mV, n = 18; STEP KO = 82.70 ± 3.15 mV, n = 20; Figure 19E), AP half-duration (WT = 2.2 
± 0.25 ms, n = 18; STEP KO = 1.66 ± 0.12 ms, n = 20; Figure 19G), and first spike latency (WT 
= 270.32 ± 48.01 ms, n = 18; STEP KO = 168.33 ± 35.58 ms, n = 20; Figure 19I) in STEP KO 
neurons. These data suggest that STEP is likely to down-regulate the intrinsic excitability of 
hippocampal CA2 neurons under the normal condition. In addition, we wondered whether STEP 
regulates ionic conductance produced upon membrane hyperpolarization. To test this, we injected 
square-wised hyperpolarizing step of current injection from -50 to -500 pA for 1 s with a holding 
potential of -70 mV and measured the amplitude of voltage sag and rebound potential (Figure 20A). 
Based on the difference of maximal voltage deflection in response to hyperpolarizing current input, 
membrane potential was normalized by the maximal negative voltage and then recalculated as a 
percent. Our data reveal that STEP KO mice display elevation of voltage sag (WT = 11.37 ± 0.98 
mV at - 500 pA, n = 18; STEP KO = 17.81 ± 1.49 mV at - 500 pA, n = 16; Figure 20B), sag % 
(WT = 6.98 ± 0.7% at - 500 pA, n = 18; STEP KO = 12.78 ± 0.83% at - 500 pA, n = 16; Figure 
20C), and rebound depolarization (WT = 4.77 ± 0.63 mV at - 500 pA, n = 17; STEP KO = 7.96 ± 
0.54 mV at - 500 pA, n = 16; Figure 20D) as compared to those in WT mice. Collectively, these 
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data strongly suggest that STEP regulates the conductance of voltage-dependent ion channels that 
determine RMP, the intrinsic excitability, and voltage deflection produced by membrane 
hyperpolarization in the hippocampal CA2 pyramidal neurons.  
Genetic deletion of STEP leads to elevation of Ih currents in hippocampal CA2 neurons 
 Previous reports have demonstrated that HCN channels contribute to determining RMP, 
neuronal excitability, voltage sag, and rebound potentials in the hippocampal pyramidal neurons 
(Ludwig, Budde et al. 2003, Aponte, Lien et al. 2006, Dyhrfjeld-Johnsen, Morgan et al. 2008, Yi, 
Zhang et al. 2013). Based on our observations on depolarized RMP and elevated voltage sag in 
hippocampal CA2 pyramidal neurons lacking STEP, we hypothesized that STEP might regulate 
the function of HCN channels. To test this hypothesis, we recorded Ih currents through HCN 
channels upon membrane hyperpolarization ranging from -60 to -120 mV in the presence of Ba2+, 
an inhibitor for inward rectifying potassium channel (Figure 21A). Our recordings show that the 
amplitude of Ih currents in STEP KO neurons is higher than those in WT neurons (WT = - 43.06 
± 5.62 pA at -100 mV, n = 13; STEP KO = - 70.98 ± 6.47 pA at -100 mV, n = 12, **p < 0.01; 
Figure 21B and 21C). In addition, STEP KO neurons show positively shifted the half-maximal 
voltage (V1/2) toward depolarized potential (WT = - 99.46 ± 0.96 mV, n = 13; STEP KO = - 94.60 
± 0.64 mV, n = 12, ***p < 0.001; Figure 21D and Table.1) and alter I/Imax (WT = 0.502 ± 0.02, 
n = 13; STEP KO = 0.615 ± 0.02, n = 12, **p < 0.01; Figure 21E), the slope factor (k) (WT = 8.83 
± 0.42, n = 13; STEP KO = 9.42 ± 0.09, n = 12, *p < 0.05; Table.1),  Tau value for activation (WT 
= 222.89 ± 14.06 ms at – 100 mV, n = 13; STEP KO = 174.87 ± 9.95 ms at – 100 mV, n = 12, **p 
< 0.01; Figure 21F and Table.1), and the amplitude of tail currents (WT = - 17.16 ± 2.95 pA at – 
100 mV, n = 13; STEP KO = - 28.54 ± 2.76 pA at – 100 mV, n = 12 , **p < 0.01; Figure 21G and 
Table.1). Taken together, our slice recordings in WT and STEP KO mice propose that STEP is 
likely to down-regulate the function of HCN channels in hippocampal CA2 neurons under 
physiological condition.  
Acute inhibition of STEP elevates sag voltage and Ih currents in primary hippocampal 
cultured neurons   
 To rule out the potential genetic compensation caused by a loss of STEP, we tested if acute 
inhibition of STEP is sufficient to elevate the function of HCN channels. Previously, we used this 
 
74 
TAT-STEP46 C-S peptide, acting as a substrate-trapping protein (Figure 22A) into the primary 
hippocampal cultures (DIV12-14) and confirmed that incubation of TAT-STEP46 C-S peptide 
successfully leads to an increase in basal levels of Tyr1472 phosphorylation of GluN2B and 3Tyr-
phosphorylation of GluA2 (Jang, Royston et al. 2015). For this study, we pre-incubated TAT-
STEP46 C-S peptide into the primary hippocampal cultured neurons for 30 min before recording and 
then measured the passive and active properties in the primary cultured hippocampal neurons. 
TAT-myc was used as control peptide. Unexpectedly, our recordings reveal that the capacitance, 
RMP, input resistance, the frequency of APs, the analysis of APs do not differ between TAT-myc 
and TAT- STEP46 C-S groups (Figure 27). To measure the amplitude of voltage sag and rebound 
potential, we injected square-wised hyperpolarizing step of current injection from -20 to -200 pA 
for 1 s with a holding voltage of – 60 mV and measured the amplitude of voltage sag and rebound 
potential (Figure 21B). In TAT- STEP46 C-S groups, sag voltage (TAT-myc = 12.06 ± 1.41 mV at - 
200 pA, n = 25; TAT- STEP46 C-S = 16.54 ± 1.70 mV at – 200 pA, n = 26, *p < 0.05; Figure 21C), 
sag% (TAT-myc = 9.29 ± 0.90% at - 200 pA, n = 25; TAT- STEP46 C-S = 13.08 ± 1.07% at – 200 
pA, n = 26, **p < 0.01; Figure 21D), and rebound potential (TAT-myc = 5.47 ± 0.71 mV at - 200 
pA, n = 17; TAT- STEP46 C-S = 8.03 ± 0.89 mV at – 200 pA, n = 16, *p < 0.05; Figure 21E) are 
increased, compared to those in TAT-myc group. In addition, we recorded Ih currents elicited by 
membrane hyperpolarization ranging from – 60 mV to - 110 mV for 1 s (Figure 22A) and found 
that the amplitude of Ih currents is increased in TAT- STEP46 C-S groups (TAT-myc = - 43.47 ± 
6.10 pA at – 110 mV, n = 24; TAT- STEP46 C-S = -72.55 ± 9. 93 pA at –110 mV, n = 26, *p < 0.05; 
Figure 22B and 22C). However, we did not see any changes of biophysical properties of Ih currents 
(Figure 22D-G, Table. 2), including the half-maximal voltage (V1/2) (TAT-myc = - 96.31 ± 1.00 
mV, n = 24; TAT- STEP46 C-S = - 94.45 ± 0. 84 mV, n = 27), I/Imax (TAT-myc = 0.52 ± 0.08, n = 
24; TAT- STEP46 C-S = 0.64 ± 0.02, n = 27), the slope factor (k) (TAT-myc = 4.69 ± 0.43, n = 24; 
TAT- STEP46 C-S = 6.08 ± 0.32, n = 27), Tau value (ms) for activation (TAT-myc = 358.08 ± 43.94 
ms at -110 mV, n = 24; TAT- STEP46 C-S = 391.78 ± 28.79 ms at -110 mV, n = 27), and the 
amplitude of Tail currents (TAT-myc = - 22.46 ± 2.51 pA at -110 mV, n = 24; TAT- STEP46 C-S = 
- 38.15 ± 7.46 pA at -110 mV, n = 27). Taken together, acute inhibition of STEP activity elevates 
voltage sag, rebound potentials, and Ih currents elicited upon membrane hyperpolarization, 
suggesting that STEP down-regulate the function of HCN channels in the primary hippocampal 




Co-expression of STEP61 WT and STEP61 C/S reduces Ih currents and the total expression of 
HCN2 in CHO hm1 cells  
Since sag voltage and Ih currents are mediated by HCN channels, our findings on elevation 
of sag voltage and Ih currents under both genetic and acute inhibition of STEP (Figure 20-22) 
strongly indicate that STEP down-regulates the function of HCN channels. Previously, it was 
reported that pharmacological inhibition of tyrosine kinase reduces Ih currents mediated via HCN2 
channel, but not HCN1 channels (Yu, Lu et al. 2004) and over-expression of receptor-like tyrosine 
phosphatase-α (RPTP-α) remarkably inhibits HCN2 channel expression (Huang, Huang et al. 
2008). These literatures raise a hypothesis that STEP might negatively modulate the expression 
and/or the activation kinetics of HCN2 channels. To test this, we transfected CHO hm1 cells with 
pEGFP-HCN2 and empty pcDNA3 vector, or pcDNA3-STEP61 WT, or pcDNA3-STEP61 C/S, an 
inactive form of STEP where the cysteine residue is replaced with serine. The expression of 
mHCN2 and STEP61 proteins in CHO hm1 cells was confirmed by immunocytochemistry (Figure 
24A). We made the whole-cell patch clamp configuration into CHO hm1 cells with green 
fluorescence (Figure 24B). Table.3 displays that cell capacitance in all groups does not alter (NT 
= 13.29 ± 0.63 pF, n = 12; CTL = 12.93 ± 0.95 pF, n = 20, STEP61 WT= 15.87 ± 1.55 pF, n = 10, 
STEP61 C/S= 16.59 ± 2.07 pF, n = 10, *p < 0.05) (Table. 3), whereas co-transfection of pEGFP-
HCN2 and pcDNA3 vector leads to depolarized RMP (NT = - 17.37 ± 1.49 mV, n = 12; CTL = - 
10.45 ± 0.47 mV, n = 20, STEP61 WT= - 16.59 ± 1.72 mV, n = 10, STEP61 C/S= - 15.23 ± 1.55 
mV, n = 10, ***p < 0.001). To elicited Ih currents, we changed the membrane potentials ranging 
from 0 to – 120 mV for 1 s in voltage-clamp mode (Figure 24C). Our recordings reveal that non-
transfected CHO hm1 cells do not show Ih currents and over-expression of STEP61 WT and STEP61 
C/S reduces the density of Ih currents in CHO hm1 cells expressing mHCN2 channel (CTL = - 
20.63 ± 2.22 pA/pF at -120 mV, n = 20; STEP61 WT= - 12.89 ± 1.77 pA/pF at – 120 mV; STEP61 
C/S= -10.70 ± 1.00 pA/pF at -120 mV, *p < 0.05) (Figure 24D and 24E). In addition, however, 
there are no significant changes in biophysical properties of Ih currents (Figure 24F-I, Table. 4), 
including the half-maximal voltage (V1/2) (CTL = - 91.28 ± 1.82 mV, n = 20; STEP61 WT= - 91.09 
± 2.19 mV, n = 10; STEP61 C/S= - 91.48 ± 4.91 mV, n = 10), I/Imax (CTL = 0.57 ± 0.02, n = 20; 
STEP61 WT= 0.57 ± 0.03, n = 10; STEP61 C/S= 0.55 ± 0.05, n = 10), the slope factor (k) (CTL = 
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15.93 ± 0.96, n = 20; STEP61 WT= 15.15 ± 1.02, n = 10; STEP61 C/S= 15.59 ± 3.58, n = 10), Tau 
value (ms) for activation (CTL = 448.46 ± 43.89 ms at - 120 mV, n = 20; STEP61 WT= 426.49 ± 
62.16 ms at - 120 mV, n = 10; STEP61 C/S= 378.75 ± 62.03 ms at - 120 mV, n = 10, ***p < 0.001), 
and the amplitude of tail currents (CTL = - 42.90 ± 4.86 pA at - 120 mV, n = 20; STEP61 WT= - 
37.89 ± 5.59 pA at - 120 mV, n = 10; STEP61 C/S= - 33.08 ± 5.43 pA at - 120 mV, n = 10). 
Collectively, our electrophysiology data in CHO hm1 cells suggest that STEP inhibits the currents, 
but not kinetics of HCN2 channels.  
STEP61-mediated reduction of HCN2 channel is associated with the activity of STEP and 
proteasome pathway 
To investigate the mechanisms that underlie reduction of HCN-mediated Ih currents via 
STEP61 protein, we first executed immunoblotting using the cell lysate of CHO hm1 cells that 
express pEGFP-HCN2 and empty pcDNA3 vector, or pcDNA3-STEP61 WT, or pcDNA3-STEP61 
C/S. Consistent with electrophysiological recordings, our western data reveal that over-expression 
of STEP61 WT (Figure 25A) and STEP61 C/S (Figure 25B) leads to a significant reduction in the 
expression of HCN2 channels at 24 and 48h following transfection (STEP61 WT = 67.45 ± 8.37% 
at 24h, n = 7; STEP61 C/S = 74.29 ±  9.19% at 24h, n = 7, **p < 0.01; STEP61 WT = 48.39 ± 11.86% 
at 48h, n = 6; STEP61 C/S = 63.88 ±  9.63% at 48h, n = 6, *p < 0.05), suggesting that STEP61 
negatively regulates the protein expression of HCN2 channels. Next, we tested whether reduction 
of HCN2 channels through STEP61 protein is dependent upon the proteasome-associated 
degradation pathway, the mechanism by which the majority of intracellular proteins are degraded. 
Our data show that pharmacological inhibition of proteasome using MG132 for 12 h does not 
induce STEP61-mediated reduction of HCN2 channels (DMSO = 157.87 ± 32.46% at 24h, n = 7; 
MG132 = 157.56 ± 39.07% at 24h, n = 8, N.S versus CTL + DMSO group; Figure 25C), indicating 
that the ubiquitin-proteasome system is involved in reduction of HCN2 channel via STEP61 protein. 
Lastly, it was reported that tyrosine residue (Tyr476) in the C-linker of HCN2 channel is 
phosphorylated by Src kinase, resulting in the changes in activation kinetics of HCN2 channels 
(Zong et al. 2005). To further check whether Tyr476 and Tyr481 in HCN2 channels involve STEP61-
mediated down- regulation of HCN2 channel, we transfected with mutants (Y476F and Y481F) 
and then measured the protein expression of HCN2 channels. Our data show (Figure 25D and 25E) 
that both Y476F and Y481F do not lead to reduction of HCN2 channel (Y476F = 91.12 ± 10.68% 
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at 24h, n = 8; Y481F = 118.07 ± 28.56% at 24h, n = 5; N.S versus WT group; Figure 25D) and 
STEP WT reduces the expression of both WT HCN2 and mutated HCN2 channels (STEP WT + 
WT HCN2= 67.50 ± 9.54% at 24h, n = 8; STEP WT + Y476F = 60.45 ± 11.75% at 24h, n = 8; 
STEP WT + WT HCN2= 73.49 ± 8.10% at 24h, n = 5; STEP WT + Y481F = 65.67 ± 11.88% at 
24h, n = 5; Figure 25E), suggesting that neither tyrosine residue at 476 and 481 is associated with 
the regulation of HCN2 channel expression. 
 
DISCUSSION  
 In this study, we provide the first evidence on novel roles of STEP in regulating the intrinsic 
excitability and the function of HCN channels in hippocampal pyramidal neurons. In our 
electrophysiological recordings, we found depolarized RMP with no changes in capacitance in 
CA2 neurons of STEP KO mice (Figure 26A and 1B), implying that STEP might regulate the ionic 
conductance that determine RMP in hippocampal pyramidal neurons. In addition, our AP analysis 
reveals that STEP KO neurons display elevated frequency of APs (Figure 19C and 19D) and 
hyperpolarized APs threshold (Figure 19E), raising a possibility that the activity of low-threshold 
Na+ channel and K+ channel might be altered due to a lack of STEP. Indeed, tyrosine 
phosphorylation/dephosphorylation in voltage-dependent ion channels, including Nav, Kv, and 
HCN channels have been considered as a critical cellular event that affects their amplitude and 
kinetics. For example, genetic ablation of non-receptor tyrosine phosphatase (PTPs) causes a 
decrease in delayed-rectifier K+ channels (IK) such as Kv1.1 and Kv7.2/7.3 currents as well as an 
increase in large-conductance Ca2+-activated K+ currents, contributing to elevated excitability in 
PTP knock-out mice (Ebner-Bennatan, Patrich et al. 2012). In addition, pharmacological inhibition 
of tyrosine phosphatase leads to a negative shift in the voltage-dependence of inactivation, and 
association of Nav1.2 channel with receptor tyrosine phosphatase β (RPTPβ) gives rise to 
dephosphorylation of the channel, resulting in a depolarizing shift of inactivation and slowed 
inactivation kinetics (Ratcliffe, Qu et al. 2000). Taken together, it is highly possible that STEP-
mediated tyrosine-dephosphorylation could involve the regulation of the function of voltage-
dependent ion channels, determining neurons intrinsic properties.  
 Among a variety of voltage-dependent ion channels that activate upon membrane 
depolarization/hyperpolarization, HCN channels have unique biophysical features, including the 
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voltage deflections in response to both membrane depolarization/hyperpolarization (Biel, Wahl-
Schott et al. 2009). Moreover, at the membrane potential near RMP, HCN channels are 
constitutively open, allowing for a depolarizing and non-inactivating inward currents and thereby 
setting the membrane potential to more depolarized potentials (Biel, Wahl-Schott et al. 2009). 
Upon membrane hyperpolarization, HCN channels produce Ih currents responsible for voltage sag 
to a steady hyperpolarizing current (Banks, Pearce et al. 1993), stabilizing the membrane potential. 
Typically, elevation of Ih currents is thought to be associated with reduction of intrinsic and 
dendritic excitability via modulation of input resistance (Huang, Walker et al. 2009, Brager, 
Akhavan et al. 2012). However, an up-regulation of Ih currents is found in hyper-excitable CA1 
pyramidal neuron following experimental febrile seizures (Dyhrfjeld-Johnsen, Morgan et al. 2008). 
Consistently, computational model in CA1 pyramidal neurons reveals that only an increase of Ih 
currents could directly affect neuronal firings. These experimental and modeling results strongly 
suggest that elevation of Ih currents can co-exist with an elevation of evoked action potentials, 
consistent with our data that show an elevation of both intrinsic excitability (Figure 19C and 19D) 
and Ih currents (Figure 21). Further, it could be hypothesized that depolarized RMP (Supplemental 
figure 1) and elevated frequency of AP (Figure 19C and 19D) in STEP KO neurons might be due 
to the alterations in Ih currents mediated by HCN channels. Indeed, expectedly, we could see an 
increased amplitude of HCN channels-mediated Ih currents in STEP KO neurons (Figure 21) in 
the presence of Ba2+, an inhibitor of inward rectifier potassium channels. Consistently, we found 
an elevation in sag voltage and rebound potential generated by activated HCN channels in neurons 
where the expression and activity of STEP (Figure 20 and 22), strongly suggesting that STEP 
down-regulates the function of HCN channels under physiological condition.  
The function of HCN channels is facilitated by direct interaction of cAMP with CNBD on 
the COOH terminus of HCN channels (Wang, Chen et al. 2001, Zagotta, Olivier et al. 2003). For 
example, an elevation of cAMP through activation of D1 dopamine receptor leads to a positive 
shift of V0.5 values and an acceleration of the opening kinetics (Mercuri, Bonci et al. 1995). 
Though highly speculative, it could be plausible that a positive shift of voltage-dependency for 
channel activation and shortened Tau activation (ms) in neurons lacking STEP (Figure 21B) might 
be due to elevation of basal endogenous cAMP levels in STEP KO neurons. Indeed, given that 
STEP activity is governed via cAMP-PKA pathway triggered from D1 receptor activation, it is 
likely that absence of STEP might increase basal availability of intracellular cAMP binding to 
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CNDB in HCN channels. In addition to cyclic nucleotides-mediated regulation of HCN channels, 
the tyrosine phosphorylation/dephosphorylation of HCN channels are well-known mechanisms by 
which their function is determined. Previously, it was reported that over-expression of the receptor-
like protein-tyrosine phosphatase-alpha (RPTPalpha), known as a positive regulator of Src tyrosine 
kinase, (Ponniah, Wang et al. 1999, Su, Muranjan et al. 1999) inhibits the surface expression and 
ides tyrosine dephosphorylation of HCN2 channel, which coincides with reduced HCN2-mediated 
Ih currents (Huang, Huang et al. 2008), suggesting that dephosphorylation of HCN2 is likely to 
reduce the function of HCN2 channels. Consistently, we observed reduction in the protein 
expression of mHCN2 channel and HCN2 channel-mediated Ih current density without any 
changes in kinetics in CHO-hm1 cells expressing STEP61 WT and STEP61 C/S (Figure 24A and 
24B), indicating that STEP down-regulates HCN2 channels expression, but does not affect the 
kinetics of HCN2 channel.  
Based on our findings, we can speculate that one of possible mechanism by which STEP 
reduces the expression of HCN2 channel might be direct dephosphorylation of HCN2 channel via 
STEP. Among 17 tyrosine residues identified in HCN2 channel, we evaluated 2 tyrosine residues 
(Y476 and Y481) known to be regulated by Src kinase (Zong, Eckert et al. 2005). Although we 
could not see any changes in both the basal expression and STEP-mediated expression of HCN2 
channels upon both mutants, including Y476F and Y481F (Figure 25D and 25E), it is still likely 
that other tyrosine residues are dephosphorylated directly via STEP, leading to reduction of HCN2 
channel. Another plausible mechanism by which STEP could control the function of HCN2 
channels is by controlling the phosphorylated state of its substrates such as p-38 and ERK1/2. 
Indeed, it was reported that p38-mitogen-activated protein (MAP) kinase, a substrate of STEP, up-
regulates Ih currents through a positive shift in V1/2 of Ih activation curve with a depolarization of 
RMP in the hippocampal neurons (Poolos, Bullis et al. 2006). This allows us to speculate that 
STEP-mediated reduction of HCN2 channels could be mediated by dephosphorylating its 
substrates such as p38-MAPK. Lastly, despite no evidence on the relationship between ERK1/2 
and HCN2 channels, it is plausible that down-regulation of ERK1/2 signaling via STEP could 
reduce activation of multiple transcription factors such as Elk-1 and CREB, contributing to STEP 
-mediated reduction in HCN2 channels expression.  
Considering that immune-reactivity of STEP is intensively labeled in hippocampal CA2 
regions (Boulanger, Lombroso et al. 1995), it is plausible that STEP might contribute to 
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hippocampus-dependent behaviors such as social aspects of a memory, known to be associated 
with CA2 neurons (Hitti and Siegelbaum 2014, Alexander, Brown et al. 2018). Recent studies 
revealed that activation of CA2 neurons decreases high- frequency ripple events (Alexander, 
Brown et al. 2018) as well as induces the shift of the E/I balance toward inhibition in hippocampal 
CA3 and CA1 neurons (Boehringer, Polygalov et al. 2017). Given an inhibitory role of CA2 output 
as gates in hippocampal excitability via a feed-forward inhibition (Boehringer, Polygalov et al. 
2017), it could be hypothesized that elevated intrinsic excitability in hippocampal CA2 neurons 
lacking STEP might involve reduced hippocampal network activity and behavioral alterations in 
STEP KO mice.  
Over the past decades, accumulating evidence has suggested that impaired expression or 
dysregulation of HCN channels could underlie the pathogenesis of excitability-related 
neurological disorders such as epilepsy. For example, developmental febrile seizures are followed 
by elevation of HCN2 mRNA and reduction of HCN1 mRNA in hippocampal CA3 and CA1 
pyramidal cell layers (Brewster, Bender et al. 2002). Although we did not test behavioral 
consequence of elevated HCN function in hippocampal CA2 neurons lacking STEP, it would be 
interesting to investigate how enhanced function of HCN channels in hippocampal pyramidal CA2 
neurons affects hippocampal network excitability and seizure behaviors in STEP KO mice.  
 
FUTURE DIRECTION 
 In the future, it would be important to study the mechanisms by which STEP negatively 
regulates the intrinsic neuronal excitability and the function of HCNs under the normal condition. 
Considering that hippocampal pyramidal neurons lacking STEP protein show the changes of the 
frequency and kinetics of APs (Figure 19), it is likely that STEP might control the function of 
voltage-dependent Na+ and K+ channels that determine neuronal excitability. Further investigation 
is needed to figure out what types of ion channels activated membrane depolarization are 
controlled by STEP. In addition, HCN channels regulate somatic and dendritic excitability, which 
is known to involve the pathogenesis of multiple types of neurological disorders (Ludwig, Budde 
et al., 2003, Shah, Anderson et al., 2004). Based on the involvement of HCN channels in neuronal 
excitability, understanding regulatory mechanisms of HCNs via STEP could provide a potential 
therapeutic option that allows us to manipulate neuronal activity. Furthermore, on the basis of 
previous literature on an inhibitory role of hippocampal CA2 neurons in seizure propensity 
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(Boehringer et al., 2017), it would be intriguing to investigate how STEP-mediated modulation of 
excitability in hippocampal CA2 neuron contributes to determining seizure propensity. The use of 
CA2-specific conditional STEP KO mice would provide the clue into the role of STEP in 
hippocampal CA2 regions in network excitability and seizure behaviors.  Throughout further 
investigation suggested above, STEP could be proposed as a novel candidate for the treatment of 
neuronal hyper-excitability related diseases.  
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Figure 19. Genetic deletion of STEP alters the intrinsic excitability of hippocampal CA2 
neurons. (A) Representative immunoblots of STEP61, GluN2B-pY
1472, GluN2B, ERK1/2-
pY204/187, ERK1/2, and GAPDH in crude synaptosomal P2 membrane fractions. (B) A higher 
magnification of this image shows a CA2 neuron patched with a glass pipette (lower, scale bar 20 
μm). Whole-cell patch clamp recording of hippocampal CA2 neurons was performed in acute 
transverse hippocampal slices from STEP WT mice (n = 18 neurons in 9 mice) and STEP KO mice 
(n = 20 neurons in 5 mice). In current clamp mode, spike trains were evoked by delivering somatic 
current pulses in the range of 0 to 200 pA for 1 s duration at a holding potential of -70 mV. (C) 
Recording protocol and representative traces of action potentials (AP) and protocol. (D) Average 
AP firing rates (Hz) are elevated in hippocampal CA2 neurons of STEP KO mice compared to 
STEP WT mice. AP properties of hippocampal CA2 neurons in STEP WT mice and STEP KO 
mice were analyzed from the first single spike. (E) AP threshold (mV) was hyperpolarized in STEP 
KO CA2 neurons compared to WT neurons. No differences were observed for (F) AP amplitude 
(mV), (G) AP half-duration (ms), and (I) the first spike latency (ms). Data shown represent the 


























Figure 20. Genetic deletion of STEP increases sag voltage and rebound potential in 
hippocampal CA2 neurons. Current clamp recording was carried out in hippocampal CA2 
neurons of STEP WT mice and STEP KO mice during the hyperpolarizing current injections in 
the range of -50 to – 500 pA for 1 s duration at a holding potential of -70 mV. (A) Recording 
protocol and representative traces of membrane potentials. (B) Average sag voltage (mV) is larger 
in hippocampal CA2 neurons of STEP KO mice (n = 18 neurons in 9 mice) compared to WT 
neurons (n = 16 neurons in 5 mice). (C) Average normalized sag voltage by maximal potential 
presented as sag percentage (%). (D) Average rebound depolarization (mV) is elevated in 
hippocampal CA2 neurons of STEP KO mice (n = 18 neurons in 9 mice) compared to STEP WT 








Figure 21. Genetic deletion of STEP alters the amplitude and kinetics of Ih currents in 
hippocampal CA2 neurons. Whole-cell patch clamp recording of hippocampal CA2 neurons was 
performed in acute transverse hippocampal slices from STEP WT mice (n = 13 neurons in 4 mice) 
and STEP KO mice (n = 12 neurons in 2 mice). In voltage clamp mode, changes in currents were 
evoked by applying voltage step from the holding potential -60 mV to -120 mV. (A) Recording 
protocol and representative traces of Ih. (B) Average Ih amplitude (pA) at all voltage steps. Ih is 
larger in hippocampal CA2 neurons of STEP KO mice compared to WT neurons. (C) Average Ih 
amplitude (pA) at – 100 mV. (D) Normalized Ih current at all voltage steps. A positive shift in 
voltage-dependency for activation was observed in STEP KO hippocampal CA2 neurons 
compared to WT neurons. (E) Normalized Ih current at – 100 mV. (F) Tau activation (ms) of Ih.  








Figure 22. Acute application of a substrate trapping STEP inhibitor TAT-STEP46 C/S 
increases sag voltage and rebound potential in cultured hippocampal neurons. (A) A 
simplified schematic (not to scale) of cell-permeable TAT-STEP molecular tools including TAT-
myc (negative control) and substrate trapping TAT-STEP46 C/S containing a C300S mutation 
which allows it to bind constitutively to substrates but not to dephosphorylate them. (B-E) Whole-
cell patch clamp recording of rat dissociated hippocampal neurons in primary culture was 
performed at DIV 12-14 after the neurons were incubated for 30 min with TAT-myc (n = 24 
neurons) or TAT- STEP46 C/S (n = 27 neurons). (B) Recording protocol and representative traces 
of membrane potentials evoked by the hyperpolarizing current injections in the range of -20 to – 
200 pA for 1 s duration at a holding potential of -60 mV. (C) Average amplitude of sag voltage in 
hippocampal pyramidal neurons. (D) Average sag percentage (%). (E) Average rebound 
depolarization (mV) is elevated in hippocampal pyramidal neurons pre-treated with TAT-STEP46 
C/S compared to those treated with TAT-myc control. Data shown represent the mean ± SEM (* 




Figure 23. Acute application of a substrate trapping STEP inhibitor TAT-STEP46 C/S 
increases the amplitude but not kinetics of Ih currents in cultured hippocampal neurons.  
Whole-cell patch clamp recording of rat dissociated hippocampal neurons in primary culture was 
performed at DIV 12-14 after neurons were incubated for 30 min with TAT-myc or TAT- STEP46 
C/S. (A) Recording protocol and representative traces of Ih currents (pA) evoked by voltage step 
from the holding potential -60 mV to -110 mV. (B) Average Ih amplitude (pA) at all voltage steps. 
(C) Average Ih amplitude (pA) at – 100 mV is larger in hippocampal neurons treated with TAT- 
STEP46 C/S compared to TAT-myc. (D) Normalized Ih current at all voltage steps. (E) Normalized 
Ih current at – 100 mV. (F) Tau activation (ms) of Ih at – 110 mV.  (G) Tail currents of Ih (pA) at 









Figure 24.  Co-expression of STEP61 decreases inward currents through HCN2 channels in 
CHO-hm1 cells. (A) Immunocytochemistry of CHO hm1 cells transfected with pEGFP-HCN2 
and pcDNA3-STEP61 WT, or pEGFP-HCN2 and empty pcDNA3 vector at 48 h post transfection. 
Immunostaining was performed with anti-STEP antibody whereas nuclei are stained with DAPI. 
Expression of HCN2 was visualized by eGFP fluorescence. Scale bar 20 μm. (B-D) Whole-cell 
patch clamp recording was performed in CHO hm1 cells expressing HCN2-GFP and empty vector 
(CTL, n = 20), HCN2-GFP and STEP61 WT (n = 10),  or HCN2-GFP and STEP61 C/S (n = 10) at 
24-48 h post transfection. (B) Representative image of a patched CHOhm1 cells and (C) recording 
protocol and representative traces of inward currents evoked upon voltage step application ranging 
from the holding potential 0 mV to – 120 mV. (D) Average current density (pA/pF) at all voltage 
steps. (E) Average current density (pA/pF) at - 120 mV. (F) Normalized Ih current at all voltage 
steps. (G) Tau activation (ms) at – 120 ms. (I) Tail currents at – 120 mV. Data shown represent 









Figure 25. STEP61 decreases protein expression of HCN2 via proteasome-dependent 
degradation but independent of Tyr476 and Tyr481 phosphorylation of HCN2. (A) 
Immunoblot analyses of HCN2 and STEP61 on the lysate from CHO hm1 cells expressing HCN2 
and STEP61 WT (n = 7) or HCN2 and empty pcDNA3 vector (CTL, n = 7). GAPDH served as a 
loading control. The protein level of HCN2 was normalized to GAPDH, followed by normalization 
to CTL. (B) Immunoblot analyses of HCN2 and STEP61 in CHO hm1 cells transfected with HCN2 
and inactive mutant STEP61 C/S (n = 6) or empty vector (CTL, n = 6). Co-expression of STEP61 
WT but not STEP61 C/S decreases HCN2 protein expression. (C) Immunoblot analyses of HCN2 
and STEP61 from CHO hm1 cells after 24 h treatment with vehicle control DMSO (1% v/v) or 
proteasome inhibitor MG132 (1 μM).  MG132 treatment blocks the reduction in HCN2 expression 
caused by co-expression of STEP61. Total number of transfected cells analyzed in n = 8 
independent experiments: DMSO + HCN2 + CTL (n = 8), DMSO + HCN2 + STEP61 WT (n = 8), 
MG132 + HCN2 + CTL (n = 8), MG132 + HCN2 + STEP61 WT (n = 8). Data shown represent the 
mean ± SEM (*p < 0.05). (D-E) Immunoblot analyses of CHO hm1 cells expressing STEP61 and 
HCN2 WT or dephosphorylation-mimic mutants Y476F (D) and Y481F (E). Co-expression of 
STEP61 decreases protein levels of dephosphorylation-mimic HCN2 mutants to a similar extent as 
HCN2 WT. (D) Total number of transfected cells analyzed in n = 8 independent experiments: 
HCN2 WT + CTL (n = 8), HCN2 Y476F + CTL (n = 8), HCN2 WT + STEP61 WT (n = 8), HCN2 
Y476F + STEP61 WT (n = 8). (E) Total number of transfected cells analyzed in n = 5 independent 
experiments: HCN2 WT + CTL (n = 5, HCN2 Y481F + CTL (n = 5), HCN2 WT + STEP61 WT (n 





















Figure 26. Genetic deletion of STEP alters passive properties of hippocampal CA2 neurons. 
Whole-cell patch clamp recording of hippocampal CA2 neurons was performed in acute transverse 
hippocampal slices from STEP WT mice and STEP KO mice. The hippocampal CA2 neurons of 
STEP KO mice display (A) depolarized resting membrane potential (RMP, mV) but show (B) no 
difference in capacitance (pF) compared to WT mice (STEP WT = 19 neurons in 9 mice, STEP 
KO = 21 neurons in 5 mice). (C-D) Changes in the steady-state membrane potential (V) was 
induced by delivering brief somatic current (I) injections from – 50 pA to + 50 pA for 500 ms 
duration. Input resistance was determined by quantifying the slope from the I-V plot. (C) 
Representative traces of membrane potentials. (D) Average input resistance (MΩ) of STEP KO 
hippocampal CA2 neurons display similar input resistance as WT neurons (STEP WT = 20 














Figure 27. Acute application of a substrate trapping STEP inhibitor TAT-STEP46 C/S does 
not affect passive properties and intrinsic excitability of cultured hippocampal neurons. 
Whole-cell patch clamp recording of rat dissociated hippocampal neurons in primary culture was 
performed at DIV 12-14 after neurons were incubated for 30 min with TAT-myc (n = 24) or TAT-
STEP46 C/S (n = 27). Treatment with TAT-STEP46 C/S does not alter (A) capacitance (pF) nor (B) 
resting membrane potential (RMP, mV) (C) input resistance (MΩ) of hippocampal cultured 
neurons compared to the TAT-myc control treatment. (D) Representative traces of action 
potentials (AP) in cultured hippocampal neurons evoked by delivering somatic current pulses in 
the range of 0 to 200 pA for 1 s duration at a holding potential of -60 mV. (E) Average AP firing 
rates (Hz) in all current injections. Treatment with TAT-STEP46 C/S does not alter AP firing rates 
of hippocampal cultured neurons compared to the TAT-myc control treatment. No differences 
were observed for (F) AP threshold (mV), (G) amplitude (mV), (H) AP half-duration (ms), and (I) 





































Table 1. Biophysical properties of Ih currents recorded in pyramidal CA2 neurons  
from wild-type and STEP KO mice 
 
 
N, number; V1/2, half-activation potential calculated using normalized currents; k, the slope factor 
calculated using normalized currents. Tau activation time constant and Tail currents measured at 







Table 2. Biophysical properties of Ih currents recorded in primary hippocampal pyramidal 
neurons pre-incubated with TAT-Myc and TAT-STEP46 C/S 
 
N, number; V1/2, half-activation potential calculated using normalized currents; k, the slope factor 
calculated using normalized currents. Tau activation time constant and Tail currents measured at 






 N V1/2 (mV) k (mV/efold) 
Tau activation (ms) 
@ -100 mV 
Tail currents (pA)    
@ -100 mV 
WT 13 - 99.46 ± 0.96 *** 8.83 ± 0.42* 222.89 ± 14.06** - 17.16 ± 2.95** 
STEP KO 12 - 94.60 ± 0.64 9.42 ± 0.09 174.87 ± 9.95 - 28.54 ± 2.76 
 N V1/2 (mV) k (mV/efold) 
Tau activation (ms)      
@ -110 mV 
Tail currents (pA)       
@ -110 mV 
TAT-Myc 24 - 96.31 ± 1.00 4.69 ± 0.43 358.08 ± 43.94 - 22.46 ± 2.51 





Table 3. Passive properties of CHO hm1 cells transfected with pEGFP-HCN2, empty pcDNA3 
vector, pcDNA3-STEP61 WT, pcDNA3-STEP61 C/S 
 
N, number; Vm, resting membrane potential; Cm, whole cell membrane capacitance. Each value 






Table 4. Biophysical properties of Ih currents recorded in CHO hm1 cells transfected with 
pEGFP-HCN2, empty pcDNA3 vector, pcDNA3-STEP61 WT, pcDNA3-STEP61 C/S. 
 
 
N, number; V1/2, half-activation potential calculated using normalized currents; k, the slope factor 
calculated using normalized currents. Tau activation time constant and Tail currents measured at 






 N Cm (pF) Vm (mV) 
NT 12 13.29 ± 0.63 -17.37 ± 1.49 
HCN2 + CTL 20 12.93 ± 0.95 -10.45 ± 0.47 *** 
HCN2 + STEP61 WT 10 15.87 ± 1.55 -16.59 ± 1.72 







Tau activation (ms) 
@ -120 mV 
Tail currents (pA)  
@ -120 mV 
HCN2 + 
CTL 
20 - 91.28 ± 1.82 15.93 ± 0.96 448.46 ± 43.89 - 42.90 ± 4.86 
HCN2 + 
STEP61 WT 
10 - 91.09 ± 2.19 15.15 ± 1.02 426.49 ± 62.16 - 37.89 ± 5.59 
HCN2 + 
STEP61 C/S 
10 - 91.48 ± 4.91 15.59 ± 3.58 378.75 ± 62.03 - 33.08 ± 5.43 
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CHAPTER 6: OVERALL DISCUSSION 
In this dissertation’s experiments, I proposed that STEP involves homeostatic synaptic 
adjustment against long-term change of hippocampal network excitability under in vitro and in 
vivo conditions. Pharmacological alteration of hippocampal activity for 2 days changes the 
expression and activity of STEP in the primary hippocampal cultured neurons, contributing to 
homeostatic alteration of post-synaptic strength (Jang et al., 2015). In this project, although I did 
not study the underlying mechanism by which the expression of STEP is altered in response to 
chronic activity challenge, it is likely that altered expression of STEP is mediated via several 
immediate early genes such as brain-derived neurotrophic factor (BDNF) (Lee et al., 2015) and/or 
retinoic acid (RA) signaling via retinoic acid receptor-α (RARα) (Aoto et al., 2008). Further study 
designed to understand the detail mechanisms of altered STEP via chronic activity changes should 
offer substantial insight into the homeostatic control of STEP in the hippocampus.  
 Under in vivo condition, ECS successfully induces stage 4-5 seizures and the expression 
of STEP is elevated at 48 h following seizure (Jang et al., 2016).  In addition, the expression of 
APP and Aβ oligomers is increased at 72 h following a single seizure (Jang et al., 2016). In KA-
induced SE model, while the amount of Aβ in S2 fraction is elevated at 24h following SE in WT 
hippocampus, hippocampal lacking STEP protein leads to no increase of Aβ following SE. Given 
that STEP KO mice display seizure propensity associated with neuronal network activity, it is 
likely that reduced network activity in STEP KO mice might result in no significant elevation of 
Aβ production of at the early time point following SE. Further study should address the detail 
mechanisms by which STEP alters seizure propensity and network activity, affecting the 
production of Aβ in the hippocampus.  
Given that STEP and Aβ oligomers reduce post-synaptic strength (Jang et al., 2015; Palop 
et al., 2007; Palop & Mucke, 2010), elevation of STEP, APP, and Aβ oligomers upon network 
hyper-excitability might lead to homeostatic down-regulation of synaptic strength at the post-
synapses in the hippocampus. Because of a technical limitation of producing healthy hippocampal 
slices from adult rats, we could not directly measure sEPSC and/or mEPSC that reflect post-
synaptic strength in acute hippocampal slices of the rat following ECS. However, we evaluated 
GluN2B-pY1472 in the hippocampus and found reduced levels of GluN2B-pY1472 following a single 
ECS (Figure 9), suggesting that acute ECS results in homeostatic down-regulation of post-synaptic 
strength against global hyper-excitability.  
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 Besides the involvement of STEP in homeostatic synaptic plasticity, the results in Chapter 
5 of this dissertation strongly suggest that STEP plays a role in controlling the intrinsic neuronal 
excitability and the function of HCN channels. Previously, it was reported that voltage-dependent 
Na+ and K+ channels that determine neuronal excitability are regulated via tyrosine 
phosphorylation, raising the hypothesis that STEP is likely to control the function of voltage-
dependent ion channels via de-phosphorylation at their tyrosine residues. Indeed, we found that 
neurons lacking STEP gene show elevated frequency of action potentials (APs) (Figure 19), 
strongly supporting our hypothesis. Among many types of ion channels, especially, HCN channels 
are non-selective cation channels that fully activate upon membrane hyperpolarization. The key 
feature of this channel is that HCN channels constitutively open at RMP, setting the membrane 
potential to more depolarized potentials (Biel et al. 2009). In addition, opening of HCN channels 
upon membrane hyperpolarization produces Ih currents, stabilizing the membrane potential (Banks 
et al., 1993). Because of the unique features of HCN channels in neurons, the alteration of HCN1/2 
mRNA expression has been considered to underlie the pathogenesis of neurological disorders 
associated with neuronal hyper-excitability (Brewster, Bender et al. 2002). In this study, we also 
found that seizure propensity is reduced (Figure 16) and the function of HCN channels (Figure 21-
27) is elevated in STEP KO mice. These observations suggest that an increase of HCN function in 
hippocampal CA2 neurons lacking STEP gene could underlie a decrease of seizure susceptibility 
in STEP KO. Based on the data from STEP KO mice, further study should address whether STEP 
affect network excitability and oscillatory rhythmic activity which reflect the summated electrical 
activity of a population of neurons.  
Collectively, through several independent projects introduced in this dissertation, we 
discovered that STEP involves homeostatic regulation of synaptic strength as well as determines 
somatic excitability in the hippocampal neurons. Recently, it was reported that pharmacological 
inhibition of STEP using TC-2153 reverses cognitive deficits in a mouse model of Alzheimer’s 
disease (Xu et al., 2014). In the same line with previous report, our results would propose a novel 
therapeutic possibility of using STEP inhibitor for the treatment of neurological diseases 
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Electroconvulsive seizure (ECS) is an experimental animal model of electroconvulsive 
therapy, the most effective treatment for severe depression. ECS induces generalized tonic clonic 
seizures with low mortality and neuronal death, and hence it is a widely used model to screen anti-
epileptic drugs. Here we describe an ECS induction method in which a brief current of 55 mA was 
delivered for 0.5 sec to male rats of 200-250 grams via ear-clip electrodes. Such bilateral 
stimulation produced stage 4-5 clonic seizures that lasted about 10 sec.  After cessation of acute 
or chronic ECS, most rats recovered to be behaviorally indistinguishable from sham "no seizure" 
rats. Because ECS globally elevates brain activity, it has also been utilized to examine activity-
dependent alterations of synaptic proteins and their effects on synaptic strength by multiple 
methods. In particular, subcellular fractionation of the postsynaptic density (PSD) in combination 
with western blotting allows quantitative determination of the abundance of synaptic proteins at 
this specialized synaptic structure. In contrast to previous fractionation method that requires large 
amount of rodent brains, we describe here a small-scale fractionation method to isolate the PSD 
from the hippocampi of a single rat without sucrose gradient centrifugation. Using this method, 
we showed that the isolated PSD fraction contained postsynaptic membrane proteins including 
PSD95, GluN2B, and GluA2. Presynaptic marker synaptophysin and soluble cytoplasmic protein 
α-tubulin were excluded from the PSD fraction, demonstrating successful PSD isolation. 
Furthermore, ECS altered the expression of GluN2B in the PSD, indicating that our small-scale 
PSD fractionation method can be applied to detect the changes in hippocampal PSD proteins from 
a single rat after genetic, pharmacologic, or mechanical treatments.  
 
INTRODUCTION 
Electroconvulsive therapy has been used to treat patients with major depressive disorders 
including severe drug-resistant depression, bipolar depression, Parkinson’s diseases, and 
schizophrenia (Dierckx, Heijnen et al., 2012; McClintock, Choi et al., 2014). In this therapy, 
seizure is generated by electrical stimulus delivered to the head of anesthetized patients via 
epicranial electrodes (Dierckx, Heijnen et al., 2012; McClintock, Choi et al., 2014; Jelovac, 
Kolshus et al., 2013).  Repetitive administration of ECS has been clinically beneficial to drug-
resistant depressive disorders (Dierckx, Heijnen et al., 2012; McClintock, Choi et al., 2014; 
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Jelovac, Kolshus et al., 2013). However, the exact mechanism underlying its long-term efficacy of 
antidepressant effects in humans has remained elusive. ECS is an animal model of 
electroconvulsive therapy and is widely used to investigate its therapeutic mechanism. In rodents, 
both a single ECS and chronic ECS treatment promote adult neurogenesis in their hippocampi and 
reorganize neural network (Inta, Lima-Ojeda et al., 2013; Segi-Nishida, Warner-Schmidt et al., 
2008), which is likely to contribute to improvement of cognitive flexibility. Furthermore, global 
elevation of brain activity by ECS alters the abundance of transcripts such as a brain derived 
neurotropic factor (Zetterstrom, Pei et al., 1998) and multiple proteins including metabotropic 
glutamate receptor 1 and the N-methyl-D-aspartate (NMDA) type glutamate receptor subunits 
(Altar, Laeng et al., 2004). These changes are involved in mediating long-term modification of 
synapse number, structure, and strength in the hippocampus (Altar, Laeng et al., 2004; Ploski, 
Newton et al., 2006; Pusalkar, Ghosh et al., 2016).   
In ECS models, electrical stimulation is delivered to rodents via stereotaxically implanted 
electrodes, corneal electrodes, or ear electrodes in order to evoke generalized tonic-clonic seizures 
(Jang, Royston et al., 2016; Limoa, Hashioka et al., 2016). Stereotaxic implantation of electrodes 
involves brain surgery and requires significant time to improve the experimenter's surgical skills 
to minimize injury. Less invasive corneal electrodes could still cause corneal abrasion and dryness 
and require anesthesia.  The use of ear-clip electrodes bypasses these limitations because they can 
be used on rodents without surgery or anesthesia and cause minimum injury. Indeed, we found 
that current delivery to awake rats via ear-clip electrodes reliably induce stage 4-5 tonic-clonic 
seizures and alter synaptic proteins in their hippocampi (Jang, Royston et al., 2016). 
To examine ECS-induced abundance of synaptic proteins in the specific brain regions of 
the rodents, it is important to choose the experimental methods that are most suitable for their 
detection and quantification. Subcellular fractionation of the brain allows crude isolation of soluble 
cytosolic proteins, membrane proteins, organelle-bounds proteins, and even proteins in special 
subcellular structures such as postsynaptic density (PSD) (Vinade, Chang et al., 2003; Dosemeci, 
Tao-Cheng et al., 2006; Westmark, Westmark et al., 2011). The PSD is a dense and well-organized 
subcellular domain in neurons in which synaptic proteins are highly concentrated at and near the 
postsynaptic membrane (Vinade, Chang et al., 2003; Dosemeci, Tao-Cheng et al., 2006; Sheng, 
2001). The isolation of the PSD is useful to study synaptic proteins enriched at the PSD, since 
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dynamic changes in the abundance and function of postsynaptic glutamate receptors, scaffolding 
proteins, and signal transduction proteins in the PSD (Vinade, Chang et al., 2003; Sheng, 2001; 
Sheng & Hoogenraad, 2007, Ehrlich & Malinow, 2004) are correlated with synaptic plasticity and 
synaptopathy observed in several neurological disorders (Ehrlich & Malinow, 2004; Schnell, 
Sizemore et al., 2002), Previous subcellular fractionation method to purify the PSD involves the 
isolation of detergent-insoluble fraction from crude membrane fraction of the brain by differential 
centrifugation of sucrose gradients (Westmark, Westmark et al., 2011; Bermejo, Milenkovic et al., 
2014). The major challenge with this traditional method is that it requires large amount of rodent 
brains (Westmark, Westmark et al., 2011; Bermejo, Milenkovic et al., 2014). Preparation of 10-20 
rodents to isolate the PSD fraction per treatment requires extensive cost and time investment and 
is practically not feasible if there are many treatments.  
To overcome this challenge, we have adapted a simpler method that directly isolates the 
PSD fraction without sucrose gradient centrifugation (Tan, Queenan et al., 2015; Diering, Gustina 
et al., 2014), and revised it to be applicable for the PSD isolation from the hippocampi of a single 
rat brain. Our small-scale PSD fractionation method yields about 30 - 50 µg of the PSD proteins 
from 2 hippocampi sufficient to be used for several biochemical assays including 
immunoprecipitation and western blotting. Western blotting demonstrates the success of our 
method in isolating the PSD by revealing the enrichment of postsynaptic density protein 95 (PSD-
95) and exclusion of presynaptic marker synaptophysin and soluble cytoplasmic protein α-tubulin. 
Our ECS induction and small-scale PSD fractionation methods are easily adaptable to other rodent 
brain regions and provide a relatively simple and reliable way to evaluate the effects of ECS on 




Note: All experimental procedures including animal subjects have been approved by Institutional 





1. Maintaining a Rat Colony 
1.1) Breed Sprague-Dawley rats (strain origin: Charles River Laboratories) and maintain in 
standard conditions with a 12-hour (h) light-dark cycle and ad libitum access to food and water. 
1.2) Wean the rat pups at postnatal day (P) 28 and house them in groups of 2-4 male littermates or 
female littermates.  
1.3) Mark the tails of male rats with sharpies for identification. 
1.4) Weigh male rats 3 times per week and record their body weights.  
 
2. Preparation of an ECS machine  
2.1) At 7:30 am, disinfect the bench in the animal preparation room of the insitution's animal 
facility and place an ECS machine (pulse generator, ECT Unit 57800; Ugo Basile, Comerio, Italy) 
on the bench. 
2.2) Place an individual male rat weighing 200-250 grams (g) in a clean empty cage with a lid. 
Repeat this for all male rats to be treated with ECS induction. Let the rats habituate for 30 minutes 
(min).  
2.3) While the rats are habituating in their cages, set a pulse generator for ECS induction to the 
frequency of 100 pulse / sec, pulse width of 0.5 msec, shock duration of 0.5 sec, and current at 55 
mA.  
2.4) Prepare the pulse generator by pushing the "RESET" button and ensuring that the "READY" 
button is lit. Make sure that ear clips are not attached to a pulse generator, and then press the 
"SHOCK" button for a few seconds.  Now a pulse generator is ready for ECS induction. 
2.5) Plug in the ear clips to the pulse generator.  
 
3. Induction of a single ECS 
3.1) Wet the ear clips with sterile saline, and ensure that they are saturated with saline. 
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3.2) Wet the rat's ears with sterile saline by wrapping them in saline-soaked gauze. Once they are 
wet, remove the gauze. 
3.3) Attach one clip per ear beyond its main cartilage band. 
3.4) Confirm on the ECS machine that a true loop is established. If not, an error message or a 
reading of 1 will appear on the machine. 
3.5) Wear a thick non-metal glove. While holding the rat gently in a gloved hand, press the 
"SHOCK" button for a few seconds and slowly release the grip on the rat to observe seizure. For 
sham “no seizure” (NS) control, handle the rat identically but do not deliver the current. 
3.6) Disconnect the ear clips as clonus begins, and record the seizure behavior according to a 
revised Racine’s scale (Luttjohann, Fabene et al., 2009) which includes “mouth and facial movements” 
(stage 1), “head nodding” (stage 2), “forelimb clonus” (stage 3), “rearing with forelimb clonus” 
(stage 4), “rearing and falling with forelimb clonus” (stage 5). Seizure should last approximately 
10 sec. Record the seizure duration. 
3.7) Following seizure termination, return the rat to its home cage. Monitor the rat for another 5 
min to make sure the recovery of the rat from seizures. Keep it singly housed in the cage and return 
the cage to the recovery room. 
3.8) Repeat the ECS induction to the next rat.  
3.9) Monitor the rats throughout the remainder of the day, and at least once in the morning and 
once in the afternoon the following day until they are euthanized for experiments. 
Important notes on ECS induction: ECS induction method could lead to clinical signs as an 
incidental side effect, which requires attention. For example, ECS induction protocol could induce 
seizures that last longer than 15 sec and cause unnecessary distress to the rats. In this case, 
terminate the seizure by diazepam (10 mg/kg, i.p) or nembutal (25-30 mg/kg, i.p, pharmacological 
grade pentobarbital). If rats develop respiratory distress or severe behavioral abnormalities 





4. Induction of chronic ECS 
4.1) Repeat inducing a single ECS per day at the same time in the morning as described in steps 
#1-3 above for seven consecutive days. 
4.2) Monitor the rats twice a day after they are returned to their home cages. 
 
5. Homogenization and Fractionation of rat hippocampi 
5.1) Prepare a fresh homogenization buffer (Solution A) that contains 320 mM sucrose, 5 mM 
sodium pyrophospate, 1 mM EDTA, 10 mM HEPES pH 7.4, 200 nM okadaic acid, and Halt 
protease inhibitors (Thermo Fisher Scientific). Filter sterilize the buffer and place it on ice. 
5.2) At a given time point following a single ECS (acute ECS) or chronic ECS, euthanize the rat 
by CO2 inhalation for 5-10 min followed by decapitation using a guillotine.  
5.3) Remove the brain and dissect the hippocampi on the metal plate placed on ice as described. 
5.4) Place two hippocampi from one rat to a 30 mm tissue culture dish and mince them to small 
pieces using scissors.  
5.5) Transfer the minced hippocampi to a glass homogenizer and add 1 ml of ice-cold 
homogenization buffer (Solution A). Insert a round Teflon pestle to a glass homogenizer and gently 
and steadily stroke up and down 10-15 times to achieve mechanical homogenization. 
5.6) Transfer the homogenate to an eppendorf tube and centrifuge the homogenate at 800 x g for 
10 min at 4°C to separate the postnuclear supernatant (S1 fraction) from the pellet containing 
insoluble tissue and nuclei (P1 fraction). Save 50 µl of the S1 fraction to a new tube and store on 
ice. Save the P1 fraction pellet on ice. 
5.7) Transfer the rest of the S1 fraction (950 µl) to a new tube and centrifuge at 13,800 x g for 10 
min at 4°C to separate the supernatant (S2 fraction) enriched with cytosolic soluble proteins and 
the pellet (P2 fraction) enriched with membrane-bound proteins including synaptosomal proteins. 
Transfer the S2 fraction to a new tube and store on ice. 
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5.8) Resuspend the pellet (P2 fraction) in 498 µl ice-cold milli-Q water followed by addition of 2 
µl 1 M HEPES (pH7.4) to achieve 4 mM HEPES (pH 7.4) and incubate at 4°C with agitation for 
30 min.  Store the resuspended P2 fraction on ice.  
5.9) Determine the protein concentration of S1, S2, and P2 fractions using BCA assay (Pierce). 
Add 50 mM HEPES (pH 7.4) to each fraction to achieve 1 mg/mL concentration and store at -
80°C until use, or process the P2 fraction to isolate PSD. 
 
6. Isolation of Post-Synaptic Density (PSD) from crude membrane protein (P2) fraction 
6.1) Centrifuge the P2 fraction (500 µl) at 25,000 x g for 20 min at 4°C to separate the lysed 
supernatant (LS2 fraction) and the lysed pellet (LP1 fraction). Transfer the LS2 fraction to a new 
tube and store on ice. 
6.2) Resuspend the LP1 pellet in 250 µl of 50 mM HEPES (pH 7.4) mixed with 250 µl 1% Triton 
X-100 and incubate at 4°C with gentle agitation for 15 min.  
6.3) Centrifuge the resuspended LP1 pellet at 25,000 x g for 3 h at 4°C to separate the supernatant 
(non-PSD fraction) from the pellet (PSD fraction). Remove the supernatant to a new tube, and 
resuspend the PSD pellet in 100 µl of 50 mM HEPES (pH 7.4). 
6.4) Determine the protein concentration of LS2, non-PSD and PSD fractions using BCA assay. 
Add 50 mM HEPES (pH 7.4) to each fraction to achieve 1 mg/mL concentration and store at -
80°C until use. 
 
7. Western blotting 
7.1) Thaw each protein fraction on ice. Transfer 12 µl of each fraction (S2, P2, and PSD in 1 mg/ml) 
to a new eppendorf tube. 
7.2) Add 3 µl of 5x SDS sample buffer and incubate at 75°C for 30 min. Cool the sample down to 
room temperature. 
7.3) Load 10 µl of the protein sample into each well of 4-20% gradient 15-well comb SDS-
polyacrylamide gel electrophoresis (SDS-PAGE) gel (Biorad). Run the gel in the SDS-PAGE 
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apparatus (Biorad model, Mini-PROTEAN® Tetra Vertical Electrophoresis Cell, 1658004) and 
run at 80 - 100 V in Running Buffer (25 mM Tris, 190 mM glycine, 0.1% SDS, and pH 8.3). Each 
gel should contain protein samples from NS rat and ECS rats at different time point following 
acute ECS or chronic ECS.  
7.4) Transfer the proteins from the SDS-PAGE gel to polyvinyl difluoride (PVDF) membrane 
(Millipore) in the transfer apparatus (Biorad model, Mini Trans-Blot Module, 1703935EDU) at 25 
- 30 V (60 mA) for 9 - 12 h in Transfer Buffer (25 mM Tris, 190 mM Glycine, 20% Methanol, and 
pH 8.3). 
7.5) Remove the PVDF membrane from the transfer apparatus, and wash it in Tris-buffered saline 
(TBS) for 5 min. 
7.6) Block the membrane in 5% milk and 0.1% Tween-20 in TBS for 1 h and incubate it in primary 
antibodies in washing buffer (1% milk and 0.1% Tween-20 in TBS) overnight with gentle rotation 
at 4°C. 
7.7) Wash the membrane 4 times 10 min each in wash buffer, and then incubate it with horseradish 
peroxidase (HRP)-conjugated secondary antibodies in washing buffer for 1 h. 
7.8) Wash the membrane 4 times 10 min each in wash buffer, and then with TBS for 5 min. 
7.9) Incubate the membrane with enhanced chemifluorescence substrate (ECL, Thermo Fisher 
Scientific) for 1 min and expose it to X-ray film (HyBlot CL® Autoradiography File, Hyblot CL® 




Using a detailed procedure presented here, a single electrical shock (55 mA, 100 pulse / 
sec, for 0.5 sec) delivered via ear-clip electrodes induced nonrecurring stage 4-5 tonic clonic 
seizures in rats (Figure 28A-B). The seizures lasted about 10 sec and all rats recovered within 1-2 
min of seizure cessation. Sham "No Seizure" rats did not receive an electric shock and therefore 
did not display seizures. For chronic ECS induction, the rats received a single electric shock per 
day for 7 consecutive days and displayed stage 4-5 tonic clonic seizures upon each electric shock 
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(Figure 28A-B). Although most rats that received chronic ECS was behaviorally indistinguishable 
from sham "no seizure" rats, a few developed body tremors and reduced exploratory activity by 
the 7th electric shock.  
To examine if ECS-induced global elevation of activity alter protein expression in the 
hippocampi, rats were sacrificed at 3 h and 24 h after acute ECS, and at 24 h and 96 h after the 
final ECS in chronic ECS treatment (Figure 28B). Two hippocampi from each rat were rapidly 
dissected and subjected to our optimized small-scale fractionation protocol (Figure 29). The initial 
homogenate of two hippocampi free of insoluble tissue and nuclei (S1 fraction) was re-centrifuged 
at 13,800 x g for 10 min to separate the supernatant containing soluble cytoplasmic proteins (S2 
fraction) from the crude membrane pellet containing synaptosomes (P2 fraction) (Figure 29). Our 
western blot detected cytoplasmic protein α-tubulin in the S2 fractions but not P2 fractions of the 
hippocampi from rats treated with acute and chronic ECS (Figures 30-31), demonstrating 
successful fractionations of cytosolic soluble proteins from crude membrane pellets.  
PSD95 is a member of the membrane-associated guanylate kinase (MAGUK) family and 
a core component of PSD (Vinade, Chang et al., 2003; Schnell, Sizemore et al., 2002; Kim, Futai et al., 
2007). PSD95 was detected exclusively in the P2 fractions but not the S2 fractions (Figures 30-31). 
Similarly, stronger expression of glutamate receptor subunits including NMDA receptor subunit 
GluN2B and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor subunit 
GluA2 were detected in the P2 fractions compared to S2 fractions in the hippocampi (Figures 30-
31), indicating that postsynaptic membrane proteins are enriched in the crude membrane pellets. 
Interestingly, increasing trend of GluN2B expression in the P2 fraction was observed following 
acute ECS whereas decreasing trend of GluN2B level was found from rats with chronic ECS 
(Figures 30-31). Consistent with our previous report (Jang, Royston et al., 2016), there was an 
increasing trend in STEP61 expression at 24 h following acute ECS and chronic ECS (Figures 30-
31). Synaptic vesicle protein synaptophysin was detected equally in the S2 and P2 fractions 
(Figures 30-31). Considering the small size of synaptic vesicles with average diameter of 39 nm, 
the centrifugation to isolate crude membrane pellet (P2 fraction) might not have been sufficient to 
pellet all synaptic vesicles. These results together indicate that our crude fractionation protocol can 
enrich membrane-bound proteins and transmembrane proteins that are not associated with synaptic 
vesicles and possibly endosomes in crude membrane P2 fraction. To examine if ECS-induced 
global elevation of activity alters the expression of postsynaptic proteins in the hippocampi, the 
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crude membrane P2 fraction was lysed in ice-cold water, resuspended in HEPES buffer, and 
centrifuged at 25,000 x g for 20 min to isolate the lysed pellet (LP1) (Figure 29). The LP1 pellet 
was resuspended in HEPES buffer containing 1% triton X-100 detergent and centrifuged at 25,000 
x g over 3 h to obtain the PSD pellet (Figure 29). Subsequent western blot of the PSD fractions 
detected PSD95, GluN2B, and GluA2 (Figures 30-31), which are known postsynaptic proteins 
(Delaney, Sedlak et al., 2013, Ehrlich & Malinow, 2004, Kim, Futai et al., 2007). However, the 
PSD fractions lacked α-tubulin and importantly presynaptic marker synaptophysin (Figures 30-
31). STriatal Enriched Tyrosine Phosphatase (STEP61), which dephosphorylates GluN2B and 
GluA2 and acts as their negative regulator (Jang, Royston et al., 2016), was not found in the PSD 
fractions (Figures 30-31), consistent with the recent report demonstrating synaptic exclusion of 
STEP61 mediated by PSD95 enriched in the PSD. These results altogether indicate that our small-




Here, we describe an ECS induction method in rats, which elicit global stimulation of 
neuronal activity in their hippocampi. ECS is an animal model of electroconvulsive therapy, which 
is clinically used to treat drug refractory depressive disorders in humans ( Dierckx, Heijnen et al., 
2012; McClintock, Choi et al., 2014; Jelovac, Kolshus et al., 2013) . Despite therapeutic of 
electroconvulsive therapy to severe depression, the precise underlying mechanism remains unclear. 
Because ECS induces anti-depressant-like behaviors in rodents and stimulates hippocampal 
neurogenesis (Inta, Lima-Ojeda et al., 2013; Malberg, Eisch et al., 2000), ECS has been extensively 
used to investigate if new adult-born neurons in the dentate gyrus of the hippocampus contribute 
to anti-depressant behavior (Segi-Nishida, Warner-Schmidt et al., 2008; Malberg, Eisch et al., 2000).  
ECS induces mild to severe generalized tonic-clonic seizures in rodents upon current 
delivery through stereotaxically implanted electrodes, corneal electrodes, or ear-clip electrodes 
(Kandratavicius, Balista et al., 2014; Loscher, 2002). EEG recordings in patients have revealed that 
bilateral electrical stimulation causes more prominent and longer generalized seizures than 
unilateral stimulation does (Stromgren & Juul-Jensen, 1975).  In our ECS induction method, tonic 
clonic seizures are induced by current delivery through noninvasive ear-clip electrodes attached to 
both ears, mimicking seizures in humans evoked by bilateral stimulation. The critical step in the 
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ECS induction method is to experimentally dial the current intensity to elicit stage 4-5 generalized 
tonic-clonic seizures based on the age, weight, and the species of rodents. Our ECS induction 
method has been optimized for inducing stage 4-5 seizures in male Sprague-Dawley rats weighing 
200-250 g.  
ECS also offers an advantage of stimulating hyperactivity of neurons and causing acute 
transient seizures with very low mortality (Kandratavicius, Balista et al., 2014) in contrast to 
chemoconvulsants including pilocarpine and kainate which induce status epilepticus and cause 
chronic manifestation of spontaneous recurrent seizures and severe histological alterations (Duman 
& Vaidya, 1998; Andre, Ferrandon et al., 2000). Although ECS has been routinely utilized to screen 
anti-epileptic drugs (Kandratavicius, Balista et al., 2014; Loscher, 2002), acute ECS and chronic ECS 
do not result in the generation of chronic epilepsy and thus cannot be used as an animal model to 
study epileptogenesis. Instead, ECS has been widely employed to examine the extent to which 
broad elevation of brain activity alters expression and/or posttranslational modifications of 
synaptic proteins in vivo that contribute to persistent changes in synaptic strength and structures 
(Figures 30-31) (Hu, Park et al., 2010). 
Multiple methods have been employed to examine the extent to which ECS induces 
changes in neurogenesis, synaptogenesis, and synaptic plasticity (Segi-Nishida, Warner-Schmidt et 
al., 2008; Zetterstrom, Pei et al., 1998; Altar, Laeng et al., 2004; Ploski, Newton et al., 2006; Sakaida, 
Sukeno et al., 2013). Electrophysiological recording of excitatory postsynaptic current (EPSC) is 
widely used to detect the changes in synaptic strength of glutamatergic excitatory synapses (Diering, 
Gustina et al., 2014). For example, miniature EPSC recording has revealed homeostatic downscaling 
of excitatory synaptic strength in cortical pyramidal neurons of layer II-III of mice following a 
single ECS (Hu, Park et al., 2010). However, identification of synaptic proteins that contribute to 
ECS-induced synaptic plasticity is challenging because electrophysiological recordings have to be 
paired with genetic knock-out or knock-down of specific candidate synaptic proteins. Changes in 
the level of glutamate receptors at the postsynaptic membrane and synaptic proteins enriched in 
the PSD regulate the strength and efficacy of excitatory synaptic transmission (Ehrlich & Malinow, 
2004; Schnell, Sizemore et al., 2002; Kim, Futai et al., 2007). Although immunohistochemistry can be 
used to examine ECS-induced changes in the expression of synaptic proteins, this technique can 
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examine only 1-2 candidate synaptic proteins at a time and require well-validated antibodies that 
specifically recognize them without causing non-specific staining.  
Subcellular fractionation of brain tissue in combination with western blotting offers 
advantages over electrophysiology and immunohistochemistry in identifying synaptic proteins that 
are altered by ECS. Subcellular fractionation of brain tissue is a rapid and crude biochemical 
method to separate soluble cytosolic proteins (S2 fraction) from crude membranes (P2 fraction) 
including ER and Golgi membranes, membrane-bound organelles, plasma membranes, synaptic 
terminal membranes that reseal to form synaptosomes. The PSD fraction can be further isolated 
from the P2 fraction to enrich synaptic proteins. Unbiased proteomic analysis of the PSD fraction 
could identify all PSD proteins whose levels are altered by ECS. Western blotting can be 
performed rapidly to examine the expression changes of the PSD proteins which can be easily 
identified from non-specific bands.  
Previous method of brain fractionation requires large amount of rodent brain tissues 
(Blackstone, Moss et al., 1992; Lau, Mammen et al., 1996), making this technique challenging to be 
used for examining soluble or membrane proteins from an individual rodent brain or specific brain 
region from a single brain. There is an increasing demand to quantitatively compare the proteome 
from one brain region to another, and from a control animal to a transgenic animal or an animal 
that have undergone specific treatment. Hence we have revised and optimized the traditional brain 
fractionation method to isolate crude soluble and membrane fractions from two hippocampi of a 
single rat. Using this method described here, we have quantitatively shown that acute ECS 
significantly increases STEP61 expression and decreases tyrosine-phosphorylation of its substrates 
GluN2B and extracellular signal regulated kinase 1/2 in the crude membrane P2 fraction of rat 
hippocampi at 2 days following a single ECS (Jang, Royston et al., 2016).  
Although the crude membrane P2 fraction contains synaptosomes, one limitation of 
examining activity-dependent alterations of synaptic proteins in the P2 fraction is that the exact 
location of their changes cannot be determined. If synaptic proteins enriched in the PSD were to 
be determined, then further biochemical fractionation can be used to isolate the PSD. Previous 
method of the PSD fractionation requires large amount of rodent brain tissues (such as 10-20 
rodent brains) and sucrose gradients (Blackstone, Moss et al., 1992; Lau, Mammen et al., 1996). 
Because this traditional method is inadequate to isolate sufficient amount of the PSD fraction from 
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two hippocampi of a single rat, we have adapted a simpler method that directly isolates the PSD 
fraction without sucrose gradient (Tan, Queenan et al., 2015, Diering, Gustina et al., 2014). This 
method yields about 30 - 50 µg of the PSD proteins sufficient for several biochemical assays 
including western blotting. Our method enriches PSD95, GluN2B, and GluA2 known to be 
concentrated in the PSD fraction and detects their PSD expression changes following ECS 
induction (Figure 30-31). Our protocol for isolating the PSD fraction from 2 hippocampi can be 
easily modified for other rodent hippocampi or other brain regions by adjusting the volume of each 
solution based on the tissue weight. Thus, our small-scale PSD fractionation method is versatile 
and can be adopted for future applications to examine in vivo the changes in postsynaptic proteins 











































Figure 28. Schema for the induction of acute ECS and chronic ECS. (A) A rat was connected 
to a pulse generator via ear-clip electrodes and an electrical shock (55 mA, 100 pulse / sec, and 0.5 
sec) was applied to elicit stage 4-5 tonic clonic seizures. (B) Acute ECS was induced by a single 
electric shock. Chronic ECS was elicited by a single electric shock per day for 7 consecutive days. 
Time points shown represent the duration following the induction of a single ECS or the last ECS 
for chronic ECS induction prior to dissection of the hippocampi. Sham “no seizure” (NS) control 





















Figure 29. Workflow of subcellular fractionation to isolate the S2, P2, and PSD fractions 











Figure 30. Examination of synaptic proteins in hippocampal S2, P2, and PSD fractions from 
the rats that received NS or acute ECS. Representative western blots show the protein 
expression of NMDA receptor subunit GluN2B, AMPA receptor GluA2, and STEP61 in the S2, 
P2, and PSD fractions from the hippocampi of sham “no seizure” (NS) rats and rats that received 
acute ECS. The cytoplasmic soluble protein α-tubulin is enriched in the S2 fraction. Synaptophysin 
is a presynaptic vesicle protein and is enriched in crude membrane P2 fraction but not in the PSD 













Figure 31. Examination of synaptic proteins in hippocampal S2, P2, and PSD fractions from 
the rats that received NS or chronic ECS. Representative western blots of α-tubulin, 
synaptophysin, STEP61, and postsynaptic proteins including PSD95 GluN2B, and GluA2 in the 
S2, P2, and PSD fractions from the hippocampi of sham “no seizure” (NS) rats and rats that 
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Alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor (AMPAR) is one of the 
important ionotropic glutamte receptor receptors, which is involved in Hebbian plasticity such as 
long-term potentiation (LTP). How AMPARs move in and out of the post-synaptic site is crucial 
for understanding the mechanisms by which the synapses store the information. In this study, we 
chemically induced LTP in primary hippocampal cultured neurons via glycine incubation and then 
confirmed that glycine incubation increases the level of phospho-CaMKII and the amplitude of 
mEPSCs at 5 min following an induction of LTP.  
 
INTRODUCTION 
AMPARs are one of the most important ionotropic glutamate receptors in the central nerve 
system (CNS) (Sobolevsky, Rosconi et al., 2009), mediating the fast synaptic transmission at 
excitatory synapses (Earnshaw & Bressloff, 2006; Makino & Malinow, 2009). AMPARs are 
predominately located at the post synapses and are co-localized with post synaptic density (PSD) 
(Lee, Jin et al., 2017; Earnshaw & Bressloff, 2006). Researchers have confirmed that AMPARs 
are dynamically mobilized at the synapse, which is believed to contribute to long-lasting increases 
in synaptic strength (Makino & Malinow, 2009; Malinow et al., 2003). However, the detailed 
mechanisms that underlie the insertion and internalization of AMPAR during LTP still remains 
unclear due to the lack of good probes and methodologies. LTP requires the influx of Ca2+ through 
postsynaptic NMDAR, which activates Ca2+/calmodulin-dependent protein kinase II (CaMKII) 
and an increase in AMPAR insertion at the post-synaptic membrane.  
Glycine stimulation (100 - 200 μM glycine, 5 - 10 min) in Mg2+ free medium with high Ca2+ 
facilitates synaptic activation of NMDARs, inducing LTP of post-synaptic strength in 
hippocampal neuronal cultures (Shahi & Baudry, 1993; Lu, Man et al., 2001). Glycine-induced 
synaptic potentiation (GISP) is associated with an increase in mEPSC amplitude, CaMKII auto-
phosphorylation at Thr286, NMDAR-dependent synaptic formation. NMDAR-dependent LTP at 
hippocampal synapses is linked with a persistent activation of CaMKII. This activation is 
accompanied by autophosphorylation of Thr286 on α and β subunits of CaMKII (Fukunaga, 
Stoppini et al., 1993; Lisman, Schulman et al., 2002), directly phosphorylating GluA1 at Ser831 
and leading to an increase in the mean amplitude of AMPAR-mediated mEPSCs (Kristensen, 
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Jenkins et al., 2011). CaMKII-dependent phosphorylation of GluA1 AMPAR subunit at Ser831 
can also be recorded during glycine-induced LTP (Appleby, Correa et al., 2011). This is consistent 
with an elevated frequency and amplitude of mEPSCs. Chemical LTP (Chem LTP) is useful to 
identify and characterize molecular and cellular events that contribute to LTP. In this study, we 
induced chemical LTP with glycine and confirmed that incubation of glycine, a NMDAR co-
agonist, increases the level of phosphorylated CaMKII at Thr286 and the amplitude of mEPSCs.  
 
MATERIALS AND METHODS 
 
Hippocampal neuron cell culture 
Primary hippocampal cultures were prepared from E18 rats according to UIUC guidelines as 
previously described (Cai et al., 2014; Lee et al., 2017). For fluorescence measurements, 
dissociated hippocampal neurons were plated (0.2 M cells per a coverslip) and cultured on the 
fiduciary marked coverslips as we previously described (Lee et al., 2017). On DIV (days in Vitro) 
12-13, neurons were transfected with Homer1c-mGeos (1 g/coverslip, a post synaptic density 
protein used here to represent the location of the synapse), GluA1A-AP or GluA2-AP (1 
g/coverslip) and BirA-ER (1 g/coverslip) using Lipofectamine 2000 transfection reagent. For 
electrophysiology recording, dissociated neurons were plated at high density (330 cells/mm2), At 
~13 DIV, the experiments were performed. 
 
Electrophysiology and Data acquisition 
Whole-cell patch-clamp recordings of mEPSCs were performed at 23 -25 °C from pyramidal 
neurons held at -60 mV using a Multiclamp 700B amplifier, Digidata1440A, and the pClamp 10.2 
(Molecular Devices). Cells were visualized with an upright microscope with infrared differential 
interference contrast (IR-DIC) optics. Recording pipettes were pulled from glass capillaries 
(World Precision Instruments), they had a resistance of 4-6 MΩ when filled with internal solution 
containing (in mM): 130 K-gluconate, 10 KCl, 10 HEPES/K-HEPES, 2MgSO4, 0.5 EGTA, and 2 
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ATP (pH 7.3, 285-295 mOsm). The recording chamber was perfused with ACSF (Artificial 
cerebrospinal fluid) at 1 – 1.5 ml per min. For chemical LTP experiments, neurons were pre-
incubated for 5 min in ECS. GISP was induced by treating the GISP buffer to primary cultured 
neurons for 3 min. After glycine treatment, cultures were returned to the control solution. The 
mEPSCs were acquired 3 min after making the whole-cell configuration, filtered at 1 kHZ, and 
sampled at 10 kHz on gap free model (5 min). All events of mEPSCs were detected with a 10 pA 
thresholds and analyzed Mini Analysis (Synaptosoft). Data are presented as means ± SEM, 
statistical analyses were performed with Origin 9.1 (Origin Lab). The one-way ANOVA with 
Tukey’s and Fisher’s multiple comparison tests were performed to identify the statistically 




Lysate samples from primary hippocampal neurons in groups of CTL, Chem LTP, and 
Chem LTD were prepared in RIPA buffer supplemented with protease inhibitor and Tyr 
phosphatase inhibitors (1 mM NaVO3, 10 mM Na4O7P2, and 50 mM NaF) as described. Neuronal 
lysates were run on SDS-polyacrylamide gel electrophoresis (SDS-PAGE) gels and transferred to 
polyvinyl difluoride (PVDF) membrane. The blots were blocked in 5% milk and 0.1% Tween-20 
in Tris buffered saline (TBS) for 1 h and then incubated in primary antibodies against 
STEP61 (Santa Cruz) 
 
RESULTS 
It has been established that application of glycine, a NMDAR co-agonist, leads to LTP of 
both mEPSCs in primary dissociated hippocampal cultured neurons and field excitatory 
postsynaptic potential (fEPSP) in organotypic hippocampal slices (Shahi & Baudry, 1993; Lu, 
Man et al., 2001). In this study, to test whether glycine treatment induces the potentiation of 
AMPAR-mediated mEPSCs under my experimental condition, I made the whole-cell patch clamp 
with pyramidal neurons under primary cultured condition and measured mEPSCs with the holding 
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potential of – 60 mV. After 5 min of stable baseline mEPSCs recording (in ECS), 200 µM glycine 
(in GISP buffer) significantly increases the amplitude of mEPSCs (Figure 32, baseline = 16.76 pA 
± 0.71; 0 min = 16.79 pA ± 1.14; 5 min = 19.99 pA ± 1.47; 20 min = 23.23 pA ± 2.69; * p < 0.05, 
compared with baseline, ANOVA test). Meanwhile, the control neuron without glycine does not 
induce a significant change in the amplitude of mEPSCs (Figure 32, baseline = 16.84 ± 0.54; 0 
min = 17.31 pA ± 0.61; 5 min = 16.57 pA ± 0.29; 20 min = 17.14 pA ± 1.43; * p < 0.05, compared 
with baseline, ANOVA test). In addition, we measured the level of phosphorylated CaMKII 
(pCaMKII) during chem LTP. Glycine treatment increases pCaMKII at 0 and 5 min following 
GISP for 10 min (Figure 33, 0 min = 188.09% ± 33.16; 5 min = 228.00% ± 40.02; 20 min = 182.45% 
± 35.65; * p < 0.05, compared with baseline, ANOVA test), indicating that glycine treatment 
reliably induces LTP under my experiment condition. 
 
DISCUSSION 
In this paper, I verified whether glycine stimulation (100 - 200 μM glycine, 5 - 10 min) in 
Mg2+ free medium with high Ca2+ induces LTP of synaptic strength in primary cultured neurons 
(Shahi & Baudry, 1993; Lu, Man et al., 2001). Chem-LTP in neuronal cultures share many key 
properties with NMDAR-dependent LTP of CA1 neurons in hippocampal slices, both of which 
require NMDAR activation and a rise in intracellular Ca2+ concentration at the post-synaptic site. 
NMDAR-dependent LTP at hippocampal synapses is linked with a persistent activation of 
CaMKII, accompanied by autophosphorylation of Thr286 and Thr287 on α and β subunits of CaMKII. 
Consistently, I also found that glycine incubation for 10 min increases the level of pCaMKII at 0 
and 5 min (Figure 33). It was reported that active CaMKII directly phosphorylates Ser831 of GluA1 
subunit in AMPAR (Benke et al., 1998), potentiating synaptic transmission. Although the level of 
pGluA1 at Ser831 was not evaluated in this experiment, I confirmed that the amplitude of mEPSCs 
is potentiated at 5 and 20 min following GISP treatment (Figure 32), suggesting that glycine-
induced LTP (Gly-LTP) is successfully reproduced under my experimental condition. Of 
particular, glycine-induced LTP (Gly-LTP) has been widely and readily used for the investigation 
of changes in endogenous native proteins and signaling pathways during LTP. Cell culture-based 
Gly-LTP model has several advantages: (1) molecular and morphological changes associated with 
the functional plasticity are easy to detect. (2) The cell-surface and intracellular pools of native 
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receptors can be easily evaluated and distinguished using labeling with chemicals and fluorescent 
immunocytochemical techniques. Despite some limitations, including variations in basal network 
activity and a loss of complex cellular interactions (e.g. with glial cells), Gly-LTP model is very 
useful for the initial identification and characterization of molecular and cellular events that 

































Figure 32. Glycine incubation (200 μM, 3 min) potentiates the amplitude of mEPSCs in 
primary hippocampal neurons. (A) Schematic of chemical LTP protocol for this recording. 
Whole-cell patch clamp is made with cultured hippocampal neurons (DIV 15) and mEPSCs are 
recorded for 5 min as baseline. GISP buffer with glycine (200 μM) is treated for 3 min to trigger 
GISP (ECS only for 3 min under control condition). After glycine treatment, neurons are returned 
to the ECS for 0, 5, 20 min. (B) (C) Representative traces, plots, and graphs show quantification 
of the amplitude in mEPSCs at baseline, 0, 5, and 20 min after the treatment of (B) control and (C) 







Figure 33. Chem LTP induction increases the level of phospho-CaMKII (pCaMKII) in 
primary hippocampal neuron culture. (A) Schematic of Chem LTP protocol. Dissociated 
hippocampal neuronal cultures (DIV 13-15) were treated with glycine (100 μM) and without TTX, 
Mg2+, and D-APV for 10 min for triggering glycine-induced synaptic potentiation (GISP). After 
glycine treatment, cultures were returned to the control solution for 0, 5, and 20 min. (B) 
Representative blots and graphs show quantification of the ratio of pCaMKII, CaMKII, and 
pCaMKII/CaM normalized to CTL. Statistical significance was determined using ANOVA. n = 7 
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